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SUMMARY 
A Morphological Study of Human Endornetrial Stroms In Vivo and In Vitro 
by Iiüseyin Eray Bulut 
Despite its crucial role in fertility, relatively little has been published on the human 
endometrial stroma. The first experiment reported in this thesis was designed to provide 
quantitative baseline data on the human stroma during the mid to late luteal phase, when it plays 
a major part in normal pregnancy. Subsequent chapters investigate the effects of an anti- 
oestrogen (clomiphene citrate-CC); growth hormone (GH) supplementation of patients on 
hormone replacement therapy (HRT) due to lack of endogenous ovarian steroids; and patients 
with unexplained recurrent miscarriage. Finally a novel 3-dimensional in vitro model of human 
stroma is described along with the effects of steroid supplementation on stromal cells grown in 
the model. 
In all cases of in vivo studies, conventional stereological methods were used to obtain 
quantitative morphological data from at least 6 subjects per group, from both control (fertile) 
and experimental (infertile) subjects using light and electron microscopy. In addition, several 
staining techniques were also used to demonstrate qualitative changes that occur in human 
endometrial stroma. 
During the mid to late luteal phase, endometrial stroma and blood vessels underwent 
substantial changes, and thus quantitative and qualitative baseline data have been established to 
fill a gap in this important area of reproductive biology. CC caused no substantial changes in 
stromal structure in women of proven fertility and therefore its advantageous effects on 
ovulation are not negated at the level of the endometrium. GH supplementation had no effects 
on infertile human endometrial stroma from subjects on HRT, (in either premature ovarian 
failure or Turner's syndrome groups). However, both infertile groups had endometrial stroma 
which significantly differed from matched fertile endometrium, suggesting an impaired 
endometrial development in infertile subjects which was not reversed by HRT, either with or 
without Gil treatment. Stromal morphology did not differ between the recurrent miscarriage 
groups, however data suggested the existence of several subgroups which made firm 
conclusions difficult. The tissue culture model provided preliminary data suggesting it to be a 
potentially very useful technique for the study of stromal cell biology. 
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CHAPTER 1 
INTRODUCTION 
1.1. GENERAL INTRODUCTION 
The human endometrium consists of 2 compartments; epithelium and stroma, which 
also includes the blood vessels. All of the endometrial compartments undergo dramatic 
sequential changes every 28 days (the menstrual cycle) under the influence of ovarian sex 
steroid hormones. These changes require a precisely timed sequence of hormonal action 
and are designed to co-ordinate endometrial events for implantation of the blastocyst and 
the maintenance of pregnancy. Although there is a large number of reports dealing with 
the glandular epithelial morphology throughout the menstrual cycle, very little is 
published about the morphological changes that occur in human endometrial stromal and 
vascular compartments during the menstrual cycle. It is the aim of the present study to 
evaluate the human endometrial stromal and vascular structures quantitatively and 
qualitatively during the mid to late secretory phase of the menstrual cycle (when stromal 
changes are most prominent) for a better understanding of the endometrium in fertility 
and infertility. In addition to examining stroma and blood vessels, some glandular 
epithelial features will also be examined for a complete evaluation of the endometrial 
structure at this time. 
There are many reproductive tract disturbances causing fertility problems in women, 
such as premature ovarian failure (POF) (Aiman and Smentek 1985; Coulam et a!. 
1986), unexplained infertility (Fisch et a!. 1989; Graham et a!. 1990), polycystic ovary 
syndrome (PCOS) (Kettel et al. 1993), unexplained recurrent miscarriage (Crosignani 
and Rubin 1991) and so on. Many of these conditions occur in association with 
dysfunction of the ovary which may also adversely effect endometrial development and 
thus affect fertility. To overcome these infertility problems, several drug treatments are 
used such as clomiphene citrate (CC) (Glasier 1990; Guzick and Zeleznik 1990) and 
growth hormone (GH) (Katz et a!. 1993) treatments for ovulation induction along with 
hormone replacement therapy (HRT) (Navot et a!. 1986) to control endometrial 
development when the ovary is dysfunctional. However, there is little published 
information on the effects of these treatments on endometrial structure, especially on the 
stromal and the vascular elements. In the present study to examine the effects of these 
ovulation induction and ovulation enhancement protocols on endometrial morphology, a 
large number of stromal and vascular features will be evaluated quantitatively after 
i 
treatment with CC and after treatment with GH with or without HRT compared to 
normal fertile controls. 
Recurrent miscarriage is another fertility problem, but one that occurs after the 
implantation of the fetus. Many factors may be involved in recurrent miscarriage, such 
as abnormal genetic content of the embryo, infection and so on (see later). However, 
when these factors can be excluded it remains likely that the endometrium may play a 
role in recurrent miscarriage. Disturbances in stromal and vascular compartments of the 
human endometrium are likely to be involved in otherwise unexplained repeated 
pregnancy losses. It is intended to evaluate the morphological differences in the stromal 
and blood vessel components of the endometrium between persistently miscarrying 
women and women with a similar previous history of recurrent miscarriage but who had 
then had a successful pregnancy. Comparisons will also be made between fertile women 
and these recurrent miscarriage groups where possible. 
Stromal cells play an important role in preparation of the endometrium for a 
successful implantation and maintenance of pregnancy. However, for ethical and 
technical reasons, it is difficult to conduct in vivo experiments in humans. Using in vitro 
tissue culture techniques would be a more convenient way to determine the cellular 
events that take place in human endometrial stromal cells during pregnancy, but despite 
its potential importance in understanding reproduction, the function and structure of the 
stromal cell in vitro is apparently a poorly studied subject. It is an aim of the present 
study to determine the endometrial stromal cell morphology in a 3-dimensional culture 
system and establish a novel in vitro culture model that could be used subsequently as a 
reliable and accurate model for in vivo conditions. Preliminary evaluations of the effects 
of sex steroid hormones (oestrogen and progesterone) on stromal cell structure in vitro 
at different stages of the menstrual cycle are also presented. Throughout, in vitro 
results will be compared where possible to those in vivo results. 
In order to establish a complete understanding of the subject, related topics such as 
hormonal control of the endometrium, implantation, endometrial morphology throughout 
the menstrual cycle, angiogenesis (blood vessel formation) and decidualization will be 
either reviewed in this section or in later sections where relevant. 
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1.2. AIMS 
To establish baseline data for the quantitative and qualitative morphology of fertile 
human endometrial stromal and vascular compartments during mid to late luteal 
phase of the menstrual cycle. 
To examine quantitatively and qualitatively the effects of ovulation induction with 
CC on the stromal and vascular structures of normally ovulating fertile women. 
To evaluate the effects of GH treatment either with or without HRT on the 
morphology of stroma and blood vessels in 2 groups of patients with non-functioning 
ovaries; those with premature ovarian failure and those with Turner's syndrome. 
To compare the morphological differences of stromal and vascular structures 
between patients with unexplained persistent recurrent miscarriage and patients with 
the history of unexplained recurrent miscarriages but at least one successful 
pregnancy. 
To establish a novel 3-D culture model for human endometrial stromal cells in vitro 
which could be used as a model for in vivo conditions, and also to determine the 
effects of steroid hormones on the structure of stromal cells using this culture system 
compared with stromal cell changes seen in vivo. 
1.3. ENDOMETRIAL STROMAL CELL DIFFERENTIATION 
(DECIDUALIZATION) 
One of the many dramatic events occurring in the human endometrium is 
decidualization of the stroma. During this process fibroblast-like mesenchymal cells 
undergo dramatic morphological changes and extensive biochemical differentiation is 
reflected by the expression of a multiplicity of new products (Tabanelli et at 1992; 
Huang et al. 1987; Clemmons et al. 1990; Tlrailkill et al. 1990; Sakbun et a!. 1990; 
Petraglia et a!. 1990; Hoffman et at 1991) which are assumed to play a still 
undetermined role in embryo implantation and maintenance of pregnancy. In humans, 
this process takes place during the normal luteal phase under the influence of 
progesterone, probably in concert with relaxin which is also secreted by the corpus 
luteum (Bryant-Greenwood 1991). It has been suggested that growth factors (such as 
epidermal growth factor, basic fibroblast growth factor and platelet-derived growth 
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factor) might be required for growth and differentiation of human endometrial stromal 
cells as well as progesterone and relaxin (Irwin et al. 1991). 
Decidualization occurs even in the absence of an implanting blastocyst in human 
(Nilsson et al. 1978). Decidualization is evident in non-pregnant women treated with 
progestins and its hormonal dependence can be further inferred from the extensive 
decidual changes observed in the endometrium during ectopic pregnancies in the absence 
of intrauterine fetal tissue (Meuris et al. 1980; Albert and Teiltman 1986). The stromal 
cells display a similar type of modification during the menstrual cycle at around day 
LH+7, which is called predecidualization or more accurately pseudo-decidualization 
(Flamigni et al. 1991). Decidual cells are believed to play a role in implantation and in 
the maintenance of pregnancy through control of trophoblast invasion (Pijnenborg et al. 
1980), nutrition of the blastocyst (Kearns and Lala 1983), endocrine secretion (Maslar et 
al. 1980), and protection of the embryo from maternal immune rejection (Golander et al. 
1981). 
Biochemically, stromal cells at this stage of differentiation produce prolactin (PRL) 
and laminin, secrete prostaglandins and express oestrogen and progesterone receptors 
(ER and PR) which provide the mechanism for these stromal cell functions (Leavitt and 
Takeda 1986). ER and PR formation in decidual cells are also under hormonal control 
and there is a significant loss of ER during the first four days of decidualization (Leavitt 
and Takeda 1986). It has been suggested that prostaglandin E2 (PGE2) enhances human 
endometrial cell differentiation and PRL production in the presence of oestradiol and 
medroxyprogesterone acetate (MPA). This indicates that there are synergistic effects 
among PGE2, oestradiol and MPA, resulting in acceleration of endometrial stromal cell 
differentiation and enhanced PRL production (Frank et al. 1994). On the other hand, 
interleukin-1 (IL-1), a critical cytokine for the initiation of the immune response to 
infection or antigenic challenge, blocks in vitro decidualization (Kariya et a1.1991). In 
addition, human chorionic gonadotrophin (hCG) and luteinizing hormone (LH) receptors 
have been demonstrated in the non-pregnant human uterus, human placenta, fetal 
membranes and decidua indicating that 11CG and LH may play a direct role in regulating 
functions of these tissues by endocrine, autocrine or paracrine mechanisms (Reshef et al. 
1990). 
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Progress in understanding the basic mechanisms that regulate uterine function has 
been limited by the complexity of the hormonal and cellular interactions that regulate this 
tissue in vivo. To overcome some of these limitations, an alternative approach is to use 
in vitro model systems. Cultured human endometrial stromal cells respond to ovarian 
steroids with increased proliferation and the production of markers characteristic of 
decidualization such as extracellular matrix (ECM) proteins and PRL (Irwin et al. 1989, 
1991; Faber et al. 1986; Maslar and Riddick 1979; Benedetto et al. 1990). In addition, 
an increase in intermediate filaments has been reported in rat uterine stromal cells 
undergoing decidualization; vimentin and desmin have been identified as intermediate 
filament proteins in rat endometrium and these proteins have been quantified during the 
process of decidualization (Glasser and Julian 1986). Another marker for the decidual 
reaction is alkaline phosphatase activity. It has been demonstrated that there is no 
alkaline phosphatase activity before day 23 of the menstrual cycle but between days 23 
and 27 alkaline phosphatase activity is present in the stromal cells surrounding spiral 
arterioles (Wilson 1969). 
Short term cultures of human decidua from early pregnancy revealed active synthesis 
of all major basement membrane (BM) components such as collagen type IV, laminin, 
heparan sulphate proteoglycan, entactin and fibronectin (Wewer et al. 1985; Kisalus et 
al. 1987; Welsh and Enders 1985). In contrast, in the non-pregnant uterine 
endometrium, there is no immunohistochemically demonstrable collagen type IV or 
laminin, except in the perivascular spaces and at the interface between stroma and the 
glandular epithelium (Damjanov and Wewer 1991). The formation of pericellular 
membranes around decidual cells appears to be coincidental with changes in stromal cell 
morphology. 
When compared to other adult tissues, endometrial stromal cells have a much higher 
proliferative capacity and doubling potential in vitro and distinct changes in morphology 
are observed when primary stromal cell cultures are exposed to progesterone, indicating 
that progestins may affect cytoskeletal proteins (Hofinka and Guteide 1987). 
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1.3.1. DECIDUAL CELL MORPHOLOGY 
As the pregnancy advances, the stromal cells gradually enlarge and shortly after 
implantation three groups of decidual cells can be distinguished: large mature polygonal 
cells measuring more than 251tm in diameter, medium sized polygonal or round decidual 
cells measuring 15-251tm in diameter preferentially located close by the dilated 
endometrial glands, and small elongated cells measuring less than 15µm in diameter 
resembling the fibroblasts or stromal cells from non-pregnant endometrium (Damjanov 
and Wewer 1991). It has been hypothesised that the medium-sized and large decidual 
cells evolve from the small elongated cells (Welsh and Enders 1985). Aller the sixth 
week to the end of the pregnancy, the decidua consists of mostly large mature cells, the 
ratio for the large, intermediate and small cells is 10: 3: 0.1 (Damjanov and Wewer 1991). 
Where decidual cells are largest and most differentiated, the amount of matrix is less, 
the surface processes in decidual cells are flattened and the cells contain few of the 
membrane-bound inclusions, however specialised gap junctions are present between 
decidual cells (Lawn et al. 1971). Specialized gap junctions are also found between 
prcdecidual cells around small arterioles in non-pregnant endometrium at the late luteal 
phase of the menstrual cycle (Lawn et al. 1971). There are several hypothesis 
concerning the function of the junctional regions between decidual cells. Either it works 
as a mechanical barrier, protecting the blastocyst and preparing for deeper invasion of the 
uterus or the junctions contain regions of high permeability where ions and large 
molecules are transferred from one cell to another (Finn and Lawn 1967). Yet another 
alternative is that signals initiating the differentiation of fibroblasts into decidual cells 
might be transmitted through this specialised junctions (Lawn et al. 1971). It is of 
course possible that all these hypothesised functions might work together in a synchrony. 
Between the 20th and 40th days of pregnancy, human decidual cells in the 
endometrial stroma come into direct contact with the trophoblastic cells eroding the 
stromal tissue (Tekelioglu-Uysal et al. 1975). The aggregates of decidual and 
trophoblastic cells (deciduo-trophoblastic complex) in the human during early pregnancy 
may function as a local humoral regulator releasing chemical factors and taking part in 
the establishment of immunological privilege at the site of implantation (Tekelioglu- 
Uysal et a!. 1975). During this process, glycoprotein biosynthesis and glycosyl 
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transferase activity are altered and these changes in patterns of glycosylation may give 
rise to altered decidual cell-matrix and cell-cell interactions during differentiation and 
play a role in the modulation of decidual cell interactions with trophoblast during early 
placentation (Jones et al. 1993). It has been suggested that the development of this type 
of connection between decidual cells is associated with a change from independent 
stromal cells into a co-ordinated assembly of interconnected cells forming a decidual 
organ (Finn and Lawn 1967). 
The Golgi apparatus of the endometrial stromal cells of pregnant mice increases in 
size with the differentiation of stromal cells into decidual cells and the activity of acid 
phosphatase in this organelle increases at this time (Bijovsky and Abrahamson 1992). 
However, the most internal decidual cells (antimesometrial decidual cells), which are 
closest to the embryo, degenerate and morphological aspects of this decidual regression 
and involution have been described in rats (Welsh and Enders 1985) and in mice (Katz 
and Abrahamson 1987; Bijovsky and Abrahamson 1992). Active growth and 
differentiation of endometrial stromal cells during the decidualization of early pregnancy 
are followed by programmed cell death (apoptosis) in the antimesometrial region of the 
decidua. The location and temporal specificity of decidual cell apoptosis and the 
identification of transforming growth factor-ß 1 (TGF f 1) and TGF032 protein and mRNA 
in the decidua suggests that members of the TGF(3 family control stromal apoptosis by 
autocrine or paracrine mechanisms (Moulton 1994). The involuting decidual cells show 
morphological and cytochemical signs of Golgi regression, such as dilated cisternae and 
lack of enzymatic activity, together with the numerous pleomorphic lysosomes 
suggesting that decidual cell death occurs by autophagic degeneration in mouse and rat 
decidua (Bijovsky and Abrahamson 1992; Jollie and Bencosme 1965). However, 
homologies between human decidual cells and primary decidual cells of the rodents are 
uncertain. In ovariectomized, oestrogen and progesterone treated rhesus monkeys, the 
decidual cells have rounded nuclei and elaborate arrangements of interconnected 
cisternae of rough endoplasmic reticulum (RER) (Sengupta et al. 1990). Granular cells 
are also present in rhesus monkey endometrium with eccentrically located nuclei and 
numerous membrane-bound, electron-dense granules in their cytoplasm and they are 
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found in increasing numbers around decidual cells, blood vessels and glandular epithelia 
suggesting that these cells have secretory functions (Sengupta et a1.1990). 
1.3.2. DECIDUAL CELL TYPES 
Decidual tissue contains number of cell types. It has been clearly demonstrated that 
the human decidua contains stromal cells of endometrial origin, together with large 
granular lymphocytes (LGLs), macrophages , T-lymphocytes, fibroblasts and 
polymorphonuclear leukocytes (Bulmer et a!. 1988b; Starkey et a!. 1988; Casey and 
MacDonald 1988; Haller et al. 1993). The lymphoid tissue in human decidua from early 
normal pregnancy has a unique cellular composition and functional properties different 
from other mucosal tissues. The role of the individual cell components is not yet known, 
but there are indications that their role is to adapt the immune system of the mother to 
the presence of the fetus, thus preventing an immunological rejection. 
Khan et al. (1991) has observed two populations of cells from term human decidua by 
immunocytochemistry. The first group of cells were a mixed cell population, 
predominantly macrophages (80%) but small numbers of T- and B-lymphocytes were 
also present. The second group were a less-dense cell population which did not contain 
significant numbers of the above cell types but did release PRL, suggesting that they are 
decidual stromal cells (Khan et al. 1991). The proportions of these different cell types 
vary throughout pregnancy. In the first trimester the LGLs are the dominant cell type, 
although by the third trimester a majority of the cells are stromal in origin, the percentage 
of LGLs is decreased and significant numbers of polymorphonuclear leukocytes are now 
present (Bulmer et al. 1988b; Finn and Pope 1991). Leukocytes classified as CD56+, 
CD3-, CD 16- have been detected predominantly in first trimester decidua. While they 
are intensely positive for CD56, they do not express other natural killer (NK) lineage 
markers such as CD 16, CD57 and CDIlb (Bulmer et al. 1991). These phenotypically 
unusual cells were described in early pregnancy decidua (Ritson and Bulmer 1987) and a 
comparable population was also described in non-pregnant endometrial stroma in the late 
secretory phase of the menstrual cycle (Marshall and Jones 1988; Bulmer et al. 1988a). 
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1.3.3. HORMONES SECRETED BY DECIDUAL CELLS 
Postovulatory endometrial cells produce PRL (Maslar and Riddick 1979; Healy 1991) 
which has been found to be one of the major secretory proteins of endometrial stromal 
cells (Zhu et al. 1990). PRL secretion by the human endometrium extends from the 
luteal phase of the menstrual cycle over the entire gestation period. The production of 
PRL positively correlates with the degree of decidualization (Irwin et al. 1989). Much 
of the PRL produced by secretory endometrium is glycosylated (G-PRL) and as 
pregnancy advances, the decidua secretes less G-PRL and more non-glycosylated PRL 
(Markoff et al. 1988). PRL synthesis in the endometrium is regulated directly by 
progesterone and indirectly by oestrogen (Casslen et al. 1990). Relaxin, insulin-like 
growth factor-1 (IGF- 1) and some progestogens enhance endometrial PRL secretion and 
the progesterone antagonist RU 486 inhibits it (Huang et al. 1987; Thrailkill et al. 1988; 
Bell et al. 1991). The highest production rate of PRL has been shown in stromal cells 
treated first with medroxyprogesterone then with relaxin (Zhu et al. 1990). On the 
other hand, it has been recently demonstrated that the tumour necrosis factor-a (TNF-a) 
and endothelin (ET), which are synthesized and released from macrophages and decidual 
cells, inhibit the synthesis and release of human decidual PRL (Chao et al. 1993; Jikiliara 
and Handwerger 1994), indicating that the inhibitory action of TNF-a and ET on basal 
and stimulated PRL release may result from an autocrine and/or paracrine effect. 
Recent evidence indicates that, in addition to the corpus luteum, relaxin is also 
produced in decidualized endometrium and the trophoblast (Seppala et al. 1992). In the 
human genome, there are two relaxin genes (H1 and 112) encoding different amino acid 
sequences. Human corpus luteum transcribes the H2 relaxin gene, whereas the H1 gene 
is expressed in the decidua (Hansell et al. 1991; Bryant-Greenwood 1991). Relaxin 
stimulates endometrial and decidual secretion of PRL (Huang et a!. 1987), prorenin 
(Poisner et a!. 1990), insulin-like growth factor binding protein-1 (IGFBP- 1) (Thrailkill 
et a!. 1990) and pregnancy-associated plasma protein-A (PAPP-A) (Bischoff and Tseng 
1986). In the monkey and the human, relaxin promotes endometrial growth and induces 
dilatation of superficial vessels (Dallenbach-Helweg et a!. 1967). In addition, relaxin 
inhibits uterine contractions and oxytocin release (Jones and Summerlee 1986; Downing 
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and Hollingsworth 1993) suggesting that relaxin and oxytocin work in an antagonistic 
manner. 
Human decidua also synthesises and secretes placental protein 14 (PP14). The PP14 
content in decidua is higher than in chorion, amnion and placenta (Julkunen 1986). 
During pregnancy, serum PP14 concentrations are highest between 6 and 12 weeks, after 
16 weeks the levels decrease then plateau at the end of the second trimester and remain 
low during the third trimester (Julkunen 1986). 
Human decidua also actively produces inhibin subunits suggesting that the decidua 
may be a further source of inhibin"related proteins during pregnancy (Petraglia et al. 
1990). In addition, human decidua produces significant amounts of somatostatin 
(Kumasaka et al. 1979) and corticotrophin releasing hormone (CRH) (Jones et al. 1989). 
It may be suggested that the decidual tissue, as well as being a hormonal target, produces 
polypeptide hormones as well as prostaglandins, indicating an important endocrine 
capacity. 
1.3.4. EXTRACELLULAR MATRIX (ECM) PROTEINS SECRETED FROM 
DECIDUAL CELLS 
It has been shown that the first trimester human decidua synthesises and releases 
ECM proteins and several collagen types. An extensive network of collagen types I and 
III are present in the first trimester human decidua and intracytoplasmic staining by 
immunocytochemistry has demonstrated the presence of these collagens in decidual cells 
(Kisalus et al. 1987). Collagen type IV and laminin localise in the external lamina which 
surrounds the differentiated decidual cells. Immunoreactive collagen type V is observed 
in close association with the external lamina and in the peridecidual matrix. Fibronectin 
localises throughout the decidual ECM in fibrillar and punctuate patterns in the decidual 
cell cytoplasm (Kisalus et al. 1987). However, it has been shown that a significant loss 
of collagen type VI occurs in the rat endometrium during decidualization (Mullholland et 
at 1992). Differentiated decidual cells also have a mesenchymal intermediate filament 
cytoskeleton and a very few keratin filaments (Kisalus et at. 1987). Glasser and Julian 
(1986) have demonstrated intermediate filaments desmin and vimentin in the rat 
endometrium. 
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1.4. BLOOD VESSEL FORMATION (ANGIOGENESIS) 
The term angiogenesis refers to formation of new blood vessels, or 
ncovascularization, and is an essential component of tissue growth and development 
(Iludlicka 1984). The angiogenic process begins with capillary proliferation, and results 
in formation of a new microcirculatory bed composed of arterioles, capillaries and 
vcnules (Folkman and Klagsbrun 1987). The initial component of angiogenesis (capillary 
formation) has been shown to consist of 3 processes: 1) fragmentation of the basal 
lamina of the existing vessel, 2) migration of endothelial cells from the existing vessel 
toward the angiogenic stimulus, and 3) proliferation of endothelial cells (Shepro and 
D'Amore 1984; Folkman and Klagsbrun 1987). Neovascularization is completed by 
formation of a capillary lumen and differentiation of some of the newly formed capillaries 
into arterioles and venules (Hudlicka 1984). 
In most adult tissues, capillary growth occurs rarely, and vascular endothelium 
represents an extremely stable population of cells with a low mitotic rate (Hudlicka 
1984). The female reproductive organs (ovary, uterus, placenta) contain some of the 
few tissues in the adult that exhibit periodic growth and regression. In addition, growth 
and regression of these tissues are extremely rapid. Therefore, female reproductive 
tissues are some of the few tissues in which regular angiogenesis occurs as a normal 
process (lludlicka 1984; Klagsbrun and D'Amore 1991). Rapid growth and regression 
of female reproductive tissues are accompanied by equally rapid changes in rates of 
blood flow (Rosenfeld et al. 1974; Ferrell 1989). In addition, vascular endothelial cells 
of these tissues exhibit mitotic rates equal to or greater than those observed for tumour 
endothelial cells (Gaede et a!. 1985). Since the tissues of the female reproductive system 
are so dynamic, they provide a unique model for studying regulation of angiogenesis 
during the process of growth, differentiation, and regression in normal adult tissues. 
1.4.1. OVARIAN VASCULAR GROWTII 
After ovulation, the remaining cells of the ruptured follicle form a transient endocrine 
gland known as the corpus luteum (Niswender and Nett 1988; Adashi 1994). Following 
rupture of the follicle, capillaries and fibroblasts from the surrounding stroma proliferate 
and penetrate the basal lamina. This rapid vascularization of the corpus luteum may be 
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guided by angiogenic factors which have been detected in the follicular fluid (Frederick 
et at. 1984). Approximately 50% of the cells of a mature corpus luteum are endothelial 
cells, and the majority of parenchymal (steroidogenic) cells are adjacent to one or more 
capillaries (Dharmarjaran et al. 1985; Niswender and Nett 1988). The mature corpus 
lutcum receives most of the ovarian blood supply, and ovarian blood flow is highly 
correlated with progesterone secretion (Reynolds 1986). In addition, inadequate luteal 
function has been associated with decreased luteal vascularization (Jones et a!. 1970), 
and several investigators have suggested that reduced ovarian blood flow may play a role 
in luteal regression (Reynolds 1986; Niswender and Nett 1988). 
1.4.2. UTERINE AND PLACENTAL VASCULAR GROW ill 
In primates, growth of endometrial vasculature begins during the proliferative phase 
and continues throughout the secretory phase of the menstrual cycle (Meschia 1983). 
Associated with endometrial capillary proliferation is increased DNA synthesis of 
vascular endothelial cells (Ferenczy et al. 1979). Endometrial growth and development 
in response to systemic concentrations of ovarian steroids was demonstrated in the 
classic experiments of Markee (1932,1940). In these studies, endometrial explants of 
rabbits or monkeys were transplanted to the anterior chamber of the eye. Not only did 
these explants quickly recruit a vascular supply, but they also underwent cyclic periods of 
growth and regression, which were associated with changes in systemic concentrations 
of steroids. 
Rate of blood flow to uterine tissues varies regularly throughout the non-pregnant 
cycle, being greatest around ovulation time, when systemic levels of oestrogen are 
greatest, and least during the luteal phase of the cycle when systemic levels of 
progesterone are greatest (Meschia 1983; Reynolds 1986; Reynolds et a1.1992). This 
varying uterine blood flow rate is temporally associated with the ratio of oestrogen to 
progesterone in systemic blood (Meschia 1983; Reynolds 1986). On the other hand, 
progesterone has the effect to modulate responsiveness of the uterine vascular bed to 
vasodilatory agents (Meschia 1983). 
It has been shown that the uterine endothelial cell proliferation is dramatically 
increased after embryo implantation in rats (Goodger and Rogers 1993). In their study, 
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the endothelial cell proliferative index in the rat endometrium rose significantly from 
approximately 1% on the first 2 days of pregnancy to 13% on day 3; and continued to 
rise to 28% on day 5, and it further rose to 71% on day 7 of the pregnancy at embryo 
sites only. These authors suggested two separate mechanisms controlling rat uterine 
endothelial cell proliferation during early pregnancy. The first mechanism is maternally 
controlled and is apparent throughout the entire endometrium from day 3; and the 
second mechanism is apparent in the entire embryo (Goodger and Rogers 1993). 
In mammals, the placenta consists of maternal (endometrial) and fetal (chorio- 
allantoic) tissues and is the site of physiological exchange between the maternal and fetal 
vascular systems. Placental vascular growth begins early in pregnancy and continues 
throughout gestation in association with a continual and dramatic increase in rates of 
uterine and umbilical blood flows (Rosenfeld et al. 1974; Ferrell 1989). The importance 
of placental vascular development in supporting fetal growth and development has long 
been recognized (Meschia 1983; Ferrell 1989). Inadequate placental vascular 
development may be a major contributor to embryonic wastage and reduced birth 
weights (Meegdes et al. 1988). Although quantitative data on the effects of ovarian 
steroids on uterine vascularity are lacking, these hormones may have substantial effects 
on the regulation of vascular growth and development of uterine tissues. 
1.4.3. ANGIOGENIC FACTORS 
In vivo and in vitro methods for the isolation and the characterization of angiogenic 
and anti-angiogenic factors have been shown by several investigators (Folkman and 
Klagsbrun 1987; Klagsbrun and D'Amore 1991; Reynolds et al. 1992). The two most 
commonly used in vivo assays for the detection of angiogenic factors are the "corneal 
pocket" assay, which permits linear measurement of capillary growth induced by a 
substance implanted in the cornea of the rabbit, mouse or rat, and the "chorio-allantoic 
membrane" (CAM) assay, which evaluates the ability of a substance to stimulate or 
inhibit neovascularization when placed onto the CAM of the chicken embryo (Folkman 
and Klagsbrun 1987; Klagsbrun and D'Amore 1991; Rizzo et al. 1995). In contrast with 
in vivo techniques, in vitro assays can be used to evaluate the ability of a factor to 
influence one of the angiogenic processes such as: 1) production of proteases by 
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endothelial cells, 2) migration of endothelial cells, and 3) proliferation of endothelial cells 
(Folkman and Klagsbrun 1987; Reynolds et al. 1992). 
Media conditioned by thecal tissues stimulates proliferation of endothelial cells 
regardless of the stage of follicular development, however granulosa cells produce an 
endothelial cell mitogen only when they are obtained from non-atretic follicles just before 
ovulation (Taraska et al. 1989). Based on these observations, it is possible to conclude 
that production of angiogenic factors by granulosa cells may help maintain the 
vasculature, and thereby the health of the preovulatory follicle. However, thecal 
production of angiogenic factors seems to be independent of the stage of preovulatory 
development or follicle status. 
The endothelial mitogen produced by preovulatory bovine follicles appears to be 
lieparin-binding (Reynolds et al. 1992). Heparin-binding growth factors (HBGF) are a 
family of closely related proteins (Folkman and Klagsbrun 1987; Burgess and Maciag 
1989). The prototypes of this family, HBGF-1 (also known as acidic fibroblast growth 
factor) and HBGF-2 (basic fibroblast growth factor), are potent angiogenic factors 
(Folkman and Klagsbrun 1987; Burgess and Maciag 1989). It has been suggested that 
the corpus luteum could be the major source for angiogenic factors, and thus angiogenic 
factors other than HBGFs could be produced by the corpus luteum and may play an 
important role in luteal angiogenesis (Redmer et al. 1988). 
Media conditioned by uterine tissues from non-pregnant cows and ewes stimulate 
migration and proliferation of endothelial cells (Millaway et a!. 1989). Production of 
angiogenic factors by endometrial tissues of ovariectomized ewes can be modulated by in 
vivo treatment with progesterone and oestradiol (Reynolds and Redmer 1988a). 
Oestradiol has been shown to stimulate HBGF-2 production by human endometrial 
adenocarcinoma cells in vitro (Presta 1988). 
Angiogenic activity of placental tissues from human, bovine, and ovine sources has 
been evaluated using in vivo (CAM) and in vitro (endothelial protease production, 
migration and proliferation) assays (Reynolds et al. 1987; Millaway et al. 1989). In 
cows and ewes, these angiogenic factors are primarily produced by maternal placental 
(endometrial) tissues but not by fetal placental tissues (Millaway et al. 1989). It has been 
suggested that maternal placental (endometrial) tissues may regulate placental 
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vascularization (Reynolds et al. 1992). If this hypothesis is correct, maternal placental 
production of angiogenic factors could have a significant of ect on placental size, 
transport and blood flow, and thereby on fetal growth and development. 
Throughout most gestation, fetal placental tissues of ewes and cows produce a factor 
or factors that inhibit endothelial cell migration and proliferation (Reynolds and Redmer 
1988b). The target of these fetal placental anti-angiogenic factors is likely to be the 
maternal placental vasculature, where they may function to limit vascular development 
and thereby prevent uncontrolled growth of capillaries and invasion of fetal tissues. 
Compounds such as transforming growth factor-ß, tumour necrosis factor-a, interferons, 
or certain steroid metabolites that have been termed angiostatic steroids, may be 
physiological inhibitors of angiogenesis in female reproductive tissues (Folkman and 
Klagsbrun 1987; Reynolds and Redmer 1988b). 
Other growth factors found in female reproductive tissues, such as vascular 
endothelial growth factor, insulin-like growth factors, epidermal growth factor and 
transforming growth factors, may also have a role in regulating the angiogenic process 
(Folkman and Klagsbrun 1987; Koos 1989; Klagsbrun and D'Amore 1991; Li et al. 
1994). In the human endometrium, the inununohistochemical localization of vascular 
endothelial growth factor (VEGF), which has a mitogenic activity specific for endothelial 
cells, was demonstrated in different concentrations at different times of the menstrual 
cycle in different cell types (Li et a!. 1994). These authors concluded that VEGF might 
serve as a paracrine mediator of the effects of ovarian steroids on endometrial vascular 
development. In addition to growth factors, other low molecular weight (e. g., 
nucleotides, eicosanoids) or high molecular weight (e. g., extracellular matrix components 
such as glycosaminoglycans or fibronectin) molecules are probably involved in regulating 
the angiogenic process in reproductive as well as other tissues (Eisenstein 1991; Odedra 
and Weiss 1991). 
Although the production of angiogenic factors by female reproductive tissues varies 
with the stage of development, and is responsive to tropic hormones, much remains to be 
discovered about the physiological role of angiogenic factors in reproductive tissue 
vascularization. This is an especially important field in reproductive research because of 
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its implications for the control of fertility and for vascular growth in other normal and 
pathological processes, the regulation of which is poorly understood. 
Previous studies were involved the differentiation of stromal cells into decidual cells, 
types of decidual cells, hormones and ECM proteins secreted from decidual cells, blood 
vessel formation of endometrium and placenta in Man. However, there is little published 
data on the quantitative morphology of normal fertile human endometrial stroma and 
blood vessels during mid to late luteal phase of the menstrual cycle which is likely to be 
crucial for further development of decidual and placental tissues. Therefore the next 
chapter of the present study is designed to establish baseline quantitative data on the 
morphology of the endometrial stroma and blood vessels during mid to late secretory 
phase of the menstrual cycle. 
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CHAPTER 2 
A QUANTITATIVE DESCRIPTION OF NORMAL FERTILE 
HUMAN ENDOMETRIAL STROMA 
2.1. INTRODUCTION 
Although the main aim of this study is to investigate the post-implantation human 
cndometrial stromal and vascular morphology, it is also necessary to consider the 
morphological changes that lead-up to this stage, such as the proliferative and pre- 
implantation periods. It is also important to consider the structural changes that occur in 
the endometrial glandular and luminal epithelial cells, as well as the stromal cells, since 
these different compartments function as a single unit during the menstrual cycle. 
The morphological changes that occur in the human endometrium in response to 
ovarian steroids are well documented (Wynn 1984; Cornillie et a!. 1985; Dockery and 
Rogers 1989; Ferenczy and Bergeron 1991; Li et a!. 1991a), and a number of 
morpliometric measurements on endometrial biopsies has been published by several 
investigators (Johannisson eta!. 1982; Dockery et al. 1988a; Dockery et al. 1990). 
During the proliferative phase of the menstrual cycle the endometrium is mainly under 
the influence of oestrogen. The histologic changes that occur during this phase of the 
cycle are not very specific and thus are not useful for precise dating of the endometrium. 
All of the tissue components, including the glands, stromal cells and endothelial cells 
demonstrate proliferation which peaks around cycle days 8 to 10 (Ferenczy et al. 1979; 
Ferenczy and Guralnick 1983). These alterations are manifest as increased mitotic 
activity, nuclear DNA and cytoplasmic RNA synthesis (Ferenczy 1980; Ferenczy and 
Bergeron 1991). Ultrastructural changes seen during this tissue proliferation include 
increased free and bound ribosomes, mitochondria, Golgi apparatus, and primary 
lysosomes in gland cells (Ferenczy et al. 1979) and stromal fibroblasts (Holinka and 
Gurpide 1987). Biochemically, these organelles provide for protein matrix, energy and 
synthesis of enzymes, all of which are required during cell proliferation. 
2.1.1. PROLIFERATIVE PHASE GLANDULAR EPITHELIUM 
During the proliferative phase of the menstrual cycle, endometrial cells undergo an 
extensive proliferation. Early in the phase the glandular epithelial cells are tall, columnar 
and relatively unspecialized (Comillie et a!. 1985). Increased ciliogenesis and 
microvillogenesis proceed at an increased rate in proliferative phase gland cells (Ferenczy 
and Bergeron 1991). These events are considerably decreased in endometrial cells that 
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are exposed to endogenous progestogens and are increased in the case of 
hyperoestrogenism (Fcrcnczy and Guralnick 1983) indicating that the glandular 
ciliogenesis and microvillogenesis are oestrogen dependent. Intercellular lateral 
membranes are unfolded and desmosomes (Cavazos et al. 1967), tight junctions and gap 
junctions may be detected (Davie et al. 1977). 
The nucleus is large and ovoid having an appearance of a cell with a high level of 
synthetic activity during this time of the cycle (Verma 1983; Comillie et al. 1985). 
Polysomes, annulate lamella and a few isolated cisternae of rough endoplasmic reticulum 
(RER) are seen in the cytoplasm (Cornillie et al. 1985). Mitochondria are of normal 
dimensions and poorly developed Golgi profiles are found in the apical cytoplasm (Wynn 
1984). The Golgi complex in those glandular cells elaborates during the mid to late 
proliferative phase of the cycle along with increased interdigitation of the lateral walls. 
Immediately prior to ovulation small amounts of glycogen accumulation is evident in the 
cytoplasm (Comillie et a!. 1985). 
2.1.2. PROLIFERATIVE PHASE ENDOMETRIAL STROMA 
In contrast to the glands, the stromal compartment of the human endometrium 
appears to have received little attention. However, its contribution to successful 
implantation and to the maintenance of pregnancy may be crucial. During the 
proliferative phase, mitoses of stromal cells reach a maximum (about 10 per 1000 cells) 
around the time of ovulation (Johannisson 1985). The proliferative potential of human 
endometrial stromal cells has been shown in vitro to be greater than that of most other 
adult tissues (Holinka and Gurpide 1987). At this time of the cycle, stromal cells 
resemble those of undifferentiated fibroblasts, and become mature fibroblasts as the 
proliferative phase advances (More et al. 1974a; Dallenbach - Helweg 1981). Around 
the time of ovulation, stromal cells are involved in the formation and remodelling of the 
extracellular matrix (Cornillie et al. 1985). The size of stromal cells increase and the 
nuclei contain elevated amounts of cuchromatin with prominent nucleoli (More et a1. 
1974a). The amount of RER increases and glycogen is evident in the cytoplasm at this 
time (Dockery and Rogers 1989). During the proliferative phase stromal cell 
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mitochondria are small and simple in structure and the smooth endoplasmic reticulum 
and Golgi complexes are poorly developed (Sengel and Stoebner 1970). 
2.1.3. SECRETORY PHASE GLANDULAR EPITIIELIUM 
During the early secretory phase of the menstrual cycle endometrial glandular cells 
undergo extensive changes which are highly correlated to the rising levels of 
progesterone. These cellular features include the nuclear channel system (NCS) 
(Terzakis 1965; Wynn and Wooley 1967; More et al. 1974b; More and McSeveney 
1980; Dockery et al. 1988b), giant mitochondrial profiles (Nilsson 1962; Wynn and 
Wooley 1967; Kohorn et al. 1972; Armstrong et al. 1973; Dockery et al. 1988b) and 
massive deposits of glycogen-rich material in the subnuclear region of the cell (Nilsson 
1962; Wynn and Wooley 1967; Cornillie et al. 1985; Dockery et al. 1988b). 
The ultrastructural changes in the human glandular epithelial cells in the early 
secretory phase are well co-ordinated (Dockery et al. 1988b). At day LH+2 glandular 
epithelial cells have large eucliromatic nuclei and small amounts of glycogen are seen in 
the basal region of the cells. The Golgi apparatus is poorly developed (Dockery and 
Rogers 1989). By day LH+3, increased amounts of glycogen-rich material are evident in 
the subnuclear region (Cornillie et al. 1985). Giant mitochondria are seen, often 
surrounded by areas of endoplasmic reticulum. The occasional nuclear channel systems 
may be seen in glandular secretory cells of the mid luteal phase (Dockery and Rogers 
1989). At day LH+4 gland cells contain abundant NCS, giant mitochondria and 
subnuclear glycogen (Dockery et al. 1988b). Prominent Golgi complexes are seen in the 
supranuclear region of the gland cells. By day LH+5 the glycogen content of the gland 
cells starts to mobilize through the apical region, which also contains dilated Golgi 
complexes. NCSs are still present on day LH+6 and the nucleus become more 
lheterocliromatic, indicating a reduced transcriptional activity in the gland cells (Dockery 
and Rogers 1989). Day LH+6 gland cells also contain extensive Golgi apparatus and 
secretory vesicles which strongly indicates an increased secretory function. Lateral cell 
membranes show extensive membrane folding and interdigitations. By day LH+8, the 
secretory activity decreases in gland cells, the nuclei become more heterochromatic and 
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lateral membrane interdigitations are most prominent (Cornillie et al. 1985; Dockery and 
Rogers 1989). 
2.1.4. LUAIINAL EPITIIELIUM OF TIIE ENDOMETRIUM 
When compared to the glandular epithelium, there are relatively few studies on 
luminal epithelium. Although the latter have had relatively little consideration, it is the 
first maternal cell layer encountered by the implanting blastocyst and its functions are 
likely to be at least as important as the other endometrial compartments. Luminal 
epithelium shows both ciliated and secretory cells which are similar to those seen in 
glands. However, the cyclical changes are less dramatic than that of glandular cells 
(Cornillie et al. 1985). Although NCS and glycogen deposits have been reported, giant 
mitocliondrial profiles are absent in the luminal epithelial cells (Dockery and Rogers 
1989). In the rat, ultrastructural changes in the luminal epithelium coincide with the 
`window' of receptivity (Ljungkvist 1972; Murphy and Rogers 1981; Murphy et a!. 
1982; Murphy and Martin 1985). It is generally agreed that a certain degree of 
synchrony is required between the arrival of the blastocyst at the site of implantation and 
the stage of development of the endometrium in order to achieve successful implantation 
(McLaren 1984; Edwards and Fishel 1986). In rats and mice, there is a narrow window 
during which implantation can be initiated. The ensuing 36-48 hours is a period in which 
embryos could survive in the uterus, but implantation would not be possible. Then there 
is a narrow window of just a few hours during which implantation can occur. After this 
time, the uterine environment becomes hostile, and any unimplanted embryo degenerates 
(Li et a!. 1991a). A similar window is thought to exist in man. However, there is as yet 
no clear evidence for a comparable window of receptivity and no detailed study has yet 
been carried out on well-timed endometrial material in human. 
2.1.5. SECRETORY PHASE ENDOMETRIAL STROMA 
In contrast to the extensive literature on epithelial cells, there is relatively little 
published on stromal cell changes during the menstrual cycle. In the early secretory 
phase, stromal cells become steadily larger, with nuclei containing less hetero chromatin, 
and structures referred to as `nuclear bodies' being seen (More et al. 1974a). The rough 
endoplasmic reticulum increases in size and activity and the cytoplasm contains many 
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vesicles, possibly concerned with transport of material to the extracellular matrix 
(Dockery and Rogers 1989). Glycogen is commonly found in the cytoplasm (Weinke et 
al. 1968; More et al. 1974a). Junctions between stromal cells are described as simple 
membrane thickenings (More et al. 1974a; Wynn 1984). The later luteal phase begins 
with stromal oedema on LH+8 to LH+10 and continues to the predecidual reaction of 
stromal cells. Since these changes occur regardless of whether a blastocyst is present or 
not (Li et al. 1991a) the term `pseudo-decidual" may be more appropriate. Stromal 
oedema is possibly mediated by prostaglandin E2 (PGE2) and prostaglandin Fla (PGF2,, ) 
and coincides also with rising oestrogen and progesterone levels (Ferenczy and Bergeron 
1991). Oestradiol stimulates the production of PGF2a, where as progesterone stimulates 
the synthesis of both PGF2a and oestrogen in in vitro conditions (Neulen et al. 1988). 
PGE2 presumably promotes capillary permeability either directly or by increasing 
histamine release resulting in stromal oedema. 
The stroma of the endometrium, especially during the mid to late secretory phase, is 
composed of highly specialized stromal cells. They are not simply fibroblasts, but 
respond to hormonal stimuli and have receptors for both oestrogen and progesterone 
(Press et al. 1984; Bergeron et al. 1988; Lessey et al. 1988). In addition they synthesize 
Prostaglandins (Smith et al. 1984), and when transformed into decidual cells actively 
secrete prolactin, immunosupressive substances and a variety of serum proteins (Riddick 
et a!. 1983). It has been suggested that the endometrial granulocytes are differentiated 
from stromal cells between days LH+8 and LH+10 (Dallenbach-Helweg 1981). 
However, recent work suggests that "endometrial granulocytes" are of bone marrow 
origin and are granulated lymphocytes (Bulmer et al. 1988a). The predecidual cells are 
larger than the stromal cells of the early secretory phase, with rounded nuclei and dilated 
rough endoplasmic reticulum. Golgi profiles and lysosomes are more obvious (Verma 
1983; Cornillie et al. 1985). The decidual tissue has been considered to play a role in 
restraining the invasiveness of the conceptus (Johnson and Everitt 1988). A detailed 
review of decidual cells and their possible functions has been given in Chapter 1. 
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2.1.6. ENDOMETRIAL BLOOD VESSELS 
The uterine arteries arise from the hypogastric arteries, which derive from the 
common iliac arteries. The arteries supplying the endometrium arc of two types: short 
branches supplying the basal region of the endometrium called `basal arteries' or 
sometimes `straight arteries'; and longer spiral arteries which vascularize the functionalis 
layer of the endometrium. The spiral arteries are involved in the process of menstruation 
whereas the basal arteries are largely unaffected. Stromal capillaries empty into veins 
which form a plexus in the stroma. It has also been suggested that a close connection 
exists between the thin capillaries and the venules by arteriovenous anastomoses and this 
connection may form the so-called "venous lakes" (Schlegel 1945; Dalgaard 1945; 
Bartelmez 1956). Ramsey (1984) suggested that the function of these structures was to 
regulate the blood volume and the rate of blood flow in the superficial part of the 
endometrium. On the other hand, the spiral arteries have also been reported to develop 
small branches in the functional layer which improves its blood supply directly (Fanger 
and Barker 1961; Ramsey 1984). 
In primates, the growth of endometrial vasculature begins during the proliferative 
phase and continues throughout the secretory phase of the menstrual cycle (Reynolds et 
al. 1992). In the proliferative phase of the menstrual cycle, growth of the vascular tree 
accompanies the increase in endometrial thickness (Dockery and Rogers 1989). Using 
intra-ocular endometrial transplants in Rhesus monkeys, Markee (1940) described a five- 
fold increase in the length of the spiral arteries during the late pre-ovulatory phase 
whereas the endometrial stroma did not exhibit the same rate of growth and the 
endometrial thickness only doubled during the same period of time. This discrepancy 
between the growth rate of the vessels and the thickness of the endometrium may be 
explained by coiling of the arteries which takes place in the late pre-ovulatory phase. The 
enzyme arachidonic acid-prostaglandin related cyclooxygenase has been localized in 
smooth muscle cells and endothelium of endometrial arterioles in the human by 
immunohistochemistry (Rao et a!. 1989). Prostaglandins are likely to be the primary 
stimulator of vascular mitotic activity, which leads to coiling of the arteriolar-capillary 
system. During the pre-ovulatory phase of the menstrual cycle, the most distal part of 
the spiral arteries become connected to the sub-epithelial capillary plexus via arterioles. 
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Like the distal arteries, the sub-epithelial capillary plexus is likely to undergo changes 
during the normal menstrual cycle. Receptors for oestrogen and progesterone are 
localized in the muscular wall of the endometrial vessels (Perrot-Applanat et al. 1988), 
and sex steroids may also play a role in vascular proliferation in the endometrium. The 
endothelial lining of endometrial vessels is uniformly free of sex steroid receptors 
(Bergeron et a1.1988; Perrot-Applanat et al. 1988). It has been suggested that the 
endometrial microvascular density did not change throughout the menstrual cycle 
whereas it increased in women using contraceptive agent levonorgestrel (Rogers et a1. 
1993). Goodger et al. (1994) also suggested that the endometrial endothelial cell 
proliferative index of levonorgestrel users was reduced compared to that seen in 
normally cycling women, whereas total numbers of endothelial cells per mm2 in 
levonorgestrel users were higher than in controls. They postulated that it was either a 
reduced rate of blood vessel regression associated with contraceptive use or a reduced 
rate of endothelial cell death or turnover. These findings may indicate a direct 
involvement of sex steroids in the mechanisms of endometrial bleeding as well as in the 
menstruation process. 
2.1.7. ENDO111ETRIUM DURING MENSTRUATION 
Withdrawal of sex steroids (especially progesterone) from a previously primed 
endometrium results in menstrual bleeding in women. However, two mechanisms, 
related to steroid levels, appear to be involved in menstrual bleeding: 1) bleeding 
associated with declining levels of peripheral steroids and 2) bleeding associated with 
steady levels of peripheral steroid levels (Smith 1989). On the other hand, daily 
measurements of oestradiol and progesterone in women with and without heavy periods 
have failed to demonstrate any correlation between steroid levels and severity of 
menstrual bleeding (Haynes et al. 1979). 
Similar to other tissues, haemostatic mechanisms exist in the uterus and they are 
involved in limiting excessive blood loss during menstruation. One of the early events in 
a haemostatic reaction is the attachment of platelets to the damaged vessel wall via the 
interaction with von Willebrand factor (vWF) secreted by the endothelial cells (Au and 
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Rogers 1993). The involvement of the activation of both coagulation and rbrinolytic 
enzyme systems in menstrual bleeding has also been suggested (Sheppard 1989). 
There are 2 different proposed mechanisms involved in the shedding of the 
endometrial tissue during menstruation. In one view, the functionalis layer of the 
endometrium is totally shed and the subsequent repair and re-growth occurs by a process 
of re-epithelization from the outgrowth of glands deep in the basalis (Ferenczy 1976; 
Wynn 1984; Ferenczy et al. 1979). The other view is that most of the functionalis is 
conserved during menses and repair takes place from the remaining tissues by "dynamic 
physiological process" (Wilbom and Flowers 1984). It is one of the aims of the present 
study to evaluate the late secretory endometrial morphology which is likely to be the 
beginning of the sequence of events leading to the shedding of the human endometrium. 
The morphology of the human endometrial glandular epithelium throughout the 
menstrual cycle has been well studied. However, despite their importance in 
implantation and maintenance of pregnancy, human endometrial stromal and vascular 
compartments have received less attention than they deserve. In order to obtain a better 
understanding of the sequential events that take place in the human endometrium during 
the menstrual cycle more reliable information on stroma and vascular tissue is needed. It 
is the aim of present study to fill this gap in human reproductive biology. 
24 
2.2. MATERIALS AND METHODS 
2.2.1. SUBJECTS 
Tliirtycight normal, healthy women volunteers of proven fertility, aged 20-40 years 
with regular menstrual cycles of 25.35 days, were used in this study. None of the 
women had used steroidal contraceptives during the previous two months. They were all 
nonpregnant and were able to communicate well with the investigators. If there was 
any clinically significant medical condition, including major uterine pathology, renal, 
hepatic, cardiovascular, gastrointestinal, psychiatric or endocrine disorders and 
hypothalamic pituitary failure, these volunteers were excluded from the study. All 
subjects were treated on an outpatient basis and were counselled and given instructions 
about the procedure of the experiment. All procedures had Ethics' Committee approval 
and all clinical procedures were carried out by Mr T. C. Li of the Jessop Hospital for 
Women, Sheffield. 
2.2.2. EXPERIMENTAL DESIGN 
In order to examine the normal Human endometrial structure from mid- to late- 
secretory phase of menstrual cycle, endometrial biopsies were obtained at 2 day intervals 
starting from day Lli+6. Eighteen subjects were divided into four groups. The first 
group, consisting of 6 individuals, had biopsies taken at day LH+6 of the menstrual cycle 
and the other groups, each consisting of 4 individuals, were biopsied at days Lli+B, 
L1i+10 and L11+12 respectively. Chronological dating of the endometrial biopsies was 
carried out by determination of the luteinizing hormone (LII) peak by daily LH assay (Li 
et al. 1987). 
2.2.3. BIOPSIES 
Biopsies were obtained, witli informed consent, as an outpatient procedure with or 
without Entonox analgesia. Using a Sharman's biopsy curette (Down's Surgical Ltd, 
Sheflicld, UK), a single specimen was taken from the fundus and upper part of the body 
of the uterus (Figure 2.1). All of the biopsies were performed by a proficient 
gynaecologist to standardize the biopsy and sampling procedure. 
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Figure 2.1: The tissue sampling design showing the various sampling levels used in the 
present study. 
2.2.4. TISSUE PROCESSING FOR LIGHT MICROSCOPY 
Each specimen was attached on a piece of dental wax at each end by pins and fixed by 
immersion in 2% glutaraldehyde in phosphate buffer (pH = 7.4) (see Appendix 1). After 
one hour, the tissue was cut up into smaller pieces in a standardized manner (See Figure 
2.1). The tissue was fixed for a further 3 hours in 2% glutaraldehyde in phosphate buffer 
solution. After washing in phosphate buffer solution, tissue was dehydrated through the 
series of 70%, 80%, 90% and 95% ethanol (1.5 hr each step). The tissue was further 
dehydrated in absolute ethanol, two changes of ihr each. Following dehydration, tissue 
was put in catalysed JB4 solution A (Appendix 1) overnight and next day tissue was 
embedded in JB4 embedding solution (Polysciences Inc., USA) and was kept in a 
refrigerator for 1-2 hours until the tissue had hardened. Two micrometer thick sections 
of this tissue were used for histological dating according to Noyes et al. (1950). 
2.2.5. SECTIONING AND STAINING FOR LIGHT MICROSCOPY 
Approximately 2 pm thick sections were cut from JB4 embedded endometrial tissues 
using an LKB 2218 Historange microtome (LKB Bromma, Sweden) and glass knives 
made with a LKB 2078 HistoKnifemaker (LKB Bromma, Sweden). Sections were 
collected on glass slides and stained with acid Fuschin-Toluidine blue staining. To do 
this, sections were stained in 1% aqueous acid Fuschin for 2 minutes. Then they were 
washed in distilled water and counter stained in 0.05% Toluidine blue (pH = 4.4) in 
acetate buffer for 2 minutes, washed in distilled water for 30 seconds, dried in air and 
mounted with a No. I coverslip with DPX. 
2.2.6. PERIODIC ACID-SCIIIFF (PAS) STAINING FOR GLYCOGEN-LIKE 
MATERIAL AT LIGHT MICROSCOPE LEVEL 
Other 2 tm thick JB4 sections, adjacent to those used for light microscopy, were 
used for PAS staining. They were put in 1% periodic acid for 5 minutes then washed in 
tap water. Sections were then put in Schiffs reagent for 15 minutes and washed well in 
running water for 15 minutes. Sections were stained in Haematoxylen 2 minutes for 
staining of the nuclei then rinsed in water, dehydrated through the ethanol series quickly, 
mounted with DPX after exposing slides to xylol. Glycogen-like material was stained 
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pink as a result of the PAS staining. A small intestine Jß4 section was included with 
every set of endometrial sections for PAS staining as a control, since the small intestine is 
known to have large glycogen deposits in its surface epithelium. 
2.2.7. TISSUE PROCESSING FOR ELECTRON MICROSCOPY 
Glutaraldehyde fixation of the tissue was the same as described in the previous 
section on tissue processing for light microscopy. Following the first fixation step, tissue 
was post-fixed in 1% aqueous osmium tetroxide (Os04) for two hours and washed in 
0.1M phosphate buffer several times until Os04 was totally removed from the tissue. 
Tissue was dehydrated through the series of 75% and 95% ethanol (20 minutes each 
step). Tissue was dehydrated in absolute ethanol (2 changes, 10 minutes each) and 
further dehydrated in absolute ethanol which was dried over anhydrous copper sulphate 
(20 minutes). Following the dehydration steps, tissue was put in propylene oxide (1,2- 
Epoxypropane) (Fisons Scientific Equipments, Loughborough, England) for 20 minutes 
(2 changes 10 minutes each). Then tissue was put in 50: 50 propylene oxide / Epon resin 
mixture overnight. The following day, tissue was put in fresh Epon resin (two changes 
2-3 hours each) and embedded in freshly prepared Epon resin and left to polymerise in an 
embedding oven (Taab, UK) at 60°C for 48 hours. Preparation of Epon resin is 
described in Appendix 1. 
2.2.8. SEMI-TIIIN SECTIONING AND STAINING FOR ELECTRON 
MICROSCOPY 
Two blocks of tissue were prepared from each biopsy. Approximately 0.5 µm thick 
sections were cut from Epon blocks using a Reichert (OMU3) ultramicrotome and 
stained with 1% Toluidine blue in 1% borax for approximately 30 seconds at 60°C on a 
hotplate, differentiated in 50% ethanol, dried in air or on the hotplate and mounted with 
a No. 1 coverslip using DPX. Glass knives were made using an LKB 7800 knifemaker 
(LKB Bromma, Sweden). 
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2.2.9. ULTRA-TIIIN SECTIONING AND STAINING FOR ELECTRON 
MICROSCOPY 
The same blocks used for semi-thin sectioning were used for ultra-thin sectioning. 
Silver-gold interference coloured ultra-thin sections (about 70nm thick) were cut by the 
same ultra-microtome, collected on 3.05 mm 100 mesh copper grids (Agar Aids, Essex, 
UK) coated with 2% pyroxylene (collodion) in amyl acetate. Sections were double 
stained with uranyl acetate (saturated in 50% ethanol) for 20 minutes in the dark and 
lead citrate for 5 minutes in a CO2 free atmosphere. A few sodium hydroxide pellets 
were placed in the lead citrate staining dish in order to absorb the CO2. Using the 
technically best parts of the sections, 10 electron micrographs per section (20 from each 
individual) in a systematic random manner (Figure 2.2). All electronmicrographs were 
taken using a Phillips 301 transmission electron microscope at an accelerating voltage of 
60 KV. A grating replica of 2,160 lines per mm (Agar Ltd, Essex, UK) was used as a 
magnification standard on each film. 
2.2.10. PERIODIC ACID TI. IIOSEMICARBAZIDE - GELATINE 
METIIENAMINE SILVER (PATSC-GMS) STAINING OF ENDOMETRIAL 
GLYCOGEN-LIKE CONTENT AND BLOOD VESSEL BASEMENT 
MEMBRANE 
This staining procedure was performed according to Namimatsu (1992). Ultra-thin 
sections of endometrial biopsies were collected on nickel grids. The sections were pre- 
incubated in 25% aqueous ammonia water for 10 minutes, oxidized in 1% aqueous 
periodic acid for 20 minutes, reacted with 0.1% thiosemicarbazide (TSC) for 1 minute, 
post-incubated in 25% ammonia water for 5 minutes, and stained with gelatine 
methenamine silver (GMS) solution (Appendix 1) for 50 minutes at 50-55 
°C in the oven. 
Observations were performed under a Philips 301 transmission electron microscope. 
2.2.11. SAMPLING METHODS 
The aim of the sampling design used in the present study was to obtain quantitative 
structural information on human endometrial stromal and vascular compartments in an 
efficient manner. It has been shown that the biological variation between different 
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individuals contributes most variation to the overall experimental variability, whereas the 
inter-block and feature to feature variations on sections are less important (Gundersen 
and Osterby 1981). Contribution of the variation at different sampling levels to the total 
variance in a biological study using experimental animals has been shown typically to be 
70% - animals; 20% - blocks; and fields and intercepts combined - 10% (Gundersen and 
T sterby 1981). However, in the case of human endometrial biopsy, the inter-block 
variance contribution is similar to that between individuals ( 42% - individuals; 37% - 
blocks; 21% - fields) (Dockery et al. 1988a). This may reflect the variability of sampling 
during the biopsy procedure combined with real variation within the uterus. However, 
this is unavoidable since the endometrial biopsy is the only way to obtain tissue from 
living individuals for morphological study. The multilevel sampling strategy (sampling 
tree) used in the present study is shown in Appendix 6 and this was designed to minimize 
the effects of variation. 
At the light microscope level, one section per block and two blocks per biopsy 
(individual subject) were taken. Systematic random samples of 10 fields of view were 
obtained from each section. Point counting (using a1 cm square grid, 10 tm on the 
tissue) was used to determine the volume fractions of several endometrial features. The 
nuclear profile diameter measurements were performed at the light microscope level 
using a digitizer-light microscope (with a drawing tube)-computer device. 
At the electron microscope level, 2 blocks per individual were selected by lottery and 
one section per block was cut. Ten electron micrographs per section were taken with a 
Philips 301 electron microscope in a systematic random pattern (Figure 2.2) and 
examined at 2800 times magnification for stromal cell volume fraction measurements 
using a1 cm square grid (3.601tm on the tissue). 
In addition, for blood vessel observations, 2 blocks per individual were selected by 
lottery and 1 section per block was cut. Blood vessels were selected randomly and 10 
electron micrographs per section were taken and examined at 5900 times magnification 
using a1 cm square grid (1.70 ltm on the tissue). A pilot study was performed to 
determine the optimum magnifications and sampling methods for morphometric 
evaluation of the endometrial tissue. 
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Figure 2.2: Sampling model for electron microscopical observations. 
EM. Grid Systematic Random Points 
These electron micrographs were also used to determine the arithmetic and harmonic 
mean thickness of the blood vessel basement membrane. 
2.2.12.111 ORPI I OM ETRY 
In order to obtain a full descriptive morphology of human endometrium a wide range 
of features were evaluated using appropriate morphometric methods (Weibel 1979). A 
nested diagram of the morphometric model used in the present study is shown in 
Appendix 7. 
2.2.12.1. FEATURES MEASURED 
For each endometrial biopsy, a large range of morphological features was measured 
to evaluate the endometrial structure. 
In glands, the following features were examined. 
a) Volume fraction of gland occupied by gland cell. 
b) Volume fraction of endometrium occupied by gland. 
Worked examples of the estimation of volume fractions is given in Appendix 3. 
Although this study primarily involve stromal tissue of the endometrium, it was 
considered important to examine some of the glandular features because of the 
interaction in functions between glandular and stromal compartments at different stages 
of the menstrual cycle. It is also necessary to evaluate some glandular structures for the 
interpretation of the functions of the whole endometrium (see Discussion). 
In stroma, the following features were examined in order to determine the changes 
occurring in the stromal compartment of the endometrium during mid to late-secretory 
phase of the menstrual cycle. 
a) Volume fraction of endometrium occupied by stroma. 
b) Volume fraction of endometrium occupied by stromal cell nucleus. 
c) Volume fraction of stromal cell occupied by nucleus. 
d) Volume fraction of nucleus occupied by euchromatin. 
e) Volume fraction of stromal cell occupied by mitochondria. 
f) Volume fraction of stromal cell occupied by "secretory apparatus" (Golgi complex, 
SER, vacuoles and vesicles were considered as "secretory apparatus"). 
30 
g) Volume fraction of stromal cell occupied by rough endoplasmic reticulum (RER). 
In addition to the above features, stromal cell nuclear profile features were measured 
in order to determine the changes in shape of the stromal cell nucleus that occur in mid 
to late secretory phase of the menstrual cycle. 
a) Stromal cell nuclear profile major axis. 
b) Stromal cell nuclear profile minor axis. 
c) Stromal cell nuclear profile mean diameter. 
d) Stromal cell nuclear axial ratio. 
In endometrial blood vessels including all types of blood vessels such as arteries, 
veins, arterioles, venules and capillaries, the following features were examined. 
a) Volume fraction of endometrium occupied by blood vessel lumen. 
b) Volume fraction of endometrium occupied by blood vessel tissue. 
c) Volume fraction of endometrium occupied by total blood vessel (obtained by the 
addition of points falling on lumen + tissue). 
The above features were chosen for the complete evaluation of the endometrial blood 
vessels in order to determine the contribution that each of these parts made to the vessels 
(See Discussion). 
In order to evaluate the endothelial cell nuclear shape, the following features were 
measured . 
a) Endothelial cell nuclear profile major axis. 
b) Endothelial cell nuclear minor axis. 
c) Endothelial cell nuclear mean diameter. 
d) Endothelial cell nuclear profile axial ratio. 
In the following endothelial cell features only the small endometrial capillaries with 
three or less endothelial cell profiles visible were chosen and evaluated. These capillaries 
were selected because they are the major site at which transport between blood and 
endometrium occurs. 
a) Volume fraction of endothelial cell occupied by nucleus. 
b) Volume fraction of endothelial cell occupied by euchromatin. 
c) Volume fraction of endothelial cell occupied by mitochondria. 
d) Volume fraction of endothelial cell occupied by secretory apparatus. 
31 
e) Volume fraction of endothelial cell occupied by RER. 
f) Arithmetic mean basement membrane thickness of the endometrial blood vessels. 
g) Harmonic mean basement membrane thickness of the endometrial blood vessels. 
2.2.12.2. ESTIMATION OF ENDOMETRIAL VASCULAR BASEMENT 
MEMBRANE THICKNESS 
Human endometrial blood vessel arithmetic mean and harmonic mean basement 
membrane thicknesses were determined according to Jensen et a!. (1978) and Hirose et 
at. (1982). 
2.2.12.2.1. TILE ARITHMETIC MEAN BASEMENT MEMBRANE 
TIIICKNES 
Micrographs of randomly selected endometrial blood vessels were taken as 
described in Section 2.2.11. Electron micrograph negatives were projected on to a 
screen where a5 cm grid was superimposed on the image. After enlarging the image at 
approximately X20,000 magnification, the exact magnification of the image was 
determined using a grating replica (2160 lines per millimetre) negative taken at the same 
magnification (X5900) as blood vessel electron micrographs. An ordinary ruler was used 
to measure the orthogonal intercepts of the blood vessel basement membrane in 
millimetres. Ten blood vessel electron micrographs per individual were used for 
basement membrane thickness measurements. The estimation of the true arithmetic 
mean basement membrane thickness was obtained using the formula below: 
Formula 2.1. Ta= 7t/4 . Pa. 
10' 
Ta: Arithmetic thickness 
n/4: Correction factor 
fa: Mean length of the orthogonal basement membrane intercepts 
Formula 2.2. ea = 1! N . EQ 
N: Total number of observations 
EQ: Total length of orthogonal intercepts 
After estimating the arithmetic mean thickness, the resultant value is divided by the 
final magnification (M) of the electron micrograph for estimation of the true arithmetic 
basement membrane thickness in nanometers. (Worked example of arithmetic mean 
basement membrane thickness estimation is given in Appendix 5). 
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2.2.12.2.2. TIIE IIAR11MONIC MEAN BASEMENT MEMBRANE THICKNESS 
The distribution of true basement membrane thickness is markedly right-skewed 
(Gundersen and Osterby 1973), and the arithmetic mean is therefore not the most 
efficient estimator of thickness. Moreover, a certain bias is always present in 
estimations, due to curvature and unevenness of the basement membrane, and this bias 
can be significant in the arithmetic mean basement membrane thickness values. For these 
reasons, it is advantageous to also estimate the harmonic mean basement membrane 
thickness which is the reciprocal of the mean reciprocal thicknesses. 
Sampling and measuring procedures for harmonic mean thickness measurements were 
the same as the arithmetic mean thickness measurements with one exception; a 
logarithmic ruler, instead of an ordinary ruler, was used to measure the thickness of the 
orthogonal intercepts of the blood vessel basement membrane. Estimation of the 
harmonic mean thickness used the following formula: 
Formula 2.3: Qh =N: E 1/Q 
Qh= Mean length of the basement membrane orthogonal intercepts 
N= Total number of observations 
Formula 2.4: Th=8/(3n). eh. 106 
Th = Harmonic mean thickness 
8/ (3n) = Correction factor for estimation of the harmonic mean thickness 
106 is used to convert the final thickness value from millimetres to nanometers. 
Final harmonic mean value is divided by the real magnification (M) of the image 
which was projected on a screen. (Worked example of the estimation of harmonic mean 
basement membrane thickness is given in Appendix 4 section) 
2.2.13. STATISTICAL ANALYSIS 
Means and standard errors were calculated for each group and data were analysed using 
a one way analysis of variance (ANOVA) test where the conventional level of 5% was 
taken as the level of significance. In addition to the ANOVA test, mean values for each 
group were compared to others individually using Bonferroni's corrected t-test. 
Statistical comparisons were performed between day LH+6 group (n=6), day LH+8 
group (n=4), day LH+10 (n=4) and day LH+12 group (n=4). 
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2.3. RESULTS 
A wide range of endometrial features were evaluated morpliometrically at cycle days 
L11+6, LH+8, LH+10 and LH+12 respectively and results of these evaluations were 
compared statistically using One Way Analysis of Variance (ANOVA) Test, paired t-test 
and unpaired Student's t-Test as appropriate. These results are presented in Tables 2.1- 
2.7. 
2.3.1. QUALITATIVE EVALUATION OF TIIE ENDOMETRIAL GLYCOGEN 
CONTENT 
A qualitative evaluation of PAS-positive material in endometrium between days 
LH+2 and LH+12 at 2-day intervals was performed. Micrographs of some of this tissue 
are shown in Figures 2.3a, b. Much of the PAS-positive material was glycogen (See 
Discussion). At day LH+2, two out of six individuals had no glycogen deposits in their 
glandular epithelium. While one individual had relatively few glycogen deposits in 
glands, the remaining three individuals had more subnuclear glycogen deposits in the 
glandular epithelium. One individual had subnuclear glycogen material in some parts of 
the luminal epithelium. At day LH+4, there was more glycogen-like material in 
subnuclear regions of the glandular epithelial cells when compared to LH+2 (Figure 2.3a; 
Figure 2.5a). Two out of six individuals had glands full of PAS-positive glycogen-like 
material in the subnuclear region of the glandular cells. At this time of the cycle one 
individual had little glycogen whereas the remaining three had more glycogen in various 
regions of the gland cells. In addition, at day LH+4 stromal cells showed 
intracytoplasmic glycogen-like material whereas this material was not evident in stromal 
cells at day LH+ 10 (Figure 2.4a, b). By day LH+6 the intracellular glycogen levels in 
glandular cells decreased (Figure 2.3b). Three individuals had no glycogen anywhere, 
whereas one individual had a few glycogen deposits in the gland cells. The remaining 
two individuals still had some glycogen-like material in the subnuclear region. Luminal 
epithelia of three individuals at day LH+6 contained glycogen deposits in the subnuclear 
region of the cells. One individual that had no glycogen in the gland cells had glycogen- 
like material in luminal region of the endometrial glands. At day LH+8, few individuals 
had glycogen deposits in any of the endometrial structures. Only two individuals had a 
34 
Figures 2.3a, b: Shows the subnuclear glycogen-like material (Gly) of endometrial gland 
cells at day LII+4 (a) and at day LH+6 (b) of the menstrual cycle in normal fertile 
controls. While there is abundant PAS positive staining in the subnuclear region of the 
gland cells at day LH+4, positive glycogen staining decreases by day LH+6 of the cycle. 
(Str) stroma. 
Staining: Periodic acid-Schiff (PAS). 
(a)- Bar represents 34 µm 
(b)- Bar represents 38 µm 
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Figures 2.4n, b: Ultrastructural demonstration of glycogen-like content (Gly) in 
subnuclear region of the glandular cells at days LH+4 (a) and LH+10 (b) of the cycle. 
Day LII+4 gland cells show extensive glycogen-like material in the subnuclear region 
whereas cells from day LI1+10 have no such material. (N) nucleus. 
Staining: Periodic Acid Thiosemicarbazide - Gelatine Methenamine Silver (PATSC- 
GMS) 
(a) Bar represents 2.30 Itm 
(b) liar represents 1.35 µm 
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Figures 2.5a, b: Endometrial stromal cells and surrounding extracellular matrix at days 
LH+4 (a) and LH+10 (b) of the menstrual cycle in control subjects. Day LH+4 stromal 
cell cytoplasm contains glycogen-like material (Gly), stromal cells have a relatively 
regular shape and collagen fibres (arrow) are also evident. Day LH+10 cells show no 
glycogen-like material, however they demonstrate extensive collagen fibres (arrow) in 
the ECM and also inside the cell itself. (N) nucleus. 
Staining: Periodic Acid Thiosemicarbazide - Gelatine Methenamine Silver Staining 
(PATSC-GMS) 
(a) Bar represents 3.00 gm 
(b) Bar represents 3.20 µm 
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very little amount of glycogen in gland cells whereas one individual had glycogen 
deposits in glandular lumen. LH+10 was similar to the LH+8 and no glycogen-like 
material in glandular epithelial cells was found (Figure 2.5b). At day LH+12 no 
individuals had any glycogen at any level. 
2.3.2. GLANDULAR EPITHELIUM 
The mean ± standard error of volume fraction of gland occupied by gland cell did not 
differ among the groups and the variability between group means was not significantly 
different (Table 2.1). Similarly the volume fraction of endometrium occupied by gland 
was not significantly different between days LH+6 to LH+12 according to the ANOVA 
Test. 
2.3.3. STRO31A 
Stromal cell nuclear profile diameter results showed significant differences among the 
groups (Table 2.3). Although stromal cell nucleus profile major axis did not differ 
between groups, the minor profile axis was significantly (p= 0.0043) different with time 
among the groups (Table 2.3) indicating that the nucleus was wider, and therefore 
rounder at day LH+12 than day LH+6 (Figures 2.6a, b, c, d). Although the stromal cell 
nuclear profile axial ratio did not differ between groups, there was a tendency of a 
decrease in axial ratio of the stromal cell nucleus which was 1.93 ± 0.10 at day LH+6 
and 1.66 ± 0.10 at day LH+12. This decrease in axial ratio was consistent with the 
increase in profile minor axis suggesting that the nuclear shape was rounder towards the 
cnd of the secretory phase of the menstrual cycle. In addition, the stromal cell nuclear 
profile diameter was significantly (p= 0.0037) different with time gradually increasing 
from 4.82 ± 0.14 pm at day LH+6 to 5.74 ± 0.11 tim at day LH+12. t-test results 
showed that the difference between day LH+6 and day LH+12 values was significant 
(p<0.05). 
Similar to the volume fraction of glandular epithelium to endometrium, the mean ± 
standard error of the volume density of endometrium occupied by stroma was not 
significantly different between days LH+6 to LH+12. However, the volume fraction 
values of stromal nucleus to endometrium was significantly (p= 0.0161) different among 
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Figures 2.6a, b: Endometrial stromal cells at days LII+6 (a) and LffI+8 (b). Both groups 
of stromal cells show similar features such as cuchromatic nuclei (N) and prominent 
nucleoli (No) with a similar amount of cellular organelles. 
Staining: Uranyl Acetate - Lead Citrate 
(a) Bar represents 3.801ttn 
(b) liar represents 4.30 µm 
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Figures 2.6c, d: Stromal cells at days LH+10 (c) and L11+12 (d). These cells are closely 
grouped together and the relative amount of cytoplasm is higher in these cells than the 
day LI1+6 and LH+8 stromal cells. Nuclei (N) at day LH+12 are beginning to become 
irregular in profile. 
Staining: Uranyl Acetate - Lead Citrate 
(c) Bar represents 4.25 ýtm 
(d) Bar represents 4.10 µm 
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the groups (Table 2.2). At day LH+6 it was 0.092 ± 0.010 with an increase at day 
L11+8 (0.138 ± 0.015) followed by a large decrease at day LH+10 (0.078 ± 0.009). The 
coefficients of variation within the groups was consistently low for this feature. The 
mean ± standard error of the volume density of stromal cell occupied by nucleus, and 
stronial cell nucleus occupied by euchromatin, did not differ among the groups (Table 
2.2) (Figures 2.6a, b, c, d). In addition, the mean ± standard error of the volume fraction 
of mitochondria to cell was not significantly different among the groups with time 
indicating no change in metabolic activity of the stromal cells during the late luteal phase. 
However, the difference in the volume fraction of "secretory apparatus" (consisting of 
SER, Golgi complex, vacuoles and vesicles) to stromal cell was marginally significant 
(p- 0.0518) showing a tendency of an increase in activity of these organelles in stromal 
cells in the late secretory phase. The volume fraction of stromal cell occupied by 
secretory apparatus was 0.054 ± 0.004 at day LH+6,00.046 ± 0.003 at day LH+8,0.052 
± 0.006 at day LH+10 reaching its peak of 0.065 ± 0.02 at day LH+12. The volume 
density of rough endoplasmic reticulum to stromal cell was significantly (p=0.0144) 
different among the groups ranging from 0.033 ± 0.004 at day LH+6 to 0.055 ± 0.007 at 
day L11+12 suggesting an increased synthetic activity of the stromal cells towards the 
end of the secretory phase (Figure2.6e). This quantitative data were consistent with 
qualitative data which showed an increased collagen secretion and accumulation in 
cndometrial stroma at the later stages of the menstrual cycle (Figure2.4b ). 
2.3.4. BLOOD VESSELS 
At the light microscope level, the mean ± standard error of the volume density of 
endomctrium occupied by blood vessel lumen, tissue and both lumen and tissue did not 
significantly differ with time (Table 2.4). Similarly, endothelial cell nucleus profile 
diameter evaluations showed no significant differences in any of these features with time 
(Table 2.5). However, there was a tendency for endothelial cell nuclear profile major 
axis, minor axis, mean diameter and nuclear axial ratio to increase during the cycle. 
On the other hand, endothelial cell features seems to be changed later in the cycle 
(Table 2.6) (Figures 2.7a, b, c, ). According to ANOVA Test, the mean ± standard error 
of the volume fraction of the endothelial cell occupied by nucleus significantly 
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Figure 2.6e: Shows a stromal cell at day LH+12 of the menstrual cycle. The nucleus 
contains abundant cuchromatin material (Eu) with prominent nucleoli (No). 111c, 
cytoplasm demonstrates abundant "secretory apparatus" including a Golgi complex 
(arrow) and vacuoles (V). 
Staining: Uranyl Acetate - Lead Citrate 
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Figures 2.7a, b: Endometrial blood vessels at days LH+6 (a) and LH+8 (b) of the 
menstrual cycle. Both vessels contain endothelial cells with rounded, euchroinatic nuclei 
(N), regular basement membranes (arrow) and cytoplasm with apparently normal 
organelle structure. At the electron microscope level, capillaries containing no more than 
2 endothelial cell profiles were selected for study since most of the transport between 
blood and endometrium occurs in these vessels. (L) lumen, (Str) stroma. 
Staining: Uranyl Acetate - Lead Citrate 
(a) Bar represents 1.85 ltm 
(b) Bar represents 1.95 ltm 
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Figure 2.7c: An endometrial blood vessel at day LH+10 of the cycle. Although 
endothelial cell nucleus (N) seems less euchromatic and irregular shaped here than the 
cells from days LH+6 and LH+8, morphometric evaluation showed no difference among 
groups. (L) lumen, (arrow) basement membrane, (Str) stroma. 
Staining: Uranyl Acetate - Lead Citrate 
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(p=0.0097) decreased towards the end of the cycle (Table 2.6). The volume density of 
nucleus to endotlielial cell was 0.595 ± 0.027 at day LH+6 and it was reduced to 0.442 ± 
0.033 at day LI1+12. In addition, Bonferroni-corrected t-Tcst results showed that the 
difference between LH+6 and LH+12 was significant (p<0.05), confirming the gradual 
decrease in volume density of the endothelial cell occupied by nucleus. The mean ± 
standard error of the volume density of eucliromatin to nucleus was significantly 
(p=0.0359) different with time. This decreased euchromatin ratio from days LH+6 to 
LII+12 is likely to indicate a decrease in synthetic and metabolic activities in endothelial 
cells. hie volume fraction of endothelial cell occupied by mitochondria was considered 
significantly different over the same time period with a significance level of p=0.0535 
(ANOVA). The mean ± standard error of the volume density of "secretory apparatus" to 
endotlielial cell significantly (p=0.0138) increased during the late secretory phase of the 
menstrual cycle, ranging from 0.039 ± 0.003 at day LH+6 to 0.067 ± 0.002 by day 
LI1+12. t-Tests result showed that the difference between days LH+6 and LH+12 was 
significant (p<0.05) indicating increased membrane turnover, possibly due to an 
increased secretory activity in endothelial cells or an increased transport between blood 
and endomctrial stroma via pinocytosis by the endothelial cells. Similar to the other 
organelle volume densities, the mean ± standard error of the volume density of 
endothelial cell occupied by rough endoplasmic reticulum (RER) was significantly 
(p=0.0180) different with time. It was relatively low at day LH+6 (0.031 ± 0.004) but 
increased on day LH+l2 (0.048 ± 0.004). This may suggest an increased synthetic 
activity in endothelial cells towards the end of the secretory phase. 
The arithmetic and harmonic mean basement membrane thicknesses of the 
cndomctrial blood vessels were also determined in order to complete the morpliometric 
evaluation of blood vessels during the late secretory phase. However, after inspection of 
other data it was decided to investigate only LH+6 and L11+10 tissues as these were 
representative days of mid and late secretory phase of the menstrual cycle (Figures 
2.8a, b). ? lie mean ± standard error of blood vessel arithmetic mean basement membrane 
thickness was significantly (p<0.001) different with time being 81.17 ± 1.92 nanometers 
at day L11+6 and 104.64 ± 2.63 nanometers at day L1I+10 (Table 2.7). Since 
coefficients of variation in both groups were low, the difference was highly significant. 
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Figures 2.8a, b: Endometrial vessels at days LH+4 (a) and LH+10 (b) of the cycle. 
Vessels were stained with a modified procedure of periodic acid staining to demonstrate 
the basement membranes (arrow) (see text for details). Basement membrane thickness of 
the vessels at day LH+10 appear thicker than those at day LH+4. Morpbometry results 
have also confirmed this qualitative observation. (N) nucleus, (L) lumen, (Str) stroma, 
(WBC) white blood cell. 
Staining: Periodic acid Tliiosemicarbazide - Gelatine Methenamine Silver (PATSC. 
GMS). 
(a) Bar represents 1.70 µm 
(b) Bar represents 1.80 Itm 
Str 
a"rý 
lib 
V. "` i 
i 4 ý''.. 
ý. ýä ý,,. ^ýý 
Pl. _ýý 
Lä, l 
1 
rr' 
Similarly the mean ± standard error of blood vessel harmonic mean basement membrane 
thickness differed significantly (p<0.001) between groups. It was 82.74 ± 1.87 
nanometers at day LH+6 and 102.00 ± 3.12 nanometers at day LH+10. Both arithmetic 
and harmonic mean basement membrane thickness results suggest a changed vascular 
structure and function in the late secretory phase of the menstrual cycle. This increase in 
blood vessel basement membrane thickness was consistent with the increase in synthetic 
activity of the endothelial cells in the late secretory phase of the menstrual cycle. 
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2.4. DISCUSSION 
This study has investigated the morphological changes that occur in human 
cndometrial stromal and vascular compartments during mid to late secretory phase of the 
menstrual cycle. Some of the glandular and luminal epithelial features were also 
examined quantitatively and qualitatively in order to determine the overall changes that 
occur during this period of the cycle in humans. 
Morphometric methods used in this study mainly involved volume fraction 
measurements, using point counting teclwiques, at light and electron microscope levels. 
The stronual and endothelial cell nuclear profile dimensions were evaluated using a 
digitizer-computer-light microscope device. In addition, endometrial blood vessel 
arithmetic and harmonic mean basement membrane thicknesses were evaluated. 
Morphometric methods used in the present study were chosen in order to obtain 
comprehensive descriptive data for the endometrial stromal and vascular morphologies. 
2.4.1. DATING TIIE ENDOMETRIAL BIOPSIES 
In the present study, dating of the endometrial biopsies was done using chronological 
dating according to the luteinizing hormone (LH) surge that occurs just before ovulation 
(Li et al. 1987). The histological dating was performed conventionally by the criteria of 
Noyes et al. (1950) on JB4 - embedded tissue stained with acid Fuschin and Toluidine 
blue. For many years, the chronological date has been assigned retrospectively from the 
onset of the next menstrual period (NMP) or according to the last menstrual period 
(LMP) (Cooke el a!. 1972; Wentz 1980). However, it is now well established that the 
menstrual cycle may vary considerably in length from cycle to cycle, mainly due to 
variation of length in the proliferative phase (Lenton et a!. 1984), so that the use of the 
onset of the NMP or the LMP as a guide to dating may introduce undesirable errors. 
Some investigators have also used basal body temperature (BBT) to identify the time of 
ovulation (Gautray et a!. 1981), or by combining the BBT with the onset of the NMP 
(Noyes and Haman 1953). However, menstrual cycles may range between 25 and 35 
day in normal healthy women and so using either NMP or LMP can lead to considerable 
error. On the other hand, LI rise reproducibly occurs about 38 hours before ovulation 
(Li et al. 1987). Also LH is easily measured by radio-immunoassay in either blood or 
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urine (Li et al. 1987). Since the luteal phase is of relatively constant length (Lenton et 
al. 1984), dating endometrial biopsies according to the LH peak seems to be most 
accurate method currently available (Tredway et al. 1973; Koninckx et al. 1977; Li et al. 
1987). 
hie accuracy and reliability of two methods of chronological dating (LH peak and the 
onset of the NMP) and their correlation with the traditional histological dating were 
examined by Li et al. (1987). They concluded that the correlation between histological 
and chronological dating is much more accurate and reliable using the LH peak than 
«wen using the retrospective method of dating from the onset of the NMP. It therefore 
appears that the most accurate and reliable method for dating the endometrial biopsy 
material is by determination of the LH peak by daily LH assay, and so this method was 
used in the present study. 
2.4.2. GLANDULAR EPITHELIUM 
While there were no changes in the glandular components of the endometrium 
examined, some of the stromal and vascular features (see later) differed significantly 
during the cycle. Most of the changes occurred later in the secretory phase around days 
LI1+10 and LH+12 of the cycle. 
Taking all stages overall (days LH+6 - LH+12), the groups did not differ significantly 
throughout the cycle when the volume fraction of endometrium occupied by gland was 
compared statistically using an ANOVA Test. Similarly the volume density of gland 
occupied by gland cell was not significantly different during the cycle. These features 
indicate the secretory functions of glands and amount of glandular epithelium in the 
«hole endometrium. That they did not differ significantly across the luteal phase may 
seem unusual, since dramatic changes in glandular epithelium can be seen qualitatively 
(sec later). However, these changes occur in a precisely co-ordinated pattern over a 
short time scale (discussed below) and are masked when examined across days LH+2 - 
Ll1+12. 
in the normal cycle around day LH+4 deposits of glycogen are seen in glandular 
epithelial cells (Noyes et a!. 1950; Dockery et a!. 1988a, 1988b; Dockery and Rogers 
1989). This increases the overall volume of gland cell cytoplasm from (mean ± SE) 
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877.3 ± 77.5 µm3 at day LH+2 to 1198.1 ± 74.7 pm3 at day L1I+4 (Dockery et a!. 
1993). Cytoplasmic accumulation of glycogen also reduces the gland lumen so the ratio 
of gland cell to gland values also increase. So a change in the volume fraction of gland 
cell to gland may indicate the accumulation glycogen in the glandular epithelial cells. 
Qualitative observations were performed in the present study using a modification of the 
PAS method for electron microscopy (Namimatsu 1992). The presence of glycogen-like 
material in the endometrium throughout the secretory phase showed a peak at day LH+4, 
in agreement with the literature published on this field (Verma 1983; Johannisson et al. 
1987; Dockery et al. 1988a, 1988b; Dockery and Rogers 1989). The peak amount of 
glycogen-like material in gland cells seen around day LH+4, decreased by day LH+6 and 
disappeared completely towards the end of the secretory phase. The secretion passes 
apically out of the cell into the gland lumen (Smith et al. 1989; Graham et al. 1990). 
These changes are widely believed to prepare the endometrium for implantation and 
since the present study focuses on the stromal cell changes that occur later in the 
secretory phase, when most glandular changes have already taken place, it was not 
unexpected to find that the volume densities of "gland cell to gland" and "gland to 
endometrium" were unchanged when the whole luteal phase was considered together. 
Previous reports published on the histology of the glandular epithelium deal with the 
early secretory phase and peri"implantation periods (Verma 1983; Johannisson et al. 
1987; Dockeryet al. 1988a; Li et al. 1991a). Dockeryet al. (1988a) reported separately 
glandular cell cytoplasmic and nuclear volumes. While there was an unchanged nuclear 
volume, the cytoplasmic volume increased by 37% between days LH+2 and LH+4 
followed by a 23% decrease from day LH+4 to day LH+5. This is consistent with an 
increase in glycogen accumulation in glandular cells until day LH+4 followed by a rapid 
loss. 71icir quantitative data agree with the qualitative data of the present study that the 
maximum glycogen accumulation in endometrial glandular cells is seen at day Lei+4. 
Kim"Bjorklund et al. (1991) performed a quantitative study of normal human 
cndomctrial morphology in postovulatory cycles. It may be expected that glandular cell 
height would increase when intracytoplasmic glycogen accumulation was high. 
Glandular cell height was maximum around days LH+4 and LH+7 and decreased around 
days LI1+8 and 1.11+ 11. However, their recruitment of the LH dated endometria put 
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specimens into broader groups than in the present study. For example they grouped 
LI1+4 - L11+3, LH+4 - LH+7 and LH+8 - LH+11 biopsies together, therefore changes 
hicli occur between days LH+2 and LH+3 and between days LH+4 and LH+5 could 
not be obtained. Nevertheless their results broadly agree with those above. 
Johannisson et al. (1987) reported an increased diameter of the endometrial glands 
between days LH-1 and LH+12. This increased gland diameter is likely to be the result 
of several things. For example, the accumulation of glycogen-like material occurs in 
gland cells around day LH+4. Aller this material is secreted into the lumen at day L11+6, 
and glandular cell height is decreased (Johannisson et al. 1987), the presence of secretion 
in the lumen could still cause the overall gland diameter to be larger than before 
ovulation. In addition in Johannisson's study, the basal vacuoles (thought to be glycogen 
containing) in gland cells disappeared after day LH+6 and no regular basal vacuolation 
appeared after that day of the cycle. This is also consistent with the reduced epithelial 
cell height and increased gland lumen volume density noted above. 
2.4.3. STROMA 
Stromal cell nuclear profile diameters showed significant differences during the cycle. 
While stromal cell nuclear profile major axis was not significantly different the minor 
profile axis differed significantly, being greater in the late secretory phase than the mid 
secretory phase. This significant difference in minor profile axis combined with 
unchanged major profile diameter indicates a wider and rounder stromal nuclear shape 
towards the end of the cycle. This change was consistent with the axial ratio of the 
nucleus being greater in the mid-luteal phase than the late-luteal phase suggesting that 
the stromal cell nuclear shape was rounder at the end of the cycle. The average profile 
diameter of the stromal cell nuclei differed significantly throughout the cycle, gradually 
increasing from 4.82 ± 0.141tm at day LH+6 to 5.74 ± 0.11 ltm at day LH+12. Overall 
change in stromal cell nuclear profile dimensions suggests that the stromal cell nucleus 
was larger and rounder towards the end of the menstrual cycle. 
The nuclear profile dimensions may be useful indicators of the functional state of the 
cells. Increased nuclear profile diameter is reflected by increased transcriptional activity 
in the nucleus. The chromatin pattern of a nucleus may be considered a guide to the 
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cell's activity. In general, cells with euchromatic nuclei are more active than those with 
condensed, heterochromatic nuclei (Junqueira et al. 1992). In euchromatic nuclei, more 
DNA surface is available for the transcription of genetic information, however, in 
hetcrochromatic nuclei, the coiling of DNA makes less surface available. As a result 
euchromatic nuclei are rounder and wider than heterochromatic nuclei (Junqucira et al. 
1992). 
The nuclear profile diameters are used to determine the prognosis of some diseases 
such as marked atypical endometrial hyperplasia (Ausems et al. 1985). In their study, 
the profile major and minor axis, profile mean diameter and axial ratio of the endometrial 
glandular cell nuclei were measured to determine whether the endometria were 
cancerous or not. However, the sampling technique used in their study was different 
from the present study. They selected the most atypical areas and nuclei in order to 
determine the prognosis of the disease. Whereas in the present study systematic random 
areas of the human endometria were used to evaluate the overall changes that occur in 
stromal nuclear shape and thus nuclear function in normal menstrual cycles. 
Determination of the true stromal cell nuclear diameter is almost an impossible task 
because of the random orientation of the cells and the random sectioning through the 
irregular cell nuclei (vertical, horizontal or tangential) (Figure 2.9). However, 
determination of the profile nuclear diameter was used in combination with Vv estimates 
to make comparisons about the changes that occur in the other parts of the cell such as 
changes in relative cytoplasmic volume or changes in overall cell volume. While it is 
recognised that the nuclear profile diameter has its limitations as a direct estimator of 
nuclear dimensions, it was used in the present study to lielp interpret Vv data. 
Dockery et al. (1990) reported increased stromal cell nuclear dimensions during the 
pert-implantation period of the normal human endometrium. In their study, stromal cell 
nuclear major and minor profile diameters significantly increased between days LH+2 
and LIM. Furthermore, stromal cell nuclear profile axial ratio significantly decreased 
and mean nuclear profile diameter increased between the same days of the cycle. 
Although their study involved only the peri-implantation period, changes in stromal 
nuclear diameters were similar to those reported here. The present study has confirmed 
and extended their data to show that a further increase in stromal cell nuclear diameters 
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occurred in the late secretory phase of the menstrual cycle. During the late secretory 
phase, More et at. (1974a) reported that endometrial stromal cells had rounded nuclei 
and prominent nucleoli, which also agrees with the present study (Figure 2.6c, d, e). 
Overall, the volume density of endometrium occupied by stroma did not significantly 
differ during the secretory phase. From the day of ovulation to the end of the cycle, 
Johannisson et a!. (1987) suggested a linear decrease in the volume density of 
cndometrium occupied by stroma and this decrease was accompanied by a linear increase 
in the volume fraction of endometrial glandular compartment. Their findings are in 
contrast with the findings of the present study where there was no overall change in the 
volume density of stromal compartment throughout the secretory phase. It is well 
established that the total glandular volume is increased between days L11+2 and LH+6 
because of the massive accumulation of glycogen material in the glandular cell cytoplasm 
(see earlier). This increase in gland volume is largely reversed after glycogen is secreted 
and a decrease in the volume density of glands occurs (Dockery et al. 1988a). However, 
the volume fraction of stromal cell nucleus to endometrium did significantly differ with 
time when comparisons were made between individual sampling points rather than 
overall changes across the cycle. There was a large increase in the volume density of 
endometrium occupied by stromal cell nucleus between days LH+6 and LH+8 followed 
by a dramatic decrease at day LH+10. Stromal oedema is at its maximum level around 
days LH+8 and LH+10 (Noyes et a!. 1950, Dockery and Rogers 1989) and this dramatic 
increase then decrease in the volume density of the endometrium occupied by stromal 
cell nucleus around these days of the cycle may be due to changed levels of stromal 
oedema, and thus changed packing density of the stromal cells. Dockery et a!. (1990) 
reported an increased packing density of the stromal cells between days LH+2 and 
LI1+6, and a decrease in packing density occurred after day LH+6. They suggested a 
possible increase in stromal oedema caused this decrease in packing density of the 
stromal cells. The results of the present study agree with their data that the large 
decrease of the volume density of stromal cell nucleus to endometrium around day 
LII+10 may be due to increased stromal oedema during this time of the menstrual cycle 
and this was confirmed qualitatively. 
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On average, the volume densities of stromal cell nucleus to cell, and nucleus occupied 
by cuchromatin did not differ during the secretory phase. Although the stromal cell 
nuclear dimensions increased towards the end of the cycle, an unchanged stromal cell 
nuclear volume density indicates that stromal cell cytoplasm increased in proportion to 
the nucleus and that the same proportion was euchromatin. Qualitative ultrastructural 
observations of the stromal cells confirmed this increased stromal cell cytoplasm volume 
during the late secretory phase of the menstrual cycle. 
The average volume fraction of mitochondria to cell in stromal cells did not differ 
significantly over the secretory phase indicating that the metabolic demand of the stromal 
cells was unchanged throughout the late secretory phase. However, the volume density 
of stromal cell occupied by "secretory apparatus", including smooth endoplasmic 
rcticulum (SER), Golgi apparatus, vacuoles and vesicles, did differ significantly at the 
times studied. The "secretory apparatus" was considered as a separate organelle in the 
present study because of the difficulties of identifying and so measuring its components 
individually. The "secretory apparatus" plays very important roles in cellular functions 
such as membrane re-cycling, vesicle transport, absorption and secretion (Junqueira et al. 
1992). The significance level was often marginal for this feature, indicating only a 
tendency of a change in secretory function of the stromal cells in the late luteal phase. 
Any such changes in this feature may not be related directly to "secretion" but to 
membrane turnover or internal transport. Similar to the "secretory apparatus", the 
volume density of stromal cell occupied by rough endoplasmic reticulum (RER) 
significantly increased in the late luteal phase, suggesting an increased protein synthetic 
activity in the stromal cells during this period of the cycle. Qualitative ultrastructural 
evaluation of the stromal cells in the late secretory phase confirmed increased amounts of 
RER, SER, Golgi apparatus and vesicles in stromal cell cytoplasm and also showed an 
apparent increase in collagen fibre accumulation in the extracellular matrix of the 
cndomctrial stroma. These qualitative observations were consistent with the quantitative 
data of the present study. 
In the normal menstrual cycle, the stromal cells undergo distinctive changes which 
correlate with proliferation, differentiation and maturation (Weinke et at 1968; More et 
at 1974a). While there are few reports of stromal cell ultrastructure in the human, More 
45 
et al. (1974a) demonstrated diffused chromatin and occasional nuclear bodies in stromal 
cell nuclei during the late luteal phase (from day 24 of the traditionally dated cycle 
onwards - about day LH+10). In their study, cytoplasm was abundant, mitochondria 
were simple in shape and scattered in the cytoplasm in small numbers, the rough 
cndoplasmic reticulum was represented by a few irregularly oriented cisternae, the 
smooth endoplasmic reticulum was extensive and often associated with a prominent 
Golgi apparatus during the late secretory phase. Their findings mainly agreed with the 
quantitative findings of the present study that the cytoplasmic organelles, especially SER 
and Golgi apparatus increased towards the end of the cycle. However, their qualitative 
study suggested an unchanged RER level during the late luteal phase, which contrasts 
with the findings of the present study. In addition, they suggested an increased collagen 
secretion in the early luteal phase, whereas an increase in collagen secretion was seen in 
the present study in the late secretory phase. The findings presented by More et al. 
(1974a) were obtained by qualitative observations. In addition, they do not mention the 
dating of the endometrial biopsies and the accuracy and reliability of the technique of 
dating they used. Since in the present study, objective morphometric methods were used 
to evaluate the endometrial stromal morphology during the mid and late secretory phase 
of the cycle from many subjects and endometrial biopsies were dated according to the 
LI I peak, the present data maybe regarded as more reliable. 
2.4.4. BLOOD VESSELS 
On average, the volume density of endometrium occupied by blood vessel did not 
differ significantly when different days of mid and late secretory phase of the menstrual 
cycle were compared using the ANOVA test. In addition, blood vessel lumen to 
cndometrium and surrounding blood vessel tissue to endometrium were not significantly 
different with time. Therefore vessels grow proportionately with the whole 
endomctrium. The capillary lumen has been described as progressively increasing in the 
late luteal phase (Sheppard and Bonner 1980). In a morphometric study of human 
cndometrial capillaries, Peek et al. (1992) reported a significantly increased dilatation of 
the sub-epithelial capillary plexus in the postovulatory phase, and they concluded that the 
dilatation might be the result of increased stromal oedema during the peri-implantation 
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stage. However, in the present study, despite clear oedema no change was found in the 
volume density of blood vessel lumen to endometrium. In the secretory phase, growth of 
the vascular tree accompanies an increase in endometrial thickness (Dockery and Rogers 
1989), and the unchanged blood vessel-endometrium proportions observed in the present 
study may be the result of a proportional increase in endometrial thickness in the luteal 
phase. Estimates of blood vessel diameter may be required to determine the changes in 
blood vessel dimensions. Unfortunately biopsies inevitably damage the endometrial 
vessels, and any statement on their diameter in biopsy material should be regarded with 
caution. 
There were no significant differences in blood vessel endothelial cell nuclear profile 
dimensions with time. Although they were not significantly different, there was a 
tendency of an increase in some of these features, such as profile major axis, minor axis 
and mean diameter during the menstrual cycle. On the other hand, according to the 
ANOVA test, the average proportions of nucleus to endothelial cell significantly 
decreased in the late secretory phase (from about 60% at day LII+6 to 45% at day 
Lll+12). This decrease in the volume fraction of endothelial nucleus to cell might be 
either due to a decreased nuclear volume or due to an increased cytoplasmic volume. 
The tendency of the increase in endothelial cell nuclear dimensions observed in the 
present study suggests the latter possibility, that there is an increase in the cytoplasmic 
volume greater than the increase in nuclear volume. This was supported by qualitative 
observations. 
The average volume fraction of endothelial cell nucleus occupied by euchromatin 
significantly decreased in the late luteal phase suggesting decreased levels of nuclear 
activities in endothelial cells during this time of the cycle. However, investigation of the 
volume density of mitochondria to endothelial cell did not show a similar effect, but an 
increase towards the end of the cycle (p=0.054). This increased mitochondrial volume 
density should be viewed with the already noted large increase in cytoplasm. 
Mitocliondrial volume has increased more than cytoplasmic volume has increased and 
therefore it is likely to indicate a much increased metabolic demand in endothelial cells. 
The average volume fraction of endothelial cell occupied by "secretory apparatus" 
significantly increased in the late luteal phase, possibly indicating an increased membrane 
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turnover in endothelial cells. This increased membrane turnover may be the result of 
either an increase in secretory activity or an increase in transport between blood and 
cndometrial stroma via pinocytosis by the endothelial cells. Additionally, the volume 
density of endothelial cell occupied by RER significantly increased in the late secretory 
phase indicating an increased protein synthetic activity in the endothelial cells during this 
period of the cycle. This increase in secretory activity was consistent with the increase in 
secretory function and the increased membrane turnover may well be the reflection of 
increased synthetic activity in endothelial cells. Qualitative investigation of the late 
secretory stage endothelial cells agreed with these increased synthetic and secretory 
activities in blood vessel endothelial cells. However, it may be considered that there is a 
discrepancy between the decreased levels of euchromatin (which means a lower 
transcriptional activity in endothelial cell nucleus) and increased levels of metabolic, 
synthetic and secretory activities in endothelial cell cytoplasm. However, this may simply 
reflect a temporal sequence with transcription finishing before translation and secretion. 
All of this activity may explain the previous increase in mitochondrial volume density. 
To complete evaluation of the endometrial blood vessel morphology and function, 
arithmetic and harmonic mean basement membrane thicknesses were also measured using 
appropriate morphometric methods. However, after consideration only days Lei+6 and 
LHI+10 were selected since they represent the mid and late luteal phase. The average 
arithmetic mean basement membrane thickness significantly differed between days LH+6 
and L11+10 with a 30% increase (81.17 ± 1.92 nm at day LH+6 and 104.64 ± 2.63 nm 
at day L11+10). Similarly, the average harmonic mean basement membrane thickness 
was significantly different between day LH+6 and day LH+10 with a 25% increase 
(82.74 ± 1.87 nm at day LH+6 and 102.00 ± 3.12 nm at day LH+10). 
Basement membranes are complex, morphologically identifiable structures physically 
separating particular cell types in various tissues and organs. Basement membranes have 
been implicated in the attachment, spreading, migration, growth, repair and 
differentiation of the overlying cell populations as well as in the physical phenomena of 
fluid filtration and gas exchange (Wracko 1982). At the ultrastructural level, the 
basement membrane is composed of a basal lamina (consisting of lamina densa and 
lamina rara) and a reticular lamina (Madri et al. 1984). The lamina densa is make up of a 
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continuous sheet of densely packed fibrillar arrays, with the lamina rara which is a less 
electron-dense layer, separating the lamina densa from the cell processes above (Madri et 
al. 1984). While the complete composition of basement membranes is still unknown, 
several components have been identified, including collagen types IV and V, laminin and 
hcparan sulphate proteoglycan (Kleinman et al. 1982; Foellmer et a1.1983). 
Arithmetic mean basement membrane thickness represents the average anatomical 
thickness whereas the harmonic mean thickness represents the `physiological" thickness 
of the diffusion barrier aspect of basement membranes. Evaluation of the arithmetic 
basement membrane thickness can give undesirable errors in interpretation of the 
function of blood vessel while harmonic mean thickness provides an indicator of the 
membrane as a barrier to diffusion. Arithmetic mean is useful, but a certain bias is 
always present in aritlunetic mean basement membrane estimates due to curvature and 
unevenness of the basement membranes. For these reasons, it is advantageous also to 
estimate the harmonic mean basement membrane thickness (which is the reciprocal of the 
mean of reciprocal thicknesses; Hirose et al. 1982). For example, if we have a 10 nm 
thick membrane and a 100 nm thick membrane, using the reciprocals of these thicknesses 
gives values of 0.1 and 0.01 respectively. When averaged the anatomically thicker 
membrane makes an appropriately smaller contribution, reflecting its poorer diffusing 
capacity. In the present study, blood vessel arithmetic and harmonic mean basement 
membrane thicknesses were consistently similar in both groups. In addition, the 
coefficients of variation for each group were consistently low suggesting that the 
thickness of the basement membranes for individual blood vessels were very consistent 
for each group. The thickness of the blood vessel basement membrane is one feature 
sk1iich can affect diffusion between blood and surrounding tissue. Others include 
distance from a vessel, type of vessel, intervening tissues and many others. In the present 
study, increased basement membrane thickness may indicate a decreased level of 
diffusion or transport through the endothelial tissue and the basement membrane. 
The anatomy of the endometrial vessels during the normal menstrual cycle has been 
described in detail (Schmidt - Matthiesen 1963). During the last 30 years, only a few 
studies have focused on the morphological changes in the endometrial vessels and their 
potential relationship to sex steroid production during the normal menstrual cycle 
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(Sheppard and Bonner 1980; Johannisson and Redard 1984; Peck et al. 1992). The 
vascularization of the endometrium may play an important role in implantation (Akerlund 
1991) and a direct effect of the sex steroids on the capillary endothelial cells cannot be 
excluded (Johannisson 1986). The influence of circulating sex steroids on the 
vascularization of uterine tissues seems to vary according to the location. The vessels of 
the myometrium do not seem to be significantly affected by sex hormones; however, the 
vessels of the upper functional layer of the endometrium are likely to be highly sensitive 
to steroid hormones and to undergo significant changes during the normal menstrual 
cycle (Schmidt-Matthiesen 1963). This sensitivity has been reported to occur in the most 
distal parts of the spiral arteries, the arterioles, the capillaries, the venous lakes and the 
veins of the functional layer (Schmidt - Matthiesen 1963). Since the present study 
involves the changes that occur in the blood vessels of the functional layer and especially 
the capillaries, it is possible that the sex steroids may have significant effects on those 
endometrial blood vessels. Peek et al. (1992) have shown a significant correlation 
between plasma progesterone levels and the mean area of the endometrial capillary 
lumen, however, there was no significant correlation between plasma levels of oestrogen 
and the mean area of the capillary lumen. The changes in the endometrial blood vessels 
during the mid and late secretory phase observed in the present study may be related to 
the amounts of circulating sex steroids. However, the interaction between the 
production of ovarian steroids, the dynamics of the endometrial blood vessels of the 
functional layer, the permeability of the capillary endothelial cells and the development of 
oedema in the endometrial stroma is likely to be a highly complex phenomenon which is 
still incompletely understood. Further studies are required to describe this relationship. 
In summary, there were no significant differences in any of the glandular epithelial 
features during mid to late luteal phase evaluated morphometrically in the present study. 
I lowcvcr, qualitative observations of the glandular glycogen content showed differences. 
Maximum glycogen - like material in the glandular epithelial cells was observed around 
day LIi+4 and a decrease occurred after this time. 
In contrast to the glandular features, statistically significant changes occurred in 
stromal cells and blood vessel endothelial cells. Profile dimensions of the stromal cell 
nuclei significantly increased towards the end of the menstrual cycle. In addition, the 
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volume density of endometrium occupied by stromal cell nucleus significantly increased 
at day LI1+8 and a remarkable decrease occurred in this feature at day L11+10 indicating 
the effect of stromal oedema on the packing density of the stromal cells. Furthermore, 
the volume fraction of stromal cell occupied by cytoplasmic organelles increased towards 
the end of the cycle, suggesting increased synthetic and secretory functions during this 
time of the cycle. Qualitative ultrastructural observations of the stromal cells confirmed 
that collagen secretion from the stromal cells was increased and abundant collagen fibre 
accumulation in the extracellular matrix was evident (Figure 2.5a, b). 
Although the endothelial cell nuclear profile diameters did not differ significantly, 
there was a tendency of an increase in this feature in the late luteal phase of the cycle. A 
linear decrease occurred in the volume fraction of nucleus to endothelial cell indicating 
(with nuclear profile data) that the cytoplasmic volume was greater towards the end of 
the cycle. The volume density of euchromatin was decreased around days LH+8 and 
LI1+10 however, it increased at day LH+12. The increase in endothelial cell cytoplasmic 
volume was consistent with the increased organelle volume densities. In addition, the 
arithmetic and harmonic mean basement membrane thicknesses increased in the late 
luteal phase. 
In conclusion, while there was no significant change in endometrial glandular features 
in mid to late luteal phase of the menstrual cycle, endometrial stroma and blood vessels 
underwent remarkable changes during this period of the cycle. 
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CHAPTER 3 
EFFECTS OF AN ANTI-OESTROGEN (CLOMIPIIENE CITRATE) 
ON NORMAL HUMAN ENDOMETRIAL STROMA AROUND THE 
TIME OF IMPLANTATION 
3.1. INTRODUCTION 
Clomiphene citrate (CC) is a widely prescribed anti-oestrogen therapeutic agent used 
for ovulation induction. CC was first synthesized in 1956 (Palopoli et al. 1967) and first 
used for induction of ovulation in the early 1960s by several investigators (Greenblatt et 
al. 1961; Roy et al. 1963; Kistner 1965). 
At low doses, CC acts as an oestrogen antagonist by blocking oestrogen receptors. 
Previous studies in normal cycling women performed in the early follicular phase (Kerin 
et al. 1985) and luteal phase (Maraucic and Casper 1987) of the menstrual cycle have 
identified a hypothalamic site of action for CC where it appears to compete with 
oestrogen receptor sites (Huppert 1979). The blockade of the oestrogen receptors has 
the effect of inhibiting the negative feed back of endogenous oestrogens, resulting in an 
elevation in gonadotrophin-releasing hormone (Gn-RH) secretion (Speroff et a!. 1989). 
The Gn-RH surge causes increased pituitary gonadotrophin secretion which stimulates 
and enhances the follicular growth and subsequent ovulation (Vandenberg and Yen 
1973; Fritz et al. 1991). CC-treatment of women with unexplained infertility is followed 
by increased plasma levels of oestrogen and progesterone (Koike eta!. 1991), supporting 
the theory that the inhibition of negative feed back of endogenous oestrogens causes the 
elevation of serum LH, FSH, oestrogen and progesterone levels. CC-induced ovulation 
in women with polycystic ovarian syndrome (PCOS) is accompanied by increased 
secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSII) with 
enhanced oestrogen and progesterone secretion, indicating an effect at the hypothalamic 
site (Fcdele et a!. 1989; Kettel et a!. 1993). Similarly, FSH levels are increased after 
induction of ovulation with CC in women with ovarian endometriosis (Tanbo et al. 
1992). Ovulation occurs 13-15 days after CC initiation (Wu 1984). 
At high doses , CC is thought to act as an oestrogen agonist by directly blocking 
gonadotrophin secretion in the pituitary (Clark and Markaverich 1982) and possibly also 
by affecting the steroidogenic activity in ovaries (Glasier 1990). CC is also used for the 
treatment of lutcal phase defects in anovulatory women (Li and Warren 1993). 
I lowever, the efficacy of CC in the treatment of luteal phase defect has been studied and 
success in treatment was achieved in only 56% of cases, suggesting that CC does not 
consistently correct this condition (Guzick and Zeleznik 1990). Therefore, most 
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recently, Rodin et al. (1994) investigated the effect of CC therapy on cyst formation and 
lutcal phase defects in unexplained infertility patients. They have shown that the 
treatment with CC reduces the incidence rates of cyst formation from 40 percent to 9 
percent and the incidence of luteal phase defects from 31 percent to 3 percent indicating 
that CC therapy must be considered as a useful treatment. It has also been suggested 
that the response of the endometrium to ovarian stimulation by CC is likely to be variable 
(Li and Warren 1993). 
Structurally CC, a non-steroidal oestrogen, is a triplienylethylene derivative (Figure 
3.1a) which is capable of interacting with oestrogen receptor binding proteins just like 
the native oestrogens (Clark and Markaverich 1982). However, the nature of the 
interaction of CC with oestrogen binding proteins may display qualitative differences 
compared to the naturally occurring ligand. Most importantly, CC is best characterized 
by the tendency to display prolonged nuclear receptor occupancy (Adashi et al. 1980; 
Clark and Markaverich 1982). Indeed, CC can occupy nuclear receptor proteins for 
weeks and this phenomenon sharply contrasts with the rather brief interaction of native 
oestrogens, known to clear the cell within 24 hours (Adashi 1993). 
in clinical use, CC is provided as a racemic mixture of its two stereochemical isomers, 
en clomiphene (trans isomer) and zu clomiphene (cis isomer) citrate (Ernst et al. 1976). 
While the en clomipliene molecule has its two unsubstituted phenyl rings on opposite 
sides of a hypothetical plane, dividing the clonvphene citrate molecule through its 
ethylene core, the two unsubstituted phenyl rings of zu clomiphene molecule are found 
on the same side of this hypothetical plane (Figure 3.1b). Studies in humans have shown 
that the en clomiphene isomer is responsible for the anti-oestrogenic action of the drug, 
while zu clomiphene is responsible for its oestrogenic activity (Clark and Markaverich 
1982; Glasier el al. 1989). However, the currently marketed formulations of CC consist 
of a mixture of en and zu clomiphene, each of which has a different ratio of agonist- 
antagonist properties (Clark and Markaverich 1982) so that the ratio of oestrogenic and 
anti-oestrogenic effects may vary from preparation to preparation. It has been suggested 
that the number of follicles and follicular phase oestrogen secretions were not changed 
after treatment with zu clomiphene but were significantly increased after en clomipliene 
treatment. This suggests that en clomiphene may be the isomer active in inducing 
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follicular development (Glasier et al. 1989). The racemic mixture administered to induce 
ovulation in women is generally made up of 38% zu clomiphene and 62% en clomiplienc 
citrate. Two common proprietary preparations of CC are Clomid (Merrel Dow 
Pharmaceuticals) and Serophene (Serono Labs UK Ltd). The initial dose of CC is 
typically 50mg administered orally for 5 days, between days 2 and 6 of a traditionally 
dated cycle. This dose is gradually increased to a maximum of 200-250mg/d with the 
therapy usually continued for 3-6 cycles (Tborneycroft 1984; Wu 1984). However, it 
has also been suggested that there are no significant differences between CC-treated 
groups who started CC therapy on the 2nd, 3rd, 4th or 5th day of cycle respectively in 
terms of anovulation rates, luteal dysfunction and normal ovulation rates (Wu and 
Winkel 1989). 
Despite its positive effects on the induction of ovulation, there are discrepancies 
between ovulation and conception rates after treatment with CC, possibly suggesting it 
has negative side effects on the reproductive tract. The pregnancy rate (30%) achieved 
following CC treatment is significantly lower than the induced ovulation rate (70%) (Wu 
1984). Such a discrepancy between ovulation and conception rates may be due to 
adverse effects of the anti-oestrogen on endometrial development (Scialli 1986). 
However, it has been shown that pregnancy rates are significantly (p<0.004) higher 
(19%) in CC treated patients with unexplained infertility than both placebo treated and 
hCG treated ones (Fisch et al. 1989). The authors concluded that CC is useful in 
treating unexplained infertility and is a reasonable initial therapy. 
Several studies on the effects of CC on endometrial development have suggested that 
CC treatment significantly decreases the endometrial thickness in humans (Saito et al. 
1991; Yagcl et a1.1992; Dickey et a1.1993). However, in all of these studies infertile 
subjects were used and it is not possible to exclude underlying pathology from the 
results. Wolman and co-workers (1994) have also examined the effect of CC on 
cndometrial thickness in women with unexplained infertility using transabdominal 
ultrasonography. In this study, 8 women who conceived aller CC treatment had a 
significantly thicker endometrium than those 38 women who did not conceive, and the 
authors concluded that CC has an adverse effect on endometrial growth. However, it 
has also been suggested that CC does not produce an effect on either the concentrations 
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or the binding affinities of either oestrogen or progesterone nuclear receptors in luteal 
phase pcri-implantation endometrium, indicating that CC has no adverse effect on these 
steroid receptors (Hecht et al. 1989; Fritz et al. 1991). Such apparently conflicting data 
are difficult to interpret, however it may indicate a range of different sub-groups in the 
population, each responding in a different way. One aim of the present study was to 
determine the precise changes in normal endometrium due to CC by using objective 
criteria. 
CC has significant effects on other regions of the female reproductive tract. For 
example, the production of cervical mucus (under the influence of oestrogen and 
progesterone) can be substantially affected by CC (Thompson et al. 1993; Assad et al. 
1993; Massai et al. 1993; Gelety and Buyalos. 1993). Cervical mucus plays a crucial 
role in the successful passage of sperm into the uterine cavity and any effects of CC on 
mucus could influence fertility rates. In several recently published studies, cervical 
mucus volume was reported to be significantly decreased after treatment with CC, 
suggesting that at least some of the discrepancies between ovulation and conception 
rates may be due to the local anti-oestrogenic effect of CC at the level of the cervix. 
The relevance of recently published studies to the efficacy of ovulation induction by 
CC and to its presumed adverse effects on the other parts of the reproductive tract 
remains uncertain. Most previous studies on the effect of CC on human endometrium 
have been performed on women being treated for infertility and it is not possible to 
exclude any underlying pathology from their results. However in the present study, 
normally ovulating women of proven fertility were used both as control and for CC 
treatment in order to overcome this problem. Therefore the aim of this study was to 
investigate the effects of CC treatment on normal fertile human endometrial morphology 
around the time of implantation by examining epithelial, stromal and vascular 
components using quantitative microscopical methods. 
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3.2. MATERIALS AND METHODS 
3.2.1. SUBJECTS 
Eight normal, healthy women volunteers with proven fertility, aged 20-40 years with 
regular menstrual cycles of 25-35 days, were used in this study. None of the persons had 
used steroidal contraceptives during the previous two months. They were all non- 
pregnant and able to communicate well with the investigators. If there was any clinically 
significant medical condition, including major uterine pathology, renal, hepatic, 
cardiovascular, gastrointestinal, psychiatric or endocrine disorders and hypothalamic 
pituitary failure, these volunteers were excluded from the study. All subjects were treated 
on an outpatient basis and were counselled and given instructions about the procedure of 
the experiment. All procedures had Ethics' Committee approval and all clinical 
procedures were carried out by Mr T. C. Li of the Jessop Hospital for Women, Sheffield. 
3.2.2. EXPERIMENTAL DESIGN 
This was an open, random ordered and controlled study to find out the effects of 
clomiphene citrate (CC) on normal human endometrial stromal morphology. Each 
volunteer had a cycle without CC treatment and control group biopsies were obtained at 
day LH+6 [6 days after the luteinizing hormone (LH) peak which occurs just before the 
ovulation] of the untreated cycle. After a "washout" period of one cycle when no 
treatment was given, volunteers were given daily 50 mg CC tablets (Seropliene, Serono, 
UK) between days LH-11 and LH-7 (11 and 7 days respectively before the LH peak) 
during the proliferative phase in the menstrual cycle following the "washout" cycle. 
Clomipliene citrate treatment group biopsies were also obtained at day LH+6 of the 
menstrual cycle (Figure 3.2). 
Biopsy procedure, LH dating, histological processing, sectioning and staining of the 
endometrial tissue for light and electron microscopy and morphometric methods used in 
this study were the same as described in Chapter 2. 
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3.2.3. STATISTICAL ANALYSIS 
Every feature was calculated on a `per individuals' basis. Means and standard errors 
were calculated for each group and data were analysed using Student's unpaired t-test 
%%-here the conventional level 5% was taken as the level of significance. Same normal 
fertile subjects were used for both groups and comparisons were made before and after 
CC administration. While untreated group consisted of 6 individuals, CC-treated group 
contained 8 individuals. 
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3.3. RESULTS 
3.3.1. GLANDULAR EPITIIELIUM 
The mean ± standard error of the volume fraction of gland occupied by gland cell 
showed that there was no significant difference between untreated (0.832 ± 0.021) and 
CC treated (0.827 ± 0.021) groups (Table 3.1). The coefficient of variation for both 
groups was small (7%). The volume fraction of endometrium occupied by gland again 
was not significantly different between the groups, being 0.223 ± 0.017 in the untreated 
group and 0.279 ± 0.030 in the CC treated group (Table 3.1). The coefficient of 
variation of gland to endometrium for controls was 3 times larger (22%) than for gland 
occupied by gland cell, even larger (30%) in the CC treated group indicating its greater 
variability. 
3.3.2. STROMA 
The mean ± standard error of the volume fraction of stroma to endometrium was 
0.777 ± 0.017 in untreated group and 0.721 ± 0.030 in CC treated group which was not 
significantly different (Table 3.3). The volume fraction of stromal cell nucleus to 
cndometrium was 0.092 ± 0.010 in untreated group and 0.111 ± 0.006 in CC-treated 
group, however this numerical difference was not significant (Table 3.3). 
Similarly the mean ± standard error values of stromal cell nuclear profile 
measurements showed that the major axis, minor axis, mean diameter and axial ratio of 
the stromal cell nuclei did not significantly differ between groups (Table 3.2). 
The mean ± standard error for volume fraction of stromal cell occupied by nucleus 
was 0.454 ± 0.013 in untreated group, 0.487 ± 0.026 in CC treated group and the 
difference was not significantly different between groups (Table 3.3) (for comparison see 
Figure 2.6a and Figure 3.3a). However, once again the variation in the CC-group was 
about twice that seen in controls. The volume fraction of stromal cell nucleus occupied 
by eucliromatin was not significantly different between groups and neither were the 
volume fractions of stromal cell occupied by mitochondria, "secretory apparatus" and 
RER different (Table 3.3). On the other hand, the coefficient of variation of "secretory 
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Table 3.1: Comparison of volume fractions for glandular features between untreated and 
anti-oestrogen (CC) treated groups. 
Feature Untreated Group CC-Treated Group 
(n=8) (n=8) 
Vv of Gland Occupied by Gland 0.832 ± 0.021 0.827 ± 0.021 
Cell 
Vv of Endometrium Occupied by 0.223 ± 0.017 0.279 ± 0.030 
Gland 
Results are means ± SE 
n= number of individuals 
Table 3.2: Shows the stromal cell nucleus dimension data in micrometers comparing the 
untreated and CC-treated groups. 
Feature Untreated Group 
(n= 8) 
CC-Treated Group 
(n=8) 
Stromal Cell Nucleus Profile Major 6.59 ± 0.27 6.37 ± 0.17 
Axis (JIM) 
Stromal Cell Nucleus Profile Minor 3.62 ± 0.12 3.71 ± 0.08 
Axis (Itm) 
Stromal Cell Nucleus Profile Mean 4.82 ± 0.14 4.80 ± 0.08 
Diameter (µm) 
Stromal Cell Nucleus Profile Axial 1.93 ± 0.10 1.84 ± 0.08 
Ratio 
Results are means ± SE 
n= number of individuals 
Table 3.3 : The comparison of the volume fraction type data of the endometrial stromal 
and ultrastructural stromal cell features between untreated and CC-treated groups. 
Features Untreated Group 
(n=6) 
CC Treated Group 
(n=7) 
Vv of Endometrium Occupied by 0.777 ± 0.017 0.721 ± 0.030 
Stroma (n=8) (n=8) 
Vv of Endometrium Occupied by 0.092 ±0.010 0.111 ± 0.006 
Stromal Cell Nucleus (n=8) (n=8) 
Vv of Stromal Cell Occupied by 0.454 ± 0.013 0.487 ± 0.026 
Nucleus 
Vv of Stromal Cell Nucleus 0.801 ± 0.034 0.806 ± 0.023 
Occupied by Euchromatin 
Vv of Stromal Cell Occupied by 0.036 ± 0.004 0.035 ± 0.002 
Mitochondria 
Vv of Stromal Cell Occupied by 0.054 ± 0.004 0.075 ± 0.012 
"Secretory Apparatus" 
Vv of Stromal Cell Occupied by 0.033 ± 0.004 0.041 ± 0.006 
RER 
Results are means ± SE 
n= number of individuals 
apparatus" feature was much higher (41%) in the CC-treated group than the untreated 
group (18%) indicating a higher inter-subject variation within the CC group. In contrast 
the variation in mitochondria to cell was higher (28%) in controls than the CC-treated 
group (11 %). 
3.3.3. BLOOD VESSELS 
While there were no significant differences in the mean ± standard error of the volume 
fractions of blood vessel lumen to endometrium, and blood vessel tissue to endometrium, 
the volume fraction of blood vessel total (consisting of the lumen and the tissue) to 
cndometrium was significantly (p<0.05) higher (0.049 ± 0.003) in the CC-treated group 
than the untreated group (0.039 ± 0.003), indicating a possible effect of the clomiphene 
citrate on the endometrial blood vessels (Table 3.4). However, the coefficient of 
variation of the blood vessel lumen to endometrium was high and was twice as high 
(82%) in controls as in the CC-treated group. 
While the volume fraction of endothelial cell occupied by nucleus was not changed by 
CC treatment (for comparison see Figure 2.7a and Figure 3.3b), the volume fraction of 
endothelial cell nucleus occupied by euchromatin was significantly (p<0.05) decreased 
after CC treatment being 0.854 ± 0.019 in controls and 0.787 ± 0.008 in CC-treated 
group (Table 3.5). This may indicate reduced transcription of DNA in the CC group. 
There was no significant change in the volume fraction of mitochondria to cell following 
the CC treatment. However, the coefficient variation in this feature in the control group 
(44%) was much higher than the CC-treated group (25%). Although the volume 
fraction of "secretory apparatus" to cell was greater in the CC-treated group (0.049 ± 
0.004) than the untreated group (0.039 ± 0.003), the significance level was not within 
the conventional 5% limits (0.05<p<O. 1) due to the high coefficient of variations within 
the groups, indicating only a tendency of an increase after the CC treatment (Table 3.5). 
The volume fraction of endothelial cell occupied by RER again was not significantly 
different between groups but there was a tendency of reduction following the CC 
treatment with the significance level of 10% (0.05<p<0.1) being 0.031 ± 0.004 in the 
untreated group and 0.021 ± 0.003 in CC-treated group. Same result for the volume 
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Table 3.4: Shows the comparison of endometrial stromal blood vessel features between 
the untreated and CC-treated group. 
Features Untreated Group 
(n=8) 
CC-Treated group 
(n=8) 
Vv of Endometrium Occupied by Blood Vessel 0.011 ± 0.003 0.018 ± 0.003 
Lumen 
Vv of Endometrium Occupied by Blood Vessel 0.028 ± 0.002 0.031 ± 0.003 
Tissue 
VV of Endometrium Occupied by Blood Vessel 0.039 ± 0.003 0.049 ±0.003* 
Total (Vessels+Lumen) 
Results are means ± SE 
n= number of individuals 
*p<0.05 
Table 3.5: The comparison of ultrastructural endothelial cell features between groups. 
Features Untreated Group 
(n=6) 
CC Treated Group 
(n=8) 
Vv of Endothelial Cell Occupied by 0.595 ± 0.027 0.560 ± 0.013 
Nucleus 
Vv of Endothelial Cell Nucleus 0.854 ± 0.019 0.787 ± 0.008* 
Occupied by Euchromatin 
Vv of Endothelial Cell Occupied by 0.025 ± 0.005 0.024 ± 0.002 
Mitochondria 
Vv of Endothelial Cell Occupied b 0.039 ± 0.003 0.049 ± 0.004t 
"Secretory Apparatus" 
Vv of Endothelial Cell Occupied by 0.031 ±0.004 0.021 ±0.003 ' 
RER 
Results arc means ± SE 
n= number of individuals 
*p<0.05 
t0.05<p<0.1 
fraction of mitochondria to cell has been observed in endothelial cells as seen in stromal 
cells that the coefficient of variation was higher (44%) in controls than the CC treated 
group (25%) indicating an unknown effect of CC on the metabolic activity of both 
stromal and endotlielial cells. 
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Figures 3.3a, b: Clomiphene citrate-treated human endometrial stroma (a) and blood 
vessel (b) at day LH+6 of the menstrual cycle. (a) Stromal cells contain generally oval 
euchromatic nuclei (N) and regular cytoplasmic features which look similar to the day 
LH+6 control group stromal cells (see Figure 2.6a for comparison). (b) Blood vessel 
have round-shaped euchromatic nuclei (N) with organelles and a basement membrane 
(arrow) which are similar to normal day LH+6 vessels (for comparison also see Figure 
2.7a). (L) lumen, (G) Golgi apparatus, (mit) mitochondria. 
Staining: Uranyl Acetate - Lead Citrate 
(a) Bar represents 4.00 pm 
(b) Bar represents 1.80 µm 
ý 
r" 
i '., 
W 17, 
ar 
d Y-, ý p 
Fýp 1. . Fri ý 
"ý4 ýT AE 
rf, 
.1 
., '' 
ýýý 
f 
Ivry 
jLi 
f 
w 
, Mº' 
" i.. _ 
.: ' .. 
I 
S 
i. 
ý 
I''ýA 
3.4. DISCUSSION 
The major aim of this study was to investigate the effect of clomiphene citrate on the 
quantitative morphology of the stromal and vascular components of the normal fertile 
human endometrium. Some glandular features were also examined to determine the 
overall effect of the anti-oestrogen on endometrial structure. Normally ovulating fertile, 
rather than infertile, women were examined because the latter may be anovulatory or 
have abnormal endometrial development. Also, any changes observed in the 
cndometrium of infertile women treated with anti-oestrogens may be associated with a 
pre-existing abnormality, or be the effects of anti-oestrogen treatment, or both. 
however, any change seen in normal fertile women receiving anti-oestrogen treatment 
must be the result of CC treatment. 
While there were no major changes in glandular and stromal morphological features, 
blood vessels were slightly affected after treatment with CC. However, the coefficient of 
variations in some of the glandular, stromal and vascular features were greater in the CC- 
treated group than the untreated one, indicating a variable response of the subjects to the 
drug treatment. 
3.4.1. GLANDULAR EPITIIELIUM 
On average, the control group was not different from the CC-treated group when the 
volume density of gland cell to gland was compared. In the normal cycle around day 
Ll1+4 deposits of glycogen are seen which increase the overall volume of gland cells 
(Dockery et al. 1988b). This has the effect of closing the gland lumen and so increases 
the ratio of gland cell to gland values. This lasts only 1 or 2 days since the glycogen is 
transported apically and secreted into the gland lumen, thereby returning the cell volume 
to its earlier proportions. This rapid change makes gland cell to gland volume density a 
useful feature to determine advances or delays in uterine development compared to 
controls. In the present experiment there was no significant difference in the Vv of gland 
cell to gland between CC-treated and control subjects suggesting that treatment with 
anti-oestrogens had no effect on endometrial glandular development at the light 
microscopical level. Similarly, the volume fraction of endometrium occupied by total 
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gland did not differ between groups indicating no retardation or delay in endometrial 
development after CC treatment. On the other hand, the coefficient of variation in gland 
cell to gland volume density was smaller than the variation of gland to endometrium 
volume fractions. This indicates that while the response of glands to CC treatment were 
consistent at the level of individual glandular glycogen production and secretion, across 
the whole endometrium glands may show subtle changes in response to CC-treatment. 
Bonhoff el at (1993) have reported that CC treatment causes impaired glandular 
maturation. In that study, different types of ovarian stimulation protocols (combined 
hMG/hCG, combined CC/hMG/hCG and CC alone) were performed on infertile women 
undergoing infertility treatment and those results were compared to results from normal 
fertile women (22 Caucasian women, 20-40 years of age with a history of one or more 
pregnancies and with regular menstrual cycles and normal hormonal profiles). A total of 
65 subjects were used in their study and CC dosage regime was 50 to 150 mg/day 
between days 3-7. However, the sample size for CC-treatment experiment was small 
«ith only 12 subjects being used for all three CC-dosage regimes. Bonhoff an co- 
workers have analysed the endometrial tissue by using semi-quantitative morphometry, 
and stereological analyses were performed by using a computerized cell image analyzer. 
They found relatively large glands, being 62.9 ± 18.8 tm in diameter in CC-treated 
group, 47.0 ± 10.4µm in diameter in CC/hMG/hCG treated group, 53.3 ± 12.7Ftm in the 
fertile group, and decreased epithelial cell height, being 17.7 ± 4.2µm in CC-treated 
group, 19.4 ± 4.8µm in CC/hMG/hCG treated group, and 23.2 ± 3.3µm in the fertile 
group, after treatment with CC in the early secretory phase. While the sub-nuclear 
vacuolation was not changed in the early secretory phase, it was increased in mid-luteal 
and late-luteal phase after treatment with CC. In addition, they reported a decreased 
volume fraction of glandular epithelium to endometrium, being 12.4 ± 3.2 in CC-treated 
group and 16.6 ± 3.8 in the fertile group, following CC administration. They suggested 
that the CC-treatment impaired the glandular maturation in human endometrium. 
In contrast, in the present study objective stereological techniques were used to 
determine the volume densities of glandular and stromal features. In Bonhoffs study, 
infertile subjects were used and results from these subjects were compared with data 
from fertile women and it is not possible to exclude underlying pathologies from their 
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results. In addition, the experimental groups used by Bonhoff et al. were not grouped 
appropriately. For example biopsies between days LH+2 and LH+6 and between days 
LIi+7 and L11+10 were grouped together. It is not good practice to group the features 
from LH+2 and LH+6 endometrium because many structural changes occur normally at 
this time (Li et al. 1991a). For example, glandular sub-nuclear glycogen content is 
maximum about day LH+4 and secretion of this glycogen content is completed by the 
end of day LH+6. Pooling groups as done by Bonhoff et al. (1993), would be likely to 
obscure such changes. In contrast, in the present study all biopsies were taken at day 
LII+6 in both untreated and CC-treated groups. In addition normally ovulating fertile 
women rather than infertiles were used in both groups and so any change in endometrial 
structure was most likely the result of CC treatment. 
In a similar study, Hosie et al. (1991) compared the endometrial glandular features 
morphometrically using a fully automated image analysis system, between different types 
of ovarian stimulation protocols and suggested that the CC-hMG treatment has a 
suppressive effect on glandular development and growth. Other drug regimes in their 
study were CC/hMG + progesterone and buserelin/gnRH/hMG treatments. All biopsies 
obtained in their study were dated as day 17 using traditional histological criteria. 
However, all subjects used in their study were infertile and all comparisons were made 
between these drug treated infertile groups. Also they have not used normal fertile 
subjects as a control group. Comparison of three different superovulatory drug regimes 
without an unsupplemented control group should not be considered as a controlled, 
comparative experiment. 
Yeko et al. (1992) have reported the histology of the mid-luteal corpus luteum and 
endomctrium in normally ovulating fertile women after gradually increasing CC 
treatment. They suggested that the corpus luteum histology was not affected by CC 
treatment in any subject and that 83% of 12 mid-luteal. phase endometria were `in-phase" 
and only 17% were "out of phase". These 17% exhibited a 3-day lag in endometrial 
development. Apart from these 17% (2 out of 12 subjects) the results shown in their 
study generally agreed with those of the present study that the CC treatment has no 
adverse effect on endometrial morphology. Interestingly, in an ultrastructural study on 
the effects of CC on mid-proliferative phase human endometrium, Fedele et al. (1988) 
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have reported that the CC taken in a dose not exceeding 100 mg/day does not impair the 
cndomctrial development in anovulatory infertile women. These authors have suggested 
that " the discrepancy between the proportion of ovulatory cycles and pregnancy rate in 
women undergoing treatment with CC cannot be explained by endometrial 
modifications". Similarly, in a semi-quantitative morphological study, Deliou et al. 
(1987) demonstrated that neither CC nor the other hyperstimulatory drugs, such as I NG 
and hCG, have adverse effects on endometrial glandular morphology. Interestingly, the 
Dehou study was performed on infertile women who were treated for IVF. In contrast, 
in a similar type of study, Birkenfield et al. (1986) suggested a direct effect of CC on the 
anovulatory human endometrium indicating advanced secretory changes in glands and 
low progesterone levels during late proliferative phase of the menstrual cycle. They have 
commented that such a premature epithelial secretory pattern may cause a functional 
desynchronization which may have its implication during the peri-implantation period. 
However, these two studies were again performed on anovulatory women who may have 
different underlying pathologies and may react to CC treatment in different ways. 
In a qualitative morphological study, Benda (1992) reported straight, narrow and less 
tortuous glands than those in infertile women after treatment with CC when compared to 
the results those from untreated patients. In their study the gland to stroma ratio was 
decreased and glandular secretion was scant throughout the secretory phase. Late 
secretory epithelium was low cuboidal and rarely showed hypersecretory change. The 
author has commented that the less mature glandular morphology and reduced function 
arc due to the hypo-oestrogenic activity of the CC by directly altering the oestrogen 
action on the endometrium. However, first of all the results of their study were made 
using subjective qualitative evaluation and secondly, like most of the other studies on the 
effect of CC on endometrium, infertile subjects were used in their study. 
In a prospective, randomized, cross-over study, Li et al. (1992) reported that neither 
CC nor cyclofenil (another anti-oestrogen) has adverse effects on human endometrial 
morphology. 10 healthy, regularly cycling and previously fertile women were used in 
their study. A 50 mg daily dosage of CC were given to subjects between days 2-6 and 
endometrial biopsies were obtained at day LH+6 of the menstrual cycle and the same 
subjects were used both for control and CC treatment. There were no significant 
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differences between untreated and CC-treated groups in any of the following features; 
glandular mitosis (per 1000 cells), subnuclear vacuoles (per 100 gland cells), 
supranuclear vacuoles (per 100 gland cells), the volume fraction of gland to stroma and 
the volume fraction of gland cell to gland. Results of the Li study fully agreed with the 
results from the present study. 
3.4.2. STROMA 
The main aim of the present study was to investigate the effects of CC on endometrial 
stroma, and no stromal features appeared to be affected by treatment. Similar to the 
volume fraction of endometrium occupied by glands, the volume density of stroma to 
cndometrium was not changed after treatment with CC. Several stromal nuclear features 
were measured to determine whether or not CC has adverse effects on stromal cell 
function. The volume density of stromal cell nuclei to endometrium was measured to 
determine the relative proportion of total stromal cell nuclei following treatment with 
CC. A change in this feature could indicate changes in nuclear size or number, however 
it was unaffected by CC treatment. Nuclear profile size was measured by direct 
digitization and average diameter and ratio of maximum to minimum diameter used to 
obtain axial ratio, a crude indicator of profile shape. Active nuclei are often larger and 
rounder than inactive ones (Dockery et al. 1990). However, in the present study no 
difference in nuclear size or shape was seen indicating CC had no effect on nuclear 
activity seen at the light microscopical level. In addition, the volume density of nucleus 
to cell was not significantly different between untreated and CC-treated groups, although 
the coefficient of variation in the CC-treated group was twice as much as that observed 
in the untreated group. This may indicate a greater inter-subject variation within CC- 
treated group. The major morphological feature used to indicate nuclear transcription is 
the euchromatin-lieterochromatin distribution, with an increased euchromatin ratio within 
the nucleus suggesting increased transcription of DNA. In the present study, the volume 
density of nucleus occupied by euchromatin did not differ between untreated and CC- 
treated groups. All these stromal cell nuclear measurement results indicate that the CC 
treatment did not change either the morphology or the function of the stromal cell nuclei. 
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By examining the relative proportion of cell made up by organdies it is possible to 
infer functional changes. For example, increased Vv of mitochondria to cell would 
indicate increased oxidative phosphorylation, increased RER suggests elevated 
translation and protein secretion. In order to determine whether or not CC had effects 
on any of these functions various organelle Vvs were estimated. At the stromal cell 
organelle level, CC treatment had no effect on the volume densities of mitochondria to 
cell, "secretory apparatus" to cell and RER to cell suggesting that neither the metabolic 
activity nor the protein synthesis and the secretory function of the stromal cells were 
affected by treatment. These results were consistent with the results of the nuclear 
cuchromatin Vv measurements which were also unchanged after the treatment. 
However, the coefficient of variation of "secretory apparatus" to cell in CC-treated 
group was much higher (41%) than in the controls (18%) showing a large inter-subject 
variation in that group. Oddly, the coefficient of variation of mitochondria to cell was 
higher in controls than the CC-treated group, although the reason for this remains 
unclear. 
Bonhoff et a!. (1993) reported an increased volume density of stromal components 
shortly after ovulation and during mid to late luteal phase after treatment with CC and 
they have suggested a "disturbed" transformation of the secretory endometrium. 
However, as it was discussed in this chapter before, sample size in that study was too 
small and a very wide range of LH dated biopsies were grouped together. In addition, in 
contrast to the present study, there was no further morphometric investigation of stromal 
cell features such as stromal cell nucleus and cytoplasmic organelles. Therefore in the 
present study, a wide range of stromal cell features were evaluated morpliometrically and 
any effect of CC on endometrial stromal cell morphology was investigated. None of the 
stromal and stromal cell features, including volume density of stroma to endometrium, 
seemed to be affected by treatment with CC in the present study. 
Dehou et al. (1987) have reported an increased endometrial stromal oedema around 
days 21 and 22 of the cycle after sequential stimulation with CC, IiMG and hCG. 
However, they have commented that "all biopsies of stimulated cycles were found `in- 
phasc" and no advanced or delayed endometrium being diagnosed". 
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Similarly, Li et al. (1992) reported no changes in normally ovulating fertile human 
endometrium after treatment with CC. None of the endometrial stromal features, such as 
stromal mitosis (per 1000 cells), volume fraction of stromal nucleus to endometrium, 
mean stromal nuclear diameter and axial ratio of the stromal cell nucleus, were affected 
by CC treatment. The authors commented that anti-oestrogens do not have a major 
adverse effect on endometrial development which is the main outcome of the present 
study. 
In a qualitative morphological study, Fedele et a!. (1988) investigated the effect of 
clomiphene citrate on anovulatory human endometrial structure during mid-proliferative 
and late-proliferative phases and postovulation days 1 to 3. Stromal cells had an 
cosinophilic cytoplasm and mitosis were abundant during the mid-proliferative phase 
after treatment with CC. At the electron microscope level during that time, stromal cells 
were spindle shaped with various digitations and elongated nuclei which are the 
characteristics of the stromal cells in proliferative phase. In the late-proliferative phase, 
stromal oedema was observed at the light microscope level. Three days after ovulation, 
stromal oedema were increased and at the ultrastructural level, stromal cells were 
rounded and had numerous glycogen particles and lipid droplets in their cytoplasm. Yet 
again, these are the characteristics of the postovulatory endometrial stroma (Li et a!. 
1991a). The authors concluded that "CC, when taken at doses not exceeding 100 
mg/day from day three of the cycle, is able to induce endometrial maturation that is 
almost identical with that of spontaneous cycle" and this conclusion fully agrees with the 
results of the present study. 
Benda (1992) reported a progressive decidualization of stroma in the late luteal phase 
of the infertile human endometrium after treatment with clomiphene citrate. In some 
cases , the predecidual cells were smaller than expected, with 
less cytoplasm, and the 
overall amount of decidua was decreased. As discussed earlier in this chapter their study 
was performed on infertile women using subjective morphological evaluation. The 
results of the present study have clearly shown that there was no major effect of CC on 
endometrial morphology of fertile, normally ovulating women. 
Although the endometrial stroma has as important a function as the endometrial 
glandular epithelium in the maintenance of pregnancy, it has been poorly investigated by 
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previous studies and there appear to be very few previous published studies which 
involve a full morpliometric evaluation of the human endometrial stroma; the present 
report aimed to fill this gap. 
3.4.3. BLOOD VESSELS 
Apart from glandular epithelium and stroma, endometrial blood vessels are another 
important compartment of the endometrium which play a crucial role for the transport of 
hormones and other essential compounds into the endometrium as well as part of the 
placenta . Any effect of 
CC on endometrial blood vessels may cause severe defects in 
cndometrial function. To evaluate this possibility, in the present study, several 
cndometrial blood vessel features were studied morphometrically at both light and 
electron microscopical levels. At the light microscope level, the volume density of blood 
vessel plus lumen to endometrium was significantly (p<0.05) increased (from 0.039 ± 
0.003 to 0.049 ± 0.003) after CC treatment. This result could indicate several possible 
reactions of blood vessels to drug treatment. First is an increase in blood vessel lumen 
volume, second is an increase in blood vessel tissue volume and/or there could be an 
increase in both. However, the volume densities of blood vessel lumen to endometrium 
and blood vessel tissue to endometrium were evaluated separately and there were no 
significant changes in either of these individual features after treatment with CC. 
Therefore, while the increase in each component was small, combined the overall effect 
was significant. This may have been due to either an increase in number of the 
endometrial blood vessels following CC treatment or by hypertrophy of existing cells. In 
blood vessel lumen to endometrium feature, the coefficient of variation was considerably 
higher in the control group (82%) than the CC-treated group, being the most variable 
cilect of the clomiphene's effect on endometrial structure and function. 
The volume density of endothelial nucleus to cell was not changed by treatment. 
However, the volume fraction of endothelial cell nucleus occupied by euchromatin was 
significantly (p<0.05) decreased after treatment with CC. Euchromatin-heterochromatin 
ratio is one way of evaluating cell function. Increased eucliromatin amount is the 
indicator of the increased transcriptional rate of DNA in the nucleus and subsequent 
increased metabolic and secretory activity in the cytoplasm. In the present study, 
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reduced cuchromatin amount in the endothelial cell nucleus may indicate an adverse 
effect of CC on endometrial blood vessels. However, further investigation of the 
endothelial cell morphology disagrees with this possibility. There was no significant 
difference in the volume fraction of mitochondria to cell, and similar to stromal cells, the 
coefficient of variation of this feature was much higher in the untreated group than the 
CC-treated group indicating the same unknown effect of the clomipliene citrate 
treatment on the metabolic activity of both cell types. Although the volume density of 
endothelial cell occupied by "secretory apparatus" was numerically greater in the CC- 
treated group than the untreated group, the significance level was not within the 
conventional 5% limits, indicating only a tendency of an increase after treatment with 
clomiphene citrate. This result may indicate two possible interpretations; it is either an 
increase in the secretory activity of the cell, or more likely an increase in transportation 
of substances between blood and stromal compartment. The volume fraction of 
endothelial cell occupied by RER again was not significantly different between groups 
but there was a tendency of a reduction after CC treatment with the probability level of 
10 percent. It could be suggested that the tendency of this reduction in the volume 
density of RER may be the reflection of the decrease in volume density of cuchromatin to 
endothelial cell nucleus. However, neither of these results were significant and so such 
comment remains speculative. 
Although a very small number of studies have dealt with the effect of CC on 
cndometrial stroma, there was not a single study published on the potentially important 
effects of CC on endometrial blood vessel and endothelial cell morphology. 
Eicosanoids, including prostaglandins, leukotrines and related substances, are potent 
biologic mediators which are produced by a variety of tissues including those in the 
cndometrium and decidua (Boura and Walters 1991). These substances act as local 
hormones with a major influence on vasomotor tone, as mediators of vasoconstriction, 
vasodilatation and vessel permeability (Shaw et al. 1994). Eicosanoid production by the 
endometrium may be important in the regulation of the menstrual cycle and possibly 
conception and implantation (Friedman 1988). In recent years, the abnormal production 
and action of these substances have been implicated in the pathophysiology of a number 
of disorders complicating pregnancy, including preterm labour and pregnancy loss 
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(Mitchell et al. 1990; Bennet et al. 1987). Prostaglandin (PG) dehydrogenase inactivates 
PGs by oxidising the 15-hydroxyl group and thus plays a key role in controlling their 
effective local concentrations (Kelly et al. 1994). This enzyme is thought to be under the 
control of steroid hormones and is found in human endometrium at high levels in the 
secretory phase of the menstrual cycle, but is absent during the proliferative phase 
(Downie et al. 1974). It has been shown that the amount of PG dehydrogenase is 
increased during the secretory phase of the menstrual cycle after treatment with 
clomiphene citrate (Kelly et al. 1994). It could be speculated that in the present study, 
slightly changed endometrial blood vessel morphology after CC treatment may be related 
to prostaglandin inactivation by CC in endometrium which plays an important role in the 
permeability of the vessels and has both vasoconstrictor and vasodilator functions. 
However, this aspect of the human endometrium needs more consideration. As is seen in 
the present study, function and morphology of the endometrial compartments including 
epithelium, stroma and blood vessels are closely related to each other and must be 
considered as a complete structure when examining the endometrium and the effects of 
drug treatment on it. 
In summary, there were no significant differences in any of the glandular epithelial 
features evaluated in the present study. Stromal cell nuclear profile values and none of 
the volume fraction values differed between groups. On the other hand, the coefficients 
of variation in some features such as "secretory apparatus to cell" and stromal nucleus to 
cell were greater in CC-treated group than the untreated group. In addition, interestingly 
the coefficient of variation in the volume fraction of stromal cell occupied by 
mitochondria was higher in the untreated group than the CC-treated group, indicating 
some unknown effect of anti-oestrogen on the metabolic activity of the stromal cells. 
'Ilse volume density of blood vessels to endometrium was increased following the 
treatment and there were no change in the volume fraction of endometrium occupied by 
blood vessel lumen and blood vessel tissue, suggesting that the increase in total volume 
of the blood vessels might be the result of either an increase in number of blood vessels 
or an increase in existing endothelial cell size after CC treatment. In addition there was a 
tendency of an increase in the volume fraction of "secretory apparatus to cell", indicating 
an increased secretory function of the endothelial cells and/or an increase in 
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transportation between blood and stromal compartment. Furthermore, there was a 
tendency of the volume fraction of RER to cell to decrease, being consistent with the 
reduction in the volume density of euchromatin to endothelial cell nucleus. Similar to the 
volume density of mitochondria to cell in stromal cells, the coefficient of variation of this 
feature in endothelial cells again was much higher in the untreated group than the CC- 
treated group, showing the same unknown effect of the anti-oestrogen on the metabolic 
activity of both cell types. 
lt could be concluded that the CC administration had no adverse effect on glandular 
epithelial and stromal morphology of the normally ovulating fertile human endometrium. 
Therefore, blood vessels seemed to be slightly affected by treatment with clomiphene 
citrate. 
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CHAPTER 4 
EFFECTS OF GROWTH HORMONE ON HUMAN 
ENDOMETRIAL STROMA AROUND THE TIME OF 
IMPLANTATION 
4.1. INTRODUCTION 
For many years, growth hormone (GH) has been used to treat children with 
hypopituitarism and short stature. More recently, it has also been used to treat patients 
with Turner's syndrome to improve the final height achieved (Wilton 1987; Massa et al. 
1993; Naeraa et al. 1994). In addition, GH has been used to augment the response of 
the human ovary to stimulation by human menopausal gonadotrophins (Homburg et al. 
1988; 1990). A growing number of reports clearly indicate the possible involvement of 
Gil in the regulation of ovarian follicle growth and development in mammals (Jia et a!. 
1986; Manson et al. 1990; Ando et a!. 1994). It is likely that GH will be used more 
often in the future for the treatment of infertility, however relatively little is known about 
exactly how it works and whether or not it has effects on reproductive organs such as the 
endometrium as well as the ovary. 
it is the aim of the present study to investigate the effects of GH supplementation on 
human endometrial stromal and vascular morphologies in two groups of patients 
undergoing hormone replacement therapy (HRT); the 2 groups are patients with 
Turner's syndrome and patients with idiopathic premature ovarian failure (POF). The 
results from the infertile groups (Turner's syndrome and idiopathic POF compared both 
separately and as a combined HRT group) will also be compared to the results from a 
group of well-characterized normal fertile individuals in order to provide a better 
understanding of the effects of GH on endometrial structure and function. In addition to 
the stromal and vascular evaluations, some glandular features will also be examined for a 
more complete picture of the endometrial morphology during GH treatment and 
hormone replacement therapy. 
4.1.1. PREMATURE OVARIAN FAILURE (POF) 
Premature ovarian failure (POF) is defined as the cessation of menses as a result of 
failing gonads, indicated by elevated gonadotrophins before the age of 40 years (de 
Morales-Ruehsen and Jones 1967; La Barbera et a!. 1988) and affects about 1% of 
women (Coulam et a!. 1986). The absence of follicles differentiates POF from the 
potentially treatable disorder (in terms of restoring fertility) termed the resistant ovary 
syndrome (Aiman and Smentek 1985; Mehta et a!. 1992). POF may occur as a result of 
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an autoimmune destruction of ovarian tissue analogous to the destruction of the thyroid 
in chronic thyroiditis. In this type of POF, sensitised lymphocytes invade the gonad and 
destroy ovarian tissue with consequent failure of hormone production (La Barbera et al. 
1988). The presence of associated autoimmune disorders in patients with POF suggests 
that up to 40% may have their ovarian failure mediated by an immune mechanism 
(Coulam 1983; Alper and Garner 1985). More commonly the ovaries may fail 
prematurely without evidence of infiltration by lymphocytes or circulating ovarian 
antibodies, and the cause of this premature ovarian failure is unknown and it is called 
idiopathic POF. In these disorders, the ovary is unable to respond to appropriate 
gonadotrophin stimulation. POF can be differentiated from other causes of anovulation 
as the serum and urinary levels of FSH will be raised. Ovarian disorders may also be 
responsible for the failure of ovulation by producing abnormal quantities of hormone 
which disrupt the hypothalamic control of gonadotrophins (Philipp and Carruthers 1981). 
4.1.2. TURNER'S SYNDROME 
Two normal X chromosomes are necessary for the maturation of female germ cells. 
If one X chromosome is absent or deficient, ovarian follicles do not develop. In this case 
the gonad is represented by a ridge on the broad ligament in the normal position of the 
ovary, and it is composed of connective tissue without follicles (Philipp and Carruthers 
1981). The XO gonad has follicles at birth though reduced to only 20% of the normal 
quantity. In the syndrome described by Turner (1938), these features of ovarian 
dysfunction were associated with shortness of stature, webbing of the neck and cubitus 
valgus. Although development of the ovary is influenced to a varying degree in different 
individuals, most patients with this syndrome are of short stature and rarely reach a 
height of more than 5 ft (Lippe 1991). Most women with this condition have only 45, 
instead of the normal 46, chromosomes and this is due to non-disjunction of the sex 
chromosome occurring during meiosis and consequently their sex chromosome 
constitution is XO instead of XX. These patients are chromatin negative on nuclear 
sexing, because the chromatin body of the cell is due to the second X chromosome 
normally present in the female cell. However, one-quarter of these patients have 46 
chromosomes and so are chromatin positive. These patients with Turner's syndrome 
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have the normal number of chromosomes but one of the X chromosomes is structurally 
abnormal. The other cause of the Turner's syndrome with a normal number of 
chromosomes is the result of what is called mosaicism. In this condition some of the 
cells have 46 chromosomes and others have 45 and this is due to non-disjunction 
occurring aller fertilization during one of the early divisions of the zygote. Such patients 
may have normal stature and some secondary sex development due to the presence of the 
XX cell line, and may even appear quite normal. 
4.1.3. GROWTH HORMONE: ITS RELEVANCE TO THE FEMALE 
REPRODUCTIVE SYSTEM 
Growth hormone (GH) is the most abundant hormonal element in the human pituitary 
gland and its role in early growth is well-documented (Wilton 1987; Massa et al. 1993; 
Naeera et al. 1994). Growth hormone is a small protein which, in human, consists of 
191 amino acids with the molecular weight of 27,000 and it has two disulphide bridges 
(Lee and Laycock 1978). It is estimated that as much as 5 to 10 mg of GH is present in 
adult pituitary somatotropic cells (Daughaday 1985). About 35% to 45% percent of the 
total cellular mass of the adult pituitary gland is made of the somatotropic cells 
(Daughaday 1985). Despite this apparent abundance, the precise role of growth 
hormone in adult life remains uncertain and while it markedly increases during puberty, it 
declines progressively thereafter ( Daughaday 1985; Katz eta!. 1993). 
GE! may enhance gonadotropin action, synergizing in the promotion of ovarian 
function. It may be viewed as a co-gonadotropin, capable of enhancing gonadotropin 
hormonal action but possibly incapable of acting by itself (Katz et a!. 1993). It is also 
possible that GH may affect ovarian function via the hypothalamic-pituitary axis. 
4.1.3.1. TIIE OVARY AS A SITE OF GII-RELEASING HORMONE (GIIRII) 
PRODUCTION, RECEPTION AND ACTION 
The presence of immunostainable growth hormone releasing hormone (GHRH) 
positive cells in human ovarian tissue was recently demonstrated (Moretti et al. 1990a) 
using a highly specific anti - GHRH serum. Specifically, GHRH immunoreactivity is 
localized in the corpora lutea of normally cycling women. Particularly strong and 
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specific staining is evident in theca-derived cells of the corpora lutea (Moretti et al. 
1989). Human GHRH reactivity is also detectable in oocytcs (Moretti et al. 1990b), 
The above mentioned findings suggest the existence of GHRH or a GIIRII-related 
protein in both the somatic (thecal) and germ cell (oocyte) components of the ovary. 
Although GHRH constitutes a central component of the somatotropic hypothalamic- 
pituitary axis, it is also possible that ovarian GHRH may play intraovarian roles distinct 
from its GH releasing property regardless of the absence or presence of ovarian GH - 
secreting cells (Katz et al. 1993). This possibility is supported by recent observations 
«bere GHRH has been shown to augment FSH - supported cAMP accumulation by 
cultured rat granulosa cells (Moretti et al. 1990b). However, it must be considered that 
the modulatory action of GHRH at the level of the ovary is FSH - dependent and that 
locally derived GHRH may synergize with FSH in the promotion of follicular 
development (Katz et al. 1993). 
4.1.3.2. THE OVARY AS A SITE OF GII PRODUCTION, RECEPTION AND 
ACTION 
Immunoreactive human GH has been found in human ovaries both by radioreceptor 
and radio-immunoassays (Kaganowicz et al. 1992). The first demonstration of the 
apparent dependence of rat ovarian function on GH were Advis et al. (1981) whose 
observations revealed that the in vitro ovarian progesterone response to both hCG and 
human FSH was distinctly increased by in vivo GH pre-treatment. Moreover, 
concomitant GH treatment increased the FSH-inducable granulosa cell LH/hCG receptor 
binding capacity by enhancing the action of low doses of FSH (Jia et al. 1986). The 
gonadotropic property of GH was investigated in rats by Jorgensen et al. (1991). They 
examined the influence of systemic treatment with human growth hormone on the length 
of oestrus cycle and the number of implantation sites and corpora lutea in the rat. A 
significant increase in the length of oestrus cycle occurred when compared to the 
placebo-treated controls. In addition, the number of implantation sites and corpora lutea 
was significantly higher in GH-treated rats (Jorgensen et al. 1991). 
Taken together, the published information strongly suggest that the ovary is in fact a 
site of Gil reception and action. However, additional formal demonstration of ovarian 
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Gil receptor gene expression and cellular localization remains to be shown. Although 
the exact role of GH in ovarian physiology remains to be determined, it may well act as a 
co-gonadotropin, i. e., as an amplifier of gonadotropin hormonal action. 
4.1.4. INSULIN-LIKE GROWTH FACTOR (IGF) SYSTEM 
Recently, the significance of intraovarian regulators has become increasingly 
recognized and much of the attention has focused on IGFs. A large number of evidence 
suggests the existence of an intraovarian IGF system complete with ligands, receptors 
and binding proteins (Adashi et al. 1985). IGF-I and IGF-II show structural homology 
to pro-insulin and have effects on cell proliferation, growth, differentiation and 
metabolism (Daughaday and Rotwein 1989). IGFs are bound to specific insulin-like 
growth factor binding proteins (IGFBPs) which play an important role in IGF action. Six 
different IGFBPs have been identified, cloned and sequenced (Shimasaki and Ling 1991). 
IGFBPs regulate the transport and presentation of IGFs to their receptors and modulate 
the biological actions of IGFs. IGFs have been shown to exert a variety of effects at the 
level of murine (Davoren et a!. 1985; Adashi et a!. 1986), porcine (Veldliuis et al. 1986; 
Maruo et a!. 1988) and human (Erickson et al. 1989,1990) somatic ovarian cells. Their 
most important role is to synergize with pituitary gonadotropins and to amplify their 
impact (Katz et al. 1993). Immunoreactive IGF-I and IGF-II gene expressions have 
been clearly demonstrated at the level of ovarian granulosa cells in several species 
(Murphy et al. 1987; Hsu and Hammond 1987). It has also been shown that the ovary is 
not only a site of IGF production but that there exist high-affinity, low-capacity type-I 
IGF binding sites in murine (Adashi et a!. 1988), porcine (Baranao and Hammond 1984), 
ovine (Monget et a!. 1989) and human (Gates et a!. 1987) ovarian granulosa cells. 
The action of GH at the ovarian level may potentially involve two separate pathways. 
On the one hand, GH may interact with GH receptors, resulting a signal transduction 
directly modulating gonadotropin hormone action. Alternatively, GH may be acting (via 
its receptor) indirectly by stimulating ovarian IGF gene expression, which could result in 
the augmentation of the gonadotropin-supported growth and differentiation of somatic 
ovarian cells (Katz et al. 1993). 
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The cndometrium also synthesizes both IGF-I and IGF-II (Seppala et a!. 1994). 
T)pe-I and type-II IGF receptors have been demonstrated in tissues, including the 
cndometrium and placenta (Marshall et al. 1974; Rutanen et al. 1988). In rat uterus, 
oestrogen stimulates both IGF-I and IGF-II as well as expression of type-I IGF receptor 
mRNA, indicating that IGFs mediate the proliferative action of the oestrogen (Murphy 
and Ghahary 1990). In human endometrium, IGF-I mRNA is abundant in the late 
proliferative phase and IGF-II mRNA in the early proliferative phase (Boehm et al. 
1990), or in the secretory phase (Giudice et al. 1991). 
4.1.5. GI[ SECRETION DURING THE MENSTRUAL CYCLE 
Gil is released from the pituitary in a pulsatile fashion (Miller et al. 1982), the 
secretion pattern being fairly constant for each individual subject (Parker et a!. 1969). 
Zadik et al. (1985) analyzed the menstrual pattern of GH release by 24-hour sampling 
and found no difference in the integrated concentrations of GH between the follicular and 
luteal phase of 23 normally cycling women studied once each phase of the cycle. More 
recently, Faria et a!. (1991) performed a study of GH release in normal women during 
the menstrual cycle. Serum GH was obtained from each of 15 women every 10 minutes 
for 24 hours during the early follicular, the late follicular and the mid-luteal phase of the 
menstrual cycle. The mean integrated serum GH concentration in late follicular phase 
women was higher than that observed in early follicular phase counterparts. The mean 
integrated serum GH concentration was intermediate in mid-luteal phase but not 
significantly different from that observed in early and late follicular phase of the cycle. In 
addition, multiple regressions revealed a positive correlation between maximal GH pulse 
amplitude and oestrogen and a significant negative correlation between maximal Gil 
pulse amplitude and progesterone (Faria eta!. 1991). These observations clearly indicate 
that late follicular phase concentrations of oestrogen may enhance GH pulse amplitude 
rather than frequency. On the other hand, progesterone may diminish this oestrogen 
cflect. lt could also be suggested that pulsatile GH release throughout the menstrual 
cycle is primarily regulated by way of amplitude modulation. 
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4.1.6. ENHANCEMENT OF OVULATION BY GROWTH HORMONE 
The view of enhancing the ovulation by GH is based on the observations previously 
performed on experimental animals and these observations indicate; 
I. That IGF-I is capable of substantial amplification of gonadotropin hormonal action 
when examined in vitro at the level of either the granulosa or the theca-interstitial cell 
(Adashi et al. 1985). 
2- That GH (in concert with oestrogens) may in fact be in position to upregulate the 
intraovarian generation of IGF-I (Hernandez et al. 1989). 
It is the combined weight of these two observations that leads to the suggestion that 
Gil may enhance the generation of intraovarian IGF-I and thus amplify gonadotropin 
hormonal action at the level of the ovary. 
Growth hormone has been used in women with hypogonadotrophic state and 
treatment with GH reduced the overall IiMG requirement in those women (Homburg et 
a!. 1988). In this study, GH significantly augmented the ovarian response to ING in 
women undergoing ovulation induction even though all of them were previously hMG 
resistant. In a following report, again GH administration reduced the duration of 
treatment and the dose of 11MG required (Homburg et a!. 1990). Furthermore, no 
significant differences were found in the circulated levels of oestrogen on the day of hCG 
administration and, more importantly, three of sixteen patients conceived in the first 
study cycle (Homburg et a!. 1990). A similar observation was indicated by Bergh et a!. 
(1994) that the fertilization rate was increased in infertile patients who had received GI I. 
4.1.7. ACTIONS OF GROWTH HORMONE AND IGF SYSTEM IN OTHER 
PARTS OF TIIE REPRODUCTIVE TRACT 
In addition to the ovulation enhancing effects, growth hormone causes a significant 
increase in circulating serum levels of IGF-I (Bergh et at. 1994; Tapanainen et al. 1991) 
and IGFBP-3 (Bergh et al. 1994). In trophoblastic cells and on placental membranes, 
IGFBP-1 inhibits the receptor binding and biological action of IGF-I (Pekonen et al. 
1988; Ritvos et al. 1988). The degree of IGFBP-1 phosphorylation increases from early 
to late gestation; thus the affinity of IGFBP-1 to bind and inhibit IGF-I action is highest 
at the end of pregnancy (Koistinen et at 1993). The decidual cells secrete IGFBP-1 
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(Scppala et a!. 1994). Because the trophoblast possesses IGF receptors and expresses 
IGF-lt mRNA but not IGFBP-1 mRNA (Pekonen et at. 1988), it is possible that IGFBP- 
1 produced by the stromal cells has an influence on embryonic cells. IGF-I and IGF-11 
mRNAs have been found in human embryos (Bondy et al. 1990). The presence of both 
the receptor and the binding protein with equal binding affinities for IGFs in adjacent 
cells indicates a paracrine interaction between trophoblastic and decidual cells (Seppala 
eta!. 1994). 
The administration of GH may optimize ovulation induction regimens to increase 
number of oocytes, improve the quality of oocytes, and most importantly it may improve 
conception rates. However, it is still not clear yet whether GH administration has effects 
on the other parts of the reproductive tract especially on structure and function of the 
endometrium which plays a crucial role for implantation and the maintenance of 
pregnancy. It is the aim the present study to evaluate the effects of GH treatment on the 
morphology of the endometrium in women with hypopituitaric conditions during HRT 
cycles. 
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4.2. MATERIALS AND METHODS 
4.2.1. SUBJECTS 
Six infertile subjects were used in the present study; 3 patients with Turner's 
syndrome and 3 patients with idiopathic premature ovarian failure (POF). All patients 
were treated on an outpatient basis. Within one month prior to entry into the study, the 
patients underwent a medical examination to ensure their eligibility for inclusion into the 
trial If no contra-indications to participation were found, patients were allocated a study 
number and commenced a prestudy cycle. Since the patients had no luteinizing hormone 
production, dating of the endometrial biopsy material in the present study was done from 
the onset of the next menstrual period (NMP). All experiments performed in the present 
study had Ethics' Committee approval and informed patient consent. These patients 
were studied over several years under the treatment of Mr T. C. Li of Jessop Hospital for 
Women. 
4.2.2. EXPERIMENTAL DESIGN 
This was an open, random order, controlled, cross - over study designed to determine 
the effect of growth hormone (Saizen, Serono, U. K. ) on the endometrial response to 
steroids in three patients with idiopathic POF and three patients with Turner's Syndrome. 
Following the prestudy medical examination, patients underwent a prestudy cycle of 
Cyclo-Progynova. Since the patients did not have sex steroid secretion, treatment of 
Cyclo - Progynova, which is a combination of oestrogen and progesterone, was used to 
start patients' reproductive response. Seven days after completion of the prestudy cycle, 
patients began their first study cycle, consisting of a standard Hormone replacement cycle 
(Navot ct al. 1986) with or without growth hormone supplementation. All patients 
underwent two study cycles (each preceded by a cycle of Cyclo-Progynova). After the 
first treatment cycle, patients crossed - over to receive the alternative treatment (i. e. 
standard hormone replacement cycle with or without growth hormone supplementation). 
Figure 4.1 illustrates the treatment process of the present study. Since this study was 
organised on an out - patient basis, patients received their medication either at the 
hospital or at home, whatever was most convenient for the patient. If a patient wished to 
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Figure 4.1 Shows the standard hormone replacement (Navot et al. 1986) and growth hormone 
administration protocols. Each individual had either HRT+GH administration or only HRT during 
the first treatment cycle, then they were crossed-over and received the alternative treatment 
(HRT+GH or only HRT) in the second study cycle. 
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administer the injections herself, she was instructed accordingly and all patients were 
required to keep a record of medications taken. An endometrial biopsy was taken on day 
19 of the each study cycle and was subjected to morphological analysis. The total 
length of the study for each patient was four months. See Figure 4.2 for the 
experimental design of the present study. 
Biopsy procedure, tissue sampling, histological processing and staining for light and 
electron microscopy and morphometric methods used in the present study are the same 
as described in Chapter 2. 
4.2.3. STATISTICAL ANALYSIS 
Every feature was calculated on a `per individual' basis. Means and standard errors 
were calculated for each group and data were analysed using a Student's unpaired t-test 
where the conventional level of 5% was taken as the level of significance. In addition to 
the comparisons between untreated and GH treated infertile groups, comparisons were 
also made between fertile day LH+6 and untreated and GH treated infertile groups. 
Figure 4.3 demonstrates sets of statistical analysis performed in the present study. Since 
the data from the normal fertile group have already been presented in Chapter 2, they are 
not repeated in this chapter. 
81 
b 
aý 
a 
aý 
b 
a 
rA a a 0 
ä4 
a r 
a 
1T 
a 
H 
b 
N 
iý 
ed 
0 
u 
cl v 
o. + 0 
N 
v U 
'i 
u L 
04 
%o ýa 
a 
0 
O 
U 
cd 
0 
ov 
Mä 
vMýý 
MM 
I' 
pä Ö 
P-1 gli P, 
o ýb p no 
. 
0ý"i 0aä 
00M Ö 
-' t1. 
M II 
PO v 'd 0"0+ 
Ei ^ 
aö ;m 11 
UM; tli 11 .C0 
;m 
`ä M jai aýO 
O ýQ 
}ö 
:- ors 
°v° o) --% ego - 
10 
e-o u C, äi 4. ) w 
55 a'' 
5- >>>ää 
(A V1 " Co) ^v ee 
U 
C) C 'ý uv im 
ii 
ii 
ii 
il 
ii 
aaaaa 4-11 
Föööööö 
C) C) C 0- wb 
äh b) b bb 
.r4. b .r .r ed . -+ ... . -. . -. .ý .ý C) C) 
OOOO 
º`p 
ýý Cx7 ÜÜÜÜÜÜ 
4.3. RESULTS 
In the present study, the effects of growth hormone (GH) on human endometrial 
stromal and vascular morphologies were evaluated morphometrically in two groups of 
patients; those with Turner's syndrome and those with idiopathic premature ovarian 
failure (POF) during hormone replacement therapy (HRT) cycles. In addition, these 
treatment cycles were compared to the results from normal day LH+6 group in order to 
determine the differences between untreated and GH treated infertility conditions with 
normal fertile conditions. Day LH+6 is selected since it is the nearest available 
corresponding time to day 19 of the menstrual cycle. Since the results of day LH+6 
group are already presented in Chapter 2, these results are not repeated in the following 
tables but where necessary, day LH+6 results will be referred to in the corresponding 
tables of Chapter 2. 
4.3.1. GLANDULAR EPITHELIUM 
There were no significant differences in any of the glandular features between 
untreated and GH treated Turner's syndrome and idiopathic POF groups (Tables 4.1; 
4.2; 4.3). In addition, Turner's + idiopathic POF groups did not differ significantly 
before or after the GH treatment (Table 4.1). However, there were significant 
differences between day LH+6 and infertile groups indicating some abnormalities of the 
endometrial glandular features in Turner's syndrome and idiopathic POF patients (for 
comparison see Table 2.1). The volume fraction of gland occupied by gland cell was 
higher in untreated Turner's syndrome + idiopathic POF group than day LH+6 group, 
being 0.832 ± 0.021 in day LH+6 group and 0.885 ± 0.010 in Turner's + idiopathic POF 
group. However, the significance level was marginal in this feature suggesting only a 
tendency of an increase. On the other hand this increase in gland cell volume density 
became much higher after treatment with GH being 0.899 ± 0.009 in GH treated 
Turner's syndrome + idiopathic POF group. This increase was significantly (p<0.05) 
different between groups. When the day LH+6 group was compared to the untreated 
Turner's syndrome group, the volume density of gland occupied by gland cell was 
significantly (p<0.02) higher in untreated Turner's syndrome patients being 0.903 ± 
0.012 in this group, suggesting a retardation in endometrial glandular epithelium 
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Table 4.1: Comparison of the endometrial glandular features between untreated and 
GII treated patients (both groups consist of Turner's syndrome and idiopathic POF 
individuals). 
Features Untreated Turner's Gil Treated Turner's 
Syndrome + Idiopathic POF Syndrome + Idiopathic POF 
(n=6) (n=6) 
Vv of Gland Occupied by 0.885 ± 0.010 0.899 ± 0.009 
Gland Cell 
Vv of Endometrium 0.261 ± 0.017 0.309 ± 0.021 
Occupied by Gland 
Results are means ± SE 
n= number of individuals 
Table 4.2: Comparison of the glandular features between untreated and GH treated 
Turner's syndrome groups. 
Features Untreated Turner's Gil Treated Turner's 
Syndrome Group (n=3) Syndrome Group (n=3) 
Vv of Gland Occupied by 0.903 ± 0.012 0.910 ± 0.006 
Gland Cell 
Vv of Endometrium 0.268 ± 0.007 0.324 ± 0.032 
Occupied by Gland 
Results are means ± SE 
n= number of individuals 
Table 4.3: Comparison of the glandular features between untreated and GH treated 
idiopathic POF groups. 
Features Untreated Idiopathic POF Gil treated Idiopathic POF 
Group (n-3) Group (n-3) 
Vv of Gland Occupied by 0.866 ± 0.008 0.888 ± 0.017 
Gland Cell 
Vv of Endometrium 0.254 ± 0.037 0.293 ± 0.030 
occupied by Gland 
Results are means ± SE 
n= number of individuals 
development. This difference in glandular cell volume density was much higher when 
treated with GH (0.910 ± 0.006 in GH treated Turner's syndrome group). The 
difference was highly significant (p<0.01) between these groups, indicating some further 
effects of GH on endometrial glandular structure and function. 
This feature was not significantly different between the day LH+6 group, and 
untreated idiopathic POF and GH treated idiopathic POF groups suggesting more normal 
cndometrial glandular structure and function in idiopathic POF patients and no effects of 
Gil on this feature. The increase in glandular cell volume density in the Turner's 
syndrome group may be the result of an increase in glandular cell glycogen content and 
qualitative observations of the present study showed more glycogen - like material in the 
subnuclear region of the glandular cells (Figure 4.4a, b). 
The volume fraction of endometrium occupied by gland did not significantly differ 
between the untreated group and the GH treated Tuner's syndrome + idiopathic POF 
group, between untreated Turner's syndrome and GH treated Turner's syndrome groups, 
nor between untreated idiopathic POF and GH treated idiopathic POF groups (Tables 
4.1; 4.2; 4.3). When compared with day LH+6 group, the untreated Turner's + 
idiopathic POF group again showed no difference. However, this feature significantly 
(p<0.01) differed between day LH+6 group and the GH treated Turner's syndrome + 
idiopathic POF group being 0.223 ± 0.017 in day LH+6 group and 0.309 ± 0.021 in GH 
treated Turner's syndrome + idiopathic POF group (see Table 2.1). This result was 
consistent with an increase in glandular cell volume density suggesting a possible delay in 
cndometrial glands in the GH treated group. 
Similarly, this feature was significantly (p<0.05) different between the day LH+6 
group and the untreated Turner's group (0.268 ± 0.007) whereas the difference between 
day LIi+6 and GH treated Turner's was further increased (p<0.05) to 0.324 ± 0.032 in 
the GH treated Turner's group. On the other hand, there was no significant difference in 
this feature between day LH+6, and untreated and Gil treated idiopathic POF groups 
suggesting a better response to HRT and GH regimens from POF patients and no 
evidence for the retarded endometrial glandular epithelium. These results may also 
indicate that the significant differences found in the glandular epithelial features between 
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Figures 4.4a, b: Light (a) and electron microscopical (b) demonstration of glycogen 
(Gly) content in glandular epithelial cells of untreated idiopathic POF group at day 19 of 
the menstrual cycle. (N) nucleus, (Str) stroma. 
Staining: (a) Periodic Acid - Schiff (PAS) 
(b) Periodic Acid Thiosemicarbazide - Gelatine Methenamine Silver (PATSC 
- GMS). 
(a) Bar represents 32 µm 
(b) Bar represents 2.30 µm 
, 6, 
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a 
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day LII+6 and Turner's syndrome + idiopathic POF groups are likely to be due mainly to 
the Turner's syndrome group. 
4.3.2. STROMA 
The volume fraction of endometrium occupied by stroma did not differ between 
untreated and GH treated Turner's syndrome + idiopathic POF groups, untreated and 
Gil treated Turner's syndrome groups and untreated and GH treated idiopathic POF 
groups (Tables 4.7; 4.8; 4.9). Moreover, the endometrial stromal volume density was 
not significantly different between untreated Turner's syndrome and idiopathic POF, and 
Gil treated Turner's syndrome and idiopathic POF groups. While the volume fraction of 
stroma to endometrium did not differ between day LH+6 and untreated Turner's 
syndrome + idiopathic POF groups, it was significantly (p<0.01) different between day 
L11+6 (0.777 ± 0.017) and GH treated Turner's syndrome + idiopathic POF groups 
(0.691 ± 0.021). In addition, the volume density of endometrial stroma was significantly 
(p<0.05) different between day LH+6 and untreated Turner's syndrome groups (0.732 ± 
0.007) and between day LH+6 and GH treated Turner's syndrome groups (0.676 ± 
0.032). There were no significant differences between day LH+6 and untreated 
idiopathic POF, nor between day LH+6 and GH treated idiopathic POF groups (for 
comparison see Table 2.2 and Tables 4.7; 4.8; 4.9). These significant differences 
between the fertile day LH+6 group and infertile groups indicate an abnormal 
development of the endometrium in these type of the infertility cases. This decreased 
endometrial stromal volume density was consistent with the increased glandular volume 
fraction of glands in infertile groups possibly indicating a retarded endometrial 
development in these groups. 
This decreased volume density of stromal compartment might cause an increase in 
packing density of the endometrial stromal cells. To evaluate this, the volume fraction of 
endometrium occupied by stromal cell nucleus were measured and there were some 
significant differences between groups. This feature was not significantly different 
between untreated Turner's + idiopathics and GH treated Turner's + idiopathics, 
between untreated Turner's and GH treated Turner's, and between untreated idiopathics 
and GH treated idiopathics. However, it was significantly (p<0.02) different between 
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Table 4.4: Comparison of the stromal cell nuclear dimension data between untreated 
and Gil treated groups of both Turner's syndrome and idiopathic POF patients. 
Features 
Untreated Turner's 
Syndrome + Idiopathic 
POF (n=6) 
Gil Treated Turner's 
Syndrome + Idiopathic 
POF n=6 
Stromal Cell Nuclear Profile 7.01 ± 0.19 6.94 ± 0.18 
Major Axis (µm) 
Stromal Cell Nuclear Profile 3.92 ± 0.14 3.83 ± 0.10 
Minor Axis (µm) 
Stromal Cell Nuclear Profile 5.16 ± 0.16 5.09 ± 0.12 
Mean Diameter (µm) 
Stromal Cell Nuclear Profile 1.98 ± 0.07 1.99 ± 0.05 
Axial Ratio 
Results are means ± SE 
n= number of individuals 
Table 4.5: Comparison of the stromal cell nuclear dimension data between groups of 
untreated and GH treated Turner's syndrome patients. 
Features Untreated Turner's 
Syndrome Group (n-3) 
Gil Treated Turner's 
Syndrome Group (n-3) 
Stromal Cell Nuclear Profile 6.86 ± 0.35 6.81 ± 0.06 
Major Axis (µm) 
Stromal Cell Nuclear Profile 4.00 ±0.28 3.81 ± 0.15 
Minor Axis (µm) 
Stromal Cell Nuclear Profile 5.17 ± 0.32 5.02 ±0.11 
Mean Diameter (µm) 
Stromal Cell Nuclear Axial 1.87 ± 0.06 1.96 ±0.10 
Ratio 
Results are means ± SE 
n= number of individuals 
Table 4.6: Comparison of the stromal cell nuclear dimension data between groups of 
untreated and GH treated idiopathic POF patients. 
Features Untreated Idiopathic 
POF Group n=3 
Gil treated Idiopathic POF 
Group (n-3) 
Stromal Cell Nuclear Profile 7.16 ± 0.20 7.08 ± 0.38 
Major Axis (pm) 
Stromal Cell Nuclear Profile 3.83 ± 0.14 3.85 ± 0.15 
Minor Axis (µm) 
Stromal Cell Nuclear Profile 5.16 ± 0.14 5.16 ± 0.24 
Mean Diameter (pm) 
Stromal Cell Nuclear Axial 2.08 ± 0.10 2.02 ± 0.03 
Ratio 
Results are means ± SE 
n= number of individuals 
Table 4.7: Comparison of the volume fraction data of the endometrial stromal features 
between untreated and GH treated groups of both Turner's syndrome and idiopathic 
POF patients. 
Features Untreated Turner's 
Syndrome + Idiopathic 
POF (n=6) 
Gil Treated Turner's 
Syndrome + Idiopathic 
POF (n=6) 
Vv of Endometrium Occupied 0.739 ± 0.017 0.691 ± 0.021 
by Stroma 
Vv of Endometrium Occupied 0.119 ± 0.007 0.126 ± 0.007 
by Stromal Cell Nucleus 
Vv of Stromal Cell Occupied 0.446 ± 0.018 0.442 ± 0.018 
by Nucleus 
Vv of Stromal Cell Nucleus 0.811 ± 0.034 0.786 ± 0.027 
Occupied by Euchromatin 
Vv of Stromal cell Occupied 0.027 ± 0.003 0.031 ± 0.003 
by Mitochondria 
Vv of Stromal Cell Occupied 0.029 ± 0.002 0.035 ± 0.004 
by "Secretory Apparatus" 
Vv of Stromal Cell Occupied 0.033 ± 0.007 0.035 ± 0.005 
by RER 
Results are means ± SE 
n= number of individuals 
Table 4.8: Comparison of the volume fraction data of the stromal features between 
groups of untreated and GH treated Turner's syndrome patients. 
Features Untreated Turner's 
Syndrome Group (n=3) 
GII Treated Turner's 
Syndrome Group (n=3) 
Vv of Endometrium Occupied 0.732 ± 0.007 0.676 ± 0.032 
by Stroma 
Vv of Endometrium Occupied 0.116 ± 0.008 t0.112 ± 0.002 
by Stromal Cell Nucleus 
Vv of Stromal Cell Occupied 0.472 ± 0.030 0.435 ± 0.019 
by Nucleus 
Vv of Stromal Cell Nucleus 0.828 ± 0.052 0.786 ± 0.049 
Occupied by Euchromatin 
Vv of Stromal Cell Occupied 0.024 ± 0.001 0.031 ± 0.005 
by Mitochondria 
Vv of Stromal Cell Occupied 0.029 ± 0.003 0.038 ± 0.008 
by "Secretory Apparatus" 
Vv of Stromal Cell Occupied 0.024 ± 0.004 0.031 ± 0.009 
by RER 
Results are means ± SE 
na number of individuals 
Table 4.9: Comparison of the volume fraction data of the stromal features between 
groups of untreated and GH treated idiopathic POF patients. 
Features Untreated Idiopathic POF 
Group (n=3) 
GI_i Treated Idiopathic 
POF Group (n=3) 
Vv of Endometrium Occupied 0.746 ± 0.037 0.707 t 0.030 
by Stroma 
Vv of Endometrium Occupied 0.122 ± 0.013 t0.141 ± 0.007 
by Stromal Cell Nucleus 
Vv of Strornal Cell Occupied 0.419 ± 0.007 0.449 t 0.035 
by Nucleus 
Vv of Stromal Cell Nucleus 0.795 ± 0.052 0.787 ± 0.036 
Occupied by Euchromatin 
Vv of Stromal cell Occupied 0.029 ± 0.004 0.032 ± 0.004 
by Mitochondria 
Vv of Stromal Cell Occupied 0.029 ± 0.004 0.031 ± 0.005 
by "Secretory Apparatus" 
Vv of Stromal Cell Occupied 0.041 ± 0.038 0.038 ± 0.004 
byRER 
Results are means ± SE 
n- number of individuals 
t Student's t- Test result (p<0.02) (GH treated Turner's syndrome vs GH treated 
idiopathic POF) 
Gil treated Turner's syndrome (0.112 ± 0.002) and idiopathic POF groups (0.141 ± 
0.007) indicating either an increase in packing density of stromal cells or an increase in 
stromal cell nuclear dimensions after treatment with GH. The volume density of stromal 
cell nucleus was numerically higher in untreated Turner's syndrome + idiopathic POF 
group than day LH+6 group, however, the significance level was marginal when the 
results were compared statistically. On the other hand, this feature was significantly 
(p<0.05) higher in GH treated Turner's syndrome + idiopathic group being 0.126 ± 
0.007 in GH treated Turner's + idiopathics and 0.092 ± 0.010 in day LH+6 group. In 
addition, the volume fraction of endometrium occupied by stromal cell nucleus was 
significantly (p<0.01) different between day LH+6 (0.092 ± 0.010) and GH treated 
idiopathic group ( 0.141 ± 0.007) whereas day LH+6 and untreated idiopathics did not 
differ significantly (Tables 4.7; 4.8; 4.9 and Table 2.2). 
There were no significant differences between any of the untreated and GH treated 
Turner's syndrome and idiopathic POF groups in the stromal cell nuclear profile 
dimension features (Tables 4.4; 4.5; 4.6). Furthermore, there were no significant 
differences between day LH+6 and any of the untreated and GH treated groups in major 
profile axis, minor profile axis, profile mean diameter and axial ratio of the stromal cell 
nucleus (for comparison see Table 2.3 and Tables 4.4; 4.5; 4.6). 
The volume fraction of stromal cell occupied by nucleus did not differ significantly 
between any of the untreated and GH treated infertile groups (Tables 4.7; 4.8; 4.9) 
(Figures 4.5a, b and Figures 4.6a, b). Further comparisons of this feature between day 
L1i+6 and untreated and GH treated Turner's syndrome + idiopathic POF groups also 
showed no significant differences. When the volume density of stromal cell nucleus was 
compared separately between cycle day LH+6 and untreated and GH treated infertile 
groups, the only significant (p<0.05) difference was found between day LII+6 (0.454 ± 
00.013) and untreated idiopathic POF groups (0.419 ± 0.007) indicating either a 
decreased stromal cell nuclear size or an increased stromal cell cytoplasmic volume in 
untreated idiopathic POF individuals (Table 2.2 and Table 4.9). The volume density of 
stromal cell nucleus occupied by euchromatin did not differ significantly between any of 
the infertile groups, nor between day LH+6 fertile and untreated and Gil treated infertile 
groups (for comparison see Tables 4.7; 4.8; 4.9 and Table 2.2). 
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Figure 4.5a: Endometrial stromal cells of untreated Turner's syndrome group at day 19 
of the cycle. (N) nucleus 
Staining: Uranyl acetate - Lead citrate 
Bar represents 3.80 µm 
Figure 4.5b: Stromal cells of GH treated Turner's syndrome group at day 19 of the 
menstrual cycle. (N) nucleus 
Staining: Uranyl acetate - Lead citrate 
Bar represents 4.60 µm 
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Figures 4.6a, b: Endometrial stromal cells of untreated (a) and GH-treated (b) idiopathic 
POF group at day 19 of the menstrual cycle. Untreated group cells seem to have larger 
nuclei (N) than the GH-treated group cells, however quantitative evaluation showed no 
significant difference between groups. 
Staining: Uranyl Acetate - Lead Citrate 
(a) Bar represents 4.10 µm 
(b) Bar represents 4.00 Itm 
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The volume fraction of stromal cell occupied by mitocliondria was not significantly 
different between any of the infertile groups, nor between day LH+6 and untreated and 
GIl treated Turner's syndrome + idiopathic POF groups. The only significant (p<0.05) 
difference in the volume density of mitochondria to cell was found between day LII+6 
(0.036 ± 0.004) and untreated Turner's syndrome groups (0.024 ± 0.001). The 
mitochondrial volume density in stromal cells was significantly lower in the untreated 
Turner's syndrome group suggesting a lower metabolic demand in stromal cells in this 
particular type of infertility. However, the volume fraction of stromal cell occupied by 
mitochondria was not significantly different between cycle day LH+6 and untreated and 
GH treated idiopathic POF groups, possibly indicating a better response from these 
individuals to HRT and GH treatment (Table 2.2 and Tables 4.7; 4.8; 4.9). 
Similar to the mitochondrial volume density data, the volume fraction of "secretory 
apparatus" to stromal cell was not significantly different between any of the untreated 
and GH treated infertile groups. However, this feature differed significantly when the 
cycle day LH+6 group were compared to untreated and GH treated infertile groups (for 
comparison see Table 2.2 and Tables 4.7; 4.8; 4.9) suggesting large deviations from the 
normal secretory activity in Turner's syndrome and idiopathic POF individuals. The 
difference in the volume fraction of stromal cell occupied by "secretory apparatus" was 
highly significant (p = 0.0002) between day LH+6 (0.054 ± 0.004) and untreated 
Turner's syndrome + idiopathic POF groups (0.029 ± 0.002). 
This difference between the same groups in the same feature remained (p<0.01) after 
treatment with GH, being 0.035 ± 0.004 in the GH treated Turner's syndrome + 
idiopathic POF group. When the volume density of "secretory apparatus " was 
compared separately between day LH+6, Turner's syndrome and idiopathic POF groups, 
they were generally significantly (p<0.01) different with or without growth hormone 
treatment, except in the comparison of GH treated Turner's syndrome group with cycle 
day LI1+6. 
Similar to other organelle features, the volume fraction of stromal cell occupied by 
RER did not differ between any of the infertile groups. In addition, no significant 
differences were found between day LH+6 and untreated and GH treated infertile 
groups, apart from the untreated idiopathics versus day LH+6 comparison. There was a 
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tendency (p<O. 1) of a higher RER to stromal cell volume density in the untreated 
idiopathic POF group (0.041 ± 0.004) than the cycle day LH+6 group, (0.033 ± 0.004) 
possibly suggesting a higher synthetic activity in this group. 
4.3.3. BLOOD VESSELS 
At the light microscope level, the volume fraction of endometrial blood vessel 
features did not significantly differ between any of the untreated and GH treated infertile 
groups (Tables 4.10; 4.11; 4.12). While there were no significant differences in the 
volume fraction of endometrium occupied by blood vessel lumen between cycle day 
L1; +6 and untreated Turner's syndrome + idiopathic POF groups, the volume density of 
blood vessel tissue significantly (p<0.005) differed between the same groups being 0.028 
± 0.002 in the day LH+6 group and 0.017 ± 0.002 in the untreated Turner's syndrome + 
idiopathic POF group. Furthermore, the volume fraction of endometrium occupied by 
total blood vessel (vessels + tissue) significantly (p<0.05) differed between these groups 
(0.039 ± 0.003 in day LH+6 group and 0.025 ± 0.004 in untreated Turner's + 
idiopathics). The volume fraction of blood vessel lumen was not significantly different 
between day LH+6 and GH treated Turner's + idiopathic POF groups. However, the 
volume density of total blood vessel differed significantly (p<0.05) between the same 
groups being 0.026 ± 0.005 in GH treated Turner's + idiopathic POF group (for 
comparison see Table 2.4 and Table 4.10). There was a significant (p<0.02) difference 
in the volume fraction of endometrium occupied by blood vessel tissue between day 
L1l+6 (0.028 ± 0.002) and untreated Turner's syndrome group (0.017 ± 0.003). The 
same significant (p<0.02) difference was found in the volume density of total blood 
vessel when the same groups were compared being 0.039 ± 0.003 in day Lei+6 group 
and 0.021 ± in untreated Turner's syndrome group. 
In the Turner's syndrome group after treatment with GH, the significant difference 
found in the volume density of blood vessel tissue disappeared. However, the significant 
(p<0.05) difference in the volume fraction of total endometrial blood vessel remained 
between day LH+6 and GH treated Turner's group. When day Lli+6 group were 
compared to the untreated idiopathic POF group, the only significant (p<0.05) difference 
found was in the volume density of blood vessel tissue, being 0.018 ± 0.003 in the 
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Table 4.10: Comparison of endometrial blood vessel features between untreated and 
Gil treated groups of both Turner's syndrome and idiopathic POF patients. 
Features Untreated Turner's 
Syndrome + Idiopathic 
POF (n=6) 
Gil Treated Turner's 
Syndrome + Idiopathic 
POF (n=6) 
Vv of Endometrium Occupied by 0.008 ± 0.003 0.006 ± 0.003 
Blood Vessel Lumen 
Vv of Endometrium occupied by 0.017 ± 0.002 0.020 ± 0.004 
Blood Vessel Tissue 
Vv of Endometrium Occupied by 0.025 ± 0.004 0.026 ± 0.005 
Blood Vessel Total 
(Vessels + Lumen) 
Results are means ± SE 
n= number of individuals 
Table 4.11: Comparison of the volume fraction of endometrial blood vessel features 
between untreated and GH treated Turner's syndrome groups. 
Features Untreated Turner's 
Syndrome Group 
(n=3) 
Gil Treated Turner's 
Syndrome Group (n=3) 
Vv of Endometrium Occupied by 0.004 ± 0.002 0.004 ± 0.003 
Blood Vessel Lumen 
Vv of Endometrium occupied by 0.017 ± 0.003 0.017 ± 0.006 
Blood Vessel Tissue 
Vv of Endometrium Occupied by 0.021 ± 0.005 0.021 ± 0.006 
Blood Vessel Total 
(Vessels + Lumen) 
Results are means ± SE 
n= number of individuals 
Table 4.12: Comparison of the volume fraction of endometrial blood vessel features 
between untreated and Gil treated idiopathic POP groups. 
Features Untreated Idiopathic 
POP Group (n-3) 
Gil Treated Idiopathic 
POF Group (n-3) 
Vv of Endometrium Occupied by 0.011 ±0.005 0.008 ±0.004 
Blood Vessel Lumen 
Vv of Endometrium occupied by 0.018 ± 0.003 0.022 ± 0.004 
Blood Vessel Tissue 
Vv of Endometrium Occupied by 0.029 ± 0.005 0.031 ± 0.008 
Blood Vessel Total 
(Vessels + Lumen) 
Rcsults are means ± SE 
n- number of individuals 
untreated idiopathic POF group. The remaining blood vessel features were not 
significantly different between the groups indicating a closer pattern of development in 
the idiopathic POF group to the normal fertile endometrial development. Furthermore, 
the significant difference seen in idiopathic POF group disappeared after GH treatment, 
suggesting some unknown effects of GH on endometrial vascularization. 
At the electron microscope level, the volume fraction of endothelial cell occupied by 
nucleus was significantly (p<0.02) different between untreated and GH treated Turner's 
syndrome + idiopathic POF groups being 0.581 ± 0.018 in untreated group and 0.499 ± 
0.0 12 in GH treated ones (Table 4.13). However, this significant decrease in endothelial 
cell nuclear volume density disappeared when infertile groups were compared with or 
without GH treatment (Tables 4.14; 4.15) (Figures 4.7a, b). In addition, there were no 
significant differences in this feature when untreated and GH treated Turner's syndrome 
groups were compared to untreated and GH treated idiopathic POF groups separately. 
While there was no significant difference between day LH+6 and untreated Turner's 
syndrome + idiopathic POF groups, it was significantly (p<0.01) different between day 
LH+6 (0.595 ± 0.027) and GH treated Turner's + idiopathic POF groups (0.499 ± 
0.012). On the other hand, there was no significant difference between day LH+6 and 
untreated Turner's syndrome groups, however, these groups were significantly different 
(p<0.05) when the Turner's syndrome group were treated with GH (0.502 ± 0.022). 
The same results were observed between fertile day LH+6 and idiopathic POF groups. 
While there was no difference between day LH+6 and untreated idiopathic POF group, 
the volume density of endothelial cell nucleus was decreased significantly (p<0.02) after 
treatment with GH, being 0.495 ± 0.015 (for comparison see Table 2.6 and Tables 4.13; 
4.14; 4.15). This decreased endothelial cell nuclear volume density in both groups after 
Gil treatment may suggest either a decrease in nuclear volume or an increase in 
cytoplasmic volume under the effect of growth hormone or its combination with HRT. 
There were no significant differences in the volume fraction of endothelial cell nucleus 
occupied by euchromatin between any of the untreated and GH treated infertile groups 
(Tables 4.13; 4.14; 4.15). Therefore, this feature was significantly (p<0.05) different 
between day LH+6 (0.854 ± 0.019) and untreated Turner's syndrome + idiopathic POF 
groups (0.770 ± 0.026). Furthermore this significance level (p<0.05) was preserved after 
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Table 4.13: Comparison of the volume fraction data of endothelial cell features 
between untreated and GH treated groups of both Turner's syndrome and idiopathic 
POF patients. 
Features Untreated Turner's 
Syndrome + Idiopathic 
POF (n=6) 
Gil Treated Turner's 
Syndrome + Idiopathic 
POF (n=6) 
Vv of Endothelial Cell Occupied by 0.581 ± 0.018t 0.499 t 0.012t 
Nucleus 
Vv of Endothelial Cell Nucleus 0.770 ± 0.026 0.752 t 0.036 
Occupied by Euchromatin 
Vv of Endothelial Cell Occupied by 0.023 ± 0.002 0.031 t 0.005 
Mitochondria 
Vv of Endothelial Cell Occupied by 0.029 ±0.003 0.035 t 0.003 
"Secretory Apparatus" 
Vv of Endothelial Cell Occupied by 0.018 ± 0.003 0.024 ± 0.001 
RER 
Results are means ± SE 
na number of individuals 
t Student's t- Test result (p<0.02) (untreated Turner's + idiopathic POF vs GH 
treated Turner's + idiopathic POF) 
Table 4.14: Comparison of the volume fraction data of endothelial cell features 
between untreated and GH treated Turner's syndrome groups. 
Features Untreated Turner's 
Syndrome Group (n=3) 
Gil Treated Turner's 
Syndrome Group (n-3) 
Vv of Endothelial Cell Occupied 0.606 ± 0.016 0.502 ± 0.022 
by Nucleus 
Vv of Endothelial Cell Nucleus 0.782 ± 0.026 0.743 ± 0.063 
Occupied by Euchromatin 
Vv of Endothelial Cell Occupied 0.022 ± 0.003 0.029 ± 0.008 
by Mitochondria 
Vv of Endothelial Cell Occupied 0.023 ± 0.004 0.032 ± 0.003 
by "Secretory Apparatus" 
Vv of Endothelial Cell Occupied 0.017 ± 0.005 0.023 ± 0.001 
by RER 
Results are means ±SE 
ns number of individuals 
Table 4.15: Comparison of the volume fraction data of endothelial cell features 
between untreated and GH treated idiopathic POF groups. 
Features Untreated Idiopathic 
POF Group (nm3) 
Gil Treated Idiopathic 
POF Group (n=3) 
Vv of Endothelial Cell Occupied 0.556 ± 0.028 0.495 ± 0.015 
by Nucleus 
Vv of Endothelial Cell Nucleus 0.758 ± 0.050 0.761 ± 0.048 
Occupied by Euchromatin 
Vv of Endothelial Cell Occupied 0.024 ± 0.003 0.035 ± 0.009 
by Mitochondria 
Vv of Endothelial Cell Occupied 0.034 ±0.003 0.037 ±0.007 
by "Secretory Apparatus" 
Vv of Endothelial Cell Occupied 0.018 ± 0.004 0.024 ± 0.003 
by RER 
Results are means ± SE 
n= number of individuals 
Figures 4.7a, b: Untreated idiopathic POF group (a) and GH-treated Turner's syndrome 
group (b) blood vessels. Since there were no significant differences in endothelial cells 
between untreated and GH-treated groups, GH-treated idiopathic POF group and 
untreated Turner's syndrome group blood vessel electron micrographs are not presented 
here. (N) nucleus, (L) lumen, (P) pericyte. 
Staining: Uranyl Acetate - Lead Citrate 
(a) Bar represents 1.95 µm 
(b) Bar represents 1.85 µm 
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treatment with GH, being 0.752 ± 0.036 in GH treated Turner's syndrome + idiopathic 
POF group (for comparison see Table 2.6 and Table 4.13). However, there was only a 
tendency of a decrease in the volume density of endothelial cell nuclear cuchromatin 
between day LH+6 (0.854 ± 0.019) and GH treated Turner's syndrome groups (0.743 ± 
0.063). There were no differences in this feature between day LH+6 and untreated and 
GH treated idiopathic POF groups, possibly because of the relatively high coefficients of 
variation within the infertile groups. 
No significant differences were found in the volume fraction of endothelial cell 
occupied by mitochondria between any of the untreated and GH treated infertile groups 
nor between day LH+6 and infertile groups, suggesting no change in the metabolic 
demand of the endothelial cells after treatment with GH and no differences in this feature 
between fertile (day LH+6) and infertile groups (Tables 4.13; 4.14; 4.15 and Table 2.6 in 
Chapter 2). The volume density of "secretory apparatus" to endothelial cell was also not 
significantly different between infertile groups. However, it differed significantly 
(p<0.05) between day LH+6 (0.039 ± 0.003) and untreated Turner's syndrome + 
idiopathic POF groups (0.029 ± 0.003) suggesting either a decreased secretory activity 
of endothelial cells or a decreased transport between stroma and blood in the infertile 
groups. This significant difference disappeared after GH treatment of the infertile 
individuals. When day LH+6 was compared to the infertile groups separately, the 
volume fraction of "secretory apparatus" was significantly (p<0.02) different between 
day LH+6 (0.039 ± 0.003) and untreated Turner's syndrome groups (0.023 ± 0.004). 
However, there was no difference between day LH+6 and GH treated Turner's 
syndrome group, nor between day LH+6 and untreated and Gil treated idiopathic POF 
groups indicating either a more normal secretory activity of endothelial cells in idiopathic 
POF individuals or a better response to HRT from them. 
Similar to the other endothelial cell features, the volume density of RER to 
endothelial cell was not significantly different between any of the infertile groups (Tables 
4.13; 4.14; 4.15). On the other hand, it was significantly (p<0.05) different between the 
day LH+6 and untreated Turner's syndrome + idiopathic POF groups being 0.031 ± 
0.004 in day LH+6 group and 0.018 ± 0.003 in untreated Turner's + idiopathic POF 
group. When the infertile groups received GH treatment, this significant difference 
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between fertile and infertile groups disappeared (Tables 4.13; 4.14; 4.15). Interestingly, 
the separate comparisons in this feature between day LH+6 and untreated and GH 
treated infertile groups did not generally show significant differences, apart from 
tendencies to decrease in untreated Turner's syndrome and untreated idiopathic POF 
groups. 
There were no significant differences between any of the untreated and GH treated 
infertile groups in the blood vessel arithmetic and harmonic mean basement membrane 
thicknesses (Tables 4.16; 4.17; 4.18). The arithmetic mean basement membrane 
thickness was significantly (p<0.01) different between day LH+6 (81.17 ± 1.92 nm) and 
untreated Turner's syndrome + idiopathic POF groups (101.41 ± 5.41 nm). It was again 
significantly (p<0.002) different between day LH+6 and GH treated Turner's syndrome 
+ idiopathic POF groups (105.19 ± 4.93 nm) (for comparison see Table 2.7 and Table 
4.16). When infertile groups were compared to the fertile group separately, the 
arithmetic mean thickness was significantly (p<0.02) different between day LH+6 and 
untreated Turner's syndrome group (103.92 ± 9.36 nm). The significance level 
(p<0.001) between day LH+6 and Turner's syndrome group increased when the 
Turner's syndrome group was treated with GH (101.88 ± 1.82 nm). The arithmetic 
mean basement membrane thickness was significantly (p<0.05) different between day 
LI1+6 and untreated idiopathic POF groups (97.90 ± 7.40 nm) and the significance level 
(p<0.01) was preserved when the idiopathic POF group was treated with Gil (108.49 ± 
10.35 nm) (Tables 4.17; 4.18 and Table 2.7). While there were marginally significant 
differences in the blood vessel harmonic mean basement membrane thickness between 
day L11+6 and untreated Turner's syndrome groups, and between day LI1+6 and 
untreated idiopathic POF groups, this feature was significantly (p<0.01) different 
between day L11+6 (82.74 ± 1.87 nm) and GH treated Turner's syndrome groups (93.32 
± 0.69 nm), and between day LH+6 and GH treated idiopathic POF groups (95.86 ± 
3.07 nm) (Table 2.7 and Tables 4.17; 4.18). These significant differences between fertile 
group and infertile groups indicate an abnormal blood vessel structure and function in 
these types of infertility cases. In addition, it is noteworthy that the differences were 
more significant after treatment of infertile groups with growth hormone, indicating some 
unknown effects of GH on endometrial blood vessel structure. 
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Table 4.16: Comparison of endometrial blood vessel basement membrane thicknesses 
between untreated and GH treated groups of both Turner's syndrome and idiopathic 
POF patients. 
Features Untreated Turner's Gil Treated Turner's 
Syndrome + Idiopathic Syndrome + Idiopathic 
POF (n=6) POF (n=G) 
Endometrial Blood Vessel Arithmetic 101.41 ± 5.41 105.19 ± 4.93 
Mean Basement Membrane Thickness 
(nanometers) 
Endometrial Blood Vessel harmonic 92.82 ± 2.98 94.59 ± 1.52 
Mean Basement Membrane Thickness 
(nanometers) 
Results are means ± SE 
n= number of individuals 
Table 4.17: Comparison of endometrial blood vessel basement membrane thicknesses 
between untreated and GH treated Turner's syndrome groups. 
Features Untreated Turner's 
Syndrome Group (n=3) 
Gil Treated Turner's 
Syndrome Group (n'3) 
Endometrial Blood Vessel Arithmetic 103.92 t 9.36 101.88 t 1.82 
Mean Basement Membrane Thickness 
(nanometers) 
Endometrial Blood Vessel Harmonic 94.16 t 4.74 93.32 t 0.69 
Mean Basement Membrane Thickness 
(nanometers) 
Results are means ± SE 
n= number of individuals 
Table 4.18: Comparison of endometrial blood vessel basement membrane thicknesses 
bctwecn untreated and GH treated idiopathic POF groups. 
Features Untreated Idiopathic 
POF Group (n=3) 
Gil Treated Idiopathic 
POF Group (n-3) 
Endometrial Blood Vessel Arithmetic 97.90 ± 7.40 108.49 ± 10.35 
Mean Basement Membrane Thickness 
(nanometers) 
Endometrial Blood Vessel Harmonic 91.47 ± 4.50 95.86 ± 3.07 
Mean Basement Membrane Thickness 
(nanometers) 
Results are means ± SE 
n= number of individuals 
4.4. DISCUSSION 
The present study has dealt with the effects of growth hormone (GH) on the 
morphology of endometrial stromal and vascular structures in patients with Turner's 
syndrome and patients with idiopathic POF during standard hormone replacement 
therapy (HRT). Endometrial biopsies were obtained at day 19 of the cycle. Lli dating 
of the endometrial biopsies was not performed since the subjects had no endogenous 
gonadotrophin secretion due to their infertility. Both untreated and Gil treated infertile 
groups' data were compared in order to determine the effects of GH on endometrial 
structure and function. The data from infertile subjects were also compared with data 
from normally ovulating fertile subjects (at day LH+6) for a more complete comparison 
of endometrial structure between these types of infertility conditions and normal fertile 
conditions. Day LH+6 has been selected for the fertile group since it was the nearest 
available corresponding time to day 19 of the menstrual cycle. 
As it can be seen in Figure 4.3, the experimental design of the present study is a very 
complicated one and the statistical comparisons involve the combined infertile groups 
either with or without GH treatment, and their comparisons with the day LH+6 fertile 
controls. Furthermore, the comparisons were also made between GH treated and 
untreated groups of Turner's syndrome and idiopathic POFs separately and also between 
these infertile groups and the day LH+6 controls. 
In the present study, the small sample size for the statistical comparisons was an 
unavoidable disadvantage, due to the difficulty of obtaining the endometrial tissue for 
this type of study. These blocks represent the total tissue available for Gil treated POF 
and Turner's syndrome subjects over almost 3 years. Untreated and GH treated infertile 
Turner's syndrome and idiopathic POF groups were combined together since they both 
lacked endogenous ovarian hormone secretion (although their aetiologies are different - 
see Introduction). These two infertile groups were also compared separately to the other 
groups, however, their small sample size may be one reason for the relatively low 
significance levels in separate statistical comparisons between Turner's syndrome and 
idiopathic POF groups. 
While there were no major changes in overall endometrial morphology between any 
of the untreated and GH treated infertile groups, they were significantly different 
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between fertile LH+6 group and infertile groups (either with or without GH), suggesting 
an impairment in the development of endometrium in infertile groups. In addition, the 
significance levels in some endometrial features between the day LH+6 fertile group and 
GII treated infertile groups were higher than between the day LH+6 fertile group and 
untreated infertile groups, suggesting that the treatment with GH may have some 
unknown effects on endometrial development. Since there are very few publications 
dealing with the effects of GH on the endometrial morphology (especially on the stromal 
and vascular compartments), findings of the present study will be discussed in separate 
subheadings and then comparisons with the existing available literature will be made at 
the end of this section. 
4.4.1. GLANDULAR EPITIIELIUM 
No major changes were found in glandular epithelial morphology between any of the 
untreated and GH treated infertile groups. However, both untreated and GH treated 
infertile groups differed significantly from the normal fertile group in a way which 
suggested a retardation in glandular epithelium of the infertiles. The volume density of 
gland cell to gland was significantly higher (6%) in untreated Turner's + idiopathic POF 
than the control group and the level of significance became larger when the infertile 
group was treated with GH (8% higher in the GH treated Turner's syndrome + 
idiopathic POF group). This high gland cell to gland volume fraction may be due to the 
high glycogen content present in the glandular epithelial cells of the infertile groups. 
Glycogen-like material in glandular epithelium is normally at its peak at day LH+4 of the 
menstrual cycle (corresponding to day 17 of the traditional dating according to Noyes et 
a!. 1950) and a substantial decrease occurs after this time, eventually resulting the 
disappearance of glycogen-like material from gland cells to the gland lumen later in the 
menstrual cycle (see Discussion in Chapter 2). In the present study, from qualitative 
observations both at light and electron microscope levels using glycogen specific staining 
procedures, more glycogen-like material was present in the glandular epithelium of 
infertile groups than in the LH+6 fertile group, possibly indicating a delay of secretion 
from glands in these individuals. The significant difference between both untreated and 
Gil treated infertile groups (when Turner's syndrome and idiopathic POF groups were 
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compared) was seen to be mainly due to the changes that occurred in Turner's syndrome 
group when these 2 groups were compared separately. 
While there were no significant differences in the volume density of gland cell to 
gland between day LH+6 controls and either untreated or GH treated idiopathic POF 
groups, this feature differed significantly between day LH+6 control group and Turner's 
syndrome group with or without GH. It was 8% higher in the untreated Turner's 
syndrome group than the day LH+6 fertile group and became 9% higher when the 
Turner's syndrome subjects were treated with GH. In addition, the difference between 
these groups was more significant after GH treatment indicating some extra effects of 
Gil on endometrial development in patients with Turner's syndrome. 
Li et al. (1991b) reported that the patients with premature ovarian failure had better 
response to HRT than the Turner's syndrome patients. In their ultrasonograpliic and 
histological study, 18 women with ovarian failures (10 idiopathic ovarian failure, 4 
Turner's syndrome and 4 POF patients) were examined during hormone replacement 
therapy and demonstrated that the women with Turner's syndrome had the smallest 
uterine thickness, endometrial thickness and the least advanced histological dating (both 
traditional and by morphometry) whereas POF patients had more normal endometrial 
thickness and a closer histological appearance to the normal endometrium. In their 
study, the results of histological dating of the endometrial biopsy were found to be 
positively correlated with the endometrial thickness on day 19 of the menstrual cycle. 
Although simple morphometry was used in their study at the light microscope level, their 
findings give certain implications on the effects of HRT on endometrial morphology in 
women with premature ovarian failure. Their findings agreed with the data from the 
present study that the idiopathic POF subjects, receiving HRT, had a better response to 
sex steroids whether or not they also had growth hormone supplementation. 
On average, the volume fraction of endometrium occupied by gland did not differ 
significantly between the untreated and the GH treated Turner's + idiopathic groups, 
between untreated Turner's syndrome and GH treated Turner's syndrome groups, nor 
between untreated and GH treated idiopathic POF groups. However, this feature again 
differed significantly between day LH+6 fertile group and both the untreated and the GH 
treated infertile groups. The reason for this difference in volume density of gland to 
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cndometrium between infertile groups and the fertile group may well be the delayed 
glycogen accumulation in the gland cells and thus the abnormality in development of the 
cndometrium in these type of infertility conditions. Yet again the significant difference 
between the day LH+6 fertile group and Turner's syndrome + idiopathic POF group in 
this feature was due mainly to the Turner's syndrome group indicating a great deviation 
of the endometrial development in Turner's syndrome individuals from the fertile ones 
and even from the idiopathic POF group. 
In the present study, qualitative observations of the glandular epithelium in infertile 
groups demonstrated some atrophic cells as well as the accumulation of glycogen-like 
material within these cells (Figure 4.4a and Figure 4.8). Although these glandular 
epithelial cells were present in both infertile groups, they were more abundant in the 
Turner's syndrome group regardless of treatment with GH. The question arises as to 
«1ietlier these cells were atrophic or apoptotic. However, in terms of structural patterns 
that apoptotic cells demonstrate (Piyawinijwong 1993), the cells with abnormal 
appearance observed in the present study appeared atrophic or degenerative cells not 
exhibiting features of apoptosis. For example, in the central nervous system, some nerve 
cells in the inferior olivary nucleus of the brain show apoptosis which is characterised by 
an apparent space between neighbouring cells, the presence of extremely dense nuclei, 
and smaller cells than the normal ones in appearance (Piyawinijwong 1993). In the 
present study, abnormal cells that were observed in the Turner's syndrome group had 
small nuclei with an appearance closer to that of euchromatic nuclei, and a cytoplasmic 
degeneration at different degrees in the neighbouring cells which did not loose contact 
with each other, unlike the cells described as undergoing apoptotic in brain (Figure 4.8). 
hie underlying reason for the presence of these degenerated cells in the Turner's 
syndrome endometria could be of genetic origin or due to secondary endocrinological 
factors, since these individuals are genetically abnormal (lacking the second sex 
chromosome - 45, XO). The presence of these atrophic cells in the Turner's syndrome 
cndometrial glandular epithelia may possibly suggest an abnormal endometrial structure 
and development in the Turner's syndrome individuals, either due to direct genetic 
causes or as an altered response to HRT. 
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Figure 4.8: Glandular epithelial cells of GH-treated Turner's syndrome group. Cells 
demonstrate atrophic cytoplasm (cyt) with increased amounts of vacuolation. (gm) giant 
mitochondria, (L) lumen. 
Staining: Uranyl Acetate - Lead Citrate 
Bar represents 3.85 µm 
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The reason for the use of women with Turner's syndrome in the present study was 
mostly to obtain a group of women without endogenous ovarian hormones, but for a 
different reason than the idiopathic POF group. As can be seen in the experimental 
design of the present study, the sample size of both POF group and Turner's syndrome 
group was relatively small As well as lack of ovarian steroids, Turner's syndrome 
patients have several abnormalities, such as short stature, webbing of the neck and 
lacking of the gonadal functions (see Introduction). Although women with Turner's 
syndrome may have gonads, the number of follicles present in ovaries is reduced to 20% 
of the normal quantity after puberty. This reduced quantity of the ovarian follicles is 
accompanied by the lack of steroid hormone secretion, resulting in obvious reproductive 
tract abnormalities. For example Rogers et al. (1992) reported no visible tight junctional 
complexes between uterine epithelial cells in 9 out of 11 Turner's syndrome patients 
receiving hormone replacement therapy. Their observations agree with the data from the 
present study that the Turner's syndrome subjects may have abnormal endometrial 
structure and development causing infertility in this type of condition. The opinion that 
the Turner's syndrome patients might be poor responders to the sex steroid treatment 
was also agreed by Rudolf et a!. (1989). In their study, Turner's syndrome patients were 
treated with synthetic sex steroids and the endometria from those patients showed no 
proliferation or secretion after hormone treatment indicating no response of the 
cndometrium. 
4.4.2. STROMA 
Similar to the glandular features, there were few significant differences between any 
of the infertile groups, either with or without GH treatment, suggesting that both of the 
infertile groups may display a similar type of endometrial structure and a similar response 
(or lack of response) to GH treatment. However, these features in infertile groups did 
differ significantly from the day LH+6 fertile group, indicating a great diversity from the 
normal endometrial development and function in these types of infertility cases. 
While there was no significant difference in the volume density of endometrium 
occupied by stroma between day LH+6 group and untreated Turner's + idiopathic POF 
group, it was significantly higher in the day LH+6 fertile group than the GH treated 
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Turner's syndrome + idiopathic POF group indicating a decrease in stromal volume 
density and a significant effect of GH on this feature. This feature did not differ between 
the day LH+6 group and either untreated or Gil treated idiopathic POF group. 
However, the volume density of stroma to endometrium was significantly lower in 
untreated Turner's syndrome group than the fertile group and this significant decrease 
became larger after treatment with GH hormone. This decreased endometrial stromal 
volume density was consistent with the increased glandular volume density in infertile 
groups, especially the Turner's syndrome group, possibly indicating a retarded 
cndomctrial development in infertile groups. The significant decrease of stromal volume 
density in the overall infertile group (Turner's + idiopathic POF) was mainly due to the 
Turner's group, since the idiopathic POF group had similar volume fraction values to the 
fertile group before and after GH treatment. 
The volume fraction of stromal cell nucleus to endometrium was examined in order to 
help evaluate, when combined with other measurements, indirectly whether or not the 
packing density of the cells in endometrial stroma was affected by GH treatment. This 
feature was significantly different between GH treated Turner's syndrome group and Gil 
treated idiopathic POF group, being greater in the idiopathic POF group. 77his result 
may indicate a different response in GH treatment due to the different type of infertility. 
The higher volume density of stromal cell nucleus to endometrium in Gil treated 
idiopathics suggests there is relatively more stromal cell nucleus than endometrium, 
possibly due to either an increase in the stromal cell packing density or that the stromal 
cell nuclear dimensions are larger in this group. However, the stromal cell nuclear 
profile dimensions did not differ between any of the infertile groups nor between the day 
Ll 1+6 fertile and any of the infertile groups, either with or without Gil supplementation. 
This result suggests that the reason for the increased stromal cell nuclear volume density 
in Gil treated idiopathic POF group is due to the increased packing density of the 
stromal cells. 
The volume fraction of stromal cell nucleus to endometrium was significantly higher 
in Gil treated Turner's syndrome + idiopathic POF group than the day Li1+6 fertile 
group. This feature was significantly higher in GH treated idiopathic POF group than the 
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day LI1+6 group whereas the fertile group and untreated idiopathics did not differ 
significantly. 
The volume fraction of nucleus to stromal cell differed only between the day L11+6 
group and untreated idiopathic POF group, being 8% lower in the latter. This result may 
indicate an increased stromai cell cytoplasmic volume since it was already confirmed that 
there were no significant differences in the stromal cell nuclear dimensions (shape and 
size) between the day LH+6 group and untreated idiopathic POF group. In addition, 
there were no significant changes in the volume fraction of stromal cell nucleus occupied 
by euchromatin. These unchanged stromal cell nuclear features contrast with the 
findings of the stromal cell nucleus volume fraction to cell results which was significantly 
different between the GH treated combined group and the day LH+6 control group and 
suggest that, at the functional level, stromal cell nuclei did not change either with or 
without GH supplementation and they were not significantly different from those day 
Le1+6 controls. 
The volume density of stromal cell mitochondria to cell did not differ between 
untreated and GH treated infertile groups and between day LH+6 and infertile groups, 
with only one exception; the volume density of stromal cell occupied by mitochondria 
which was significantly higher in the day LH+6 fertile group than the untreated Turner's 
syndrome group. These results suggest that the untreated Turner's syndrome group 
stromal cells demand a lower metabolic activity, than in the controls. These results may 
further indicate a better response from idiopathic POF individuals to IIRT by not being 
significantly different from day LH+6 fertile group. 
A similar result to the stromal cell mitochondrial volume density has been observed 
for the volume fraction of "secretory apparatus" to stromal cell feature in that there were 
no significant differences between any of the untreated and GH treated infertile groups. 
However, there were significant differences when the day LIi+6 control group were 
compared separately to the infertile groups, suggesting an abnormal endometrial 
development and function in these infertile subjects. This feature was significantly 
different between the day LH+6 group and the Turner's syndrome + idiopathic POF 
group both before and after treatment with GH. Further comparisons revealed that both 
infertile groups, with or without growth hormone administration, significantly differed 
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from those fertile individuals with the exception of the GH treated Tuner's syndrome 
group. However, a high coefficient of variation within the Gil treated Turner's 
syndrome group was observed possibly accounting for its lack of statistical significance. 
These generally decreased mitochondrial volume densities in stromal cells suggest that at 
the endometrial stromal cell level both Turner's syndrome and idiopathic POF individuals 
required less metabolic activity than did the fertile group, however whether this is the 
cause of the infertility or a consequence of it remains unknown. 
The volume fraction of stromal cell occupied by rough endoplasmic reticulum (RER) 
was not significantly different between any of the untreated and GH treated infertile 
groups, nor between day LH+6 fertile group and untreated and GH treated infertile 
groups, with the exception that there was a tendency of an increase in this feature in the 
untreated idiopathic POF group when compared to the day LH+6 fertile group. The 
overall conclusion for stromal cell features could be that the idiopathic POF individuals 
had a better response to HRT than Turner's syndrome subjects. However, GH treatment 
might cause some unknown effects on the stromal compartment of both infertile groups, 
since they had larger significant differences when compared to the day LH+6 fertile 
group following GH treatment. 
4.4.3. BLOOD VESSELS 
Human endometrium is a very dynamic tissue which renews itself every 28 day, and a 
precise sequence of events in the endometrial compartments are required for the 
development of a receptive endometrium. Vascularization of the endometrium aller 
menses is one of these crucial events that prepares the endometrium for a successful 
implantation and gestation. Any interruption and abnormality in the vascularization of 
the endometrium could cause infertility in women. For the above reasons, the effects of 
growth hormone on endometrial blood vessel structure, as well as on the glandular and 
stromal morphologies, have been examined at the light and electron microscope levels 
for a more precise evaluation of the endometrial structure in the Turner's syndrome and 
idiopathic POF infertility conditions. 
At the light microscope level, the volume density of endometrial blood vessel features 
were not significantly different between any of the untreated and GH treated infertile 
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groups. In addition, the volume fraction of endometrium occupied by blood vessel 
lumen did not differ significantly between the day LH+6 fertile group and any of the 
infertile groups. However, the volume density of blood vessel tissue was significantly 
higher in the day LH+6 group than the untreated Turner's syndrome + idiopathic POF 
group, possibly suggesting a poor endometrial vascularization in these types of infertility 
cases. The volume fraction of endometrium occupied by total blood vessel, which 
includes both lumen and the tissue, was again significantly higher in the day LH+6 group 
than the untreated Turner's syndrome + idiopathic POF group. Furthermore, the volume 
density of total blood vessel to endometrium was significantly higher in the fertile group 
than the GH treated Turner's + idiopathic POF group. 
However, these significant differences between the normal fertile group and the 
combined infertile groups (Turner's + idiopathics) is most likely due to the Turner's 
syndrome group, since there were more significant differences between the fertile group 
and the Turner's syndrome group (with or without GH supplementation). For example, 
the volume fractions of blood vessel tissue and the total blood vessel were significantly 
lower (39% and 46% respectively) in the untreated Turner's syndrome group than the 
fertile group, indicating an abnormal endometrial vascularization and development in this 
group. However, after treatment with growth hormone, the difference in the volume 
density of blood vessel tissue between Turner's syndrome group and the fertile group 
was not significant. Although the total blood vessel volume density remained significantly 
lower in this infertile group, the significance level was reduced suggesting an unknown 
positive effect of GH on the endometrial vascular structure and function. 
When the day LH+6 control group were compared to the idiopathic POF group 
before and after GH treatment, the only significant difference found in the endometrial 
blood vessel features was between the fertiles and the untreated POF group. This 
significant difference disappeared after treatment with GEL, again indicating a positive 
effect of GH treatment on the vascularization and development of cndometrium. These 
results suggest that the women with Turner's syndrome respond suboptimally to steroid 
hormones and have an abnormal endometrial structure and development whereas the 
women with POF have a more normal endometrial vascularization and development and 
have a better response to HRT and that both groups respond positively to GH treatment. 
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At the electron microscope level, the volume density of nucleus to endothelial cell 
was significantly higher in the untreated Turner's syndrome + idiopathic POF group than 
the Gil treated one, indicating either an increase in endothelial cell nuclear volume or a 
decrease in endothelial cell cytoplasmic volume in the untreated group. However, this 
significant difference disappeared when infertile groups were compared separately before 
and after GH treatment, probably because of the reduced sample size of infertile groups 
after separating the combined infertile group into two different infertile groups (Turner's 
syndrome and idiopathic POF groups). Although the volume density of the endothelial 
cell nucleus to cell in the infertile group (Turner's + POFs) was not different from the 
fertile group without GH treatment, a significant decrease occurred in the infertile group 
after treatment with GH. Similarly, while the volume density of endothelial cell nucleus 
was not significantly different between day LH+6 group and the untreated Turner's 
syndrome group, a significant decrease occurred in the Turner's syndrome group after 
treatment with growth hormone. Yet again the same feature did not differ between the 
fertile group and untreated idiopathic POF group. However, it decreased significantly 
, Mien the idiopathic POF group was treated with GH. This decreased endotlhelial cell 
nuclear volume density in both infertile groups after GH treatment may suggest either a 
decrease in nuclear volume or an increase in cytoplasmic volume as a result of the effects 
of the GH treatment. 
Similar to the other endothelial cell features, the euchromatin distribution in the 
endothelial cell nucleus did not differ between any of the infertile groups. however, the 
volume fraction of endothelial cell nucleus occupied by euchromatin differed significantly 
between the fertile group and the Turner's syndrome + idiopathic POF group, either with 
or without GH, being lower in the latter and possibly indicating a lower transcriptional 
rate of the endothelial cells in this group. However, there was only a tendency of a 
decrease in this feature when the day LH+6 group was compared to the untreated 
Turner's syndrome group. In addition, there were no significant differences between the 
day LII+6 group and untreated and GH treated idiopathic POF groups possibly because 
of the high coefficients of variation and small sample size of these fertile groups. On the 
other hand, this unchanged euchromatin distribution in the idiopathic POF group may 
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also suggest a closer resemblance of endomctrial development to the controls in this 
group than in the Turner's syndrome group. 
While the volume fraction of endothelial cell occupied by mitochondria did not differ 
either between any of the infertile groups or between day Ll1+6 fertile group and infertile 
groups before and after GH treatment, there were significant differences in the volume 
density of "secretory apparatus" to endothelial cell between groups. The unchanged 
mitochondrial volume density may indicate an unchanged metabolic demand in these cells 
tsith or without GH treatment. It may also suggest that the mitochondrial pattern of the 
endothelial cells in the infertile groups seem to have a close resemblance to the normal 
fertile mitochondrial structure and function. The volume density of endothelial cell 
occupied by "secretory apparatus" did not differ significantly between untreated and Gil 
treated infertile groups. However, it was significantly lower in the untreated Turner's 
syndrome + idiopathic POF group than day LH+6 control group, suggesting either a 
decreased secretory activity of the endothelial cells or a decreased transport between the 
stronia and the blood in infertile groups. After treatment of infertile groups with growth 
hormone, the significant difference between fertile and infertile groups in the volume 
density of endothelial cell "secretory apparatus" disappeared suggesting an unknown 
effect of GH on the blood vessel structure and function. When the day LH+6 group was 
compared separately to infertile groups, the volume fraction of "secretory apparatus" to 
endothelial cell was significantly lower in the untreated Turner's syndrome group. 
However, there was no significant difference between Gil treated Turner's syndrome 
group and the fertile group, nor between the fertile group and either untreated or GH 
treated idiopathic POF groups. These results may indicate an effect of GH on the 
secretory activity of the blood vessel endothelial cells in the Turner's syndrome group, 
and may possibly suggest either a more normal secretory activity of the endothelial cells 
in idiopathic POF individuals or a better response to HRT frone idiopathic individuals 
than the Turner's syndrome patients. 
Similar to the other endothelial cell features, the volume fraction of endothelial cell 
occupied by RER did not differ significantly between any of the infertile groups with or 
without GH treatment. On the other hand, it was significantly lower in untreated 
Turner's syndrome + idiopathic POF group when compared to the control group, 
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indicating a lower protein synthetic activity in this particular group. However, this 
significant difference disappeared between the same groups aller treatment with Gil (as 
in most of the other stromal and endothelial cell features), again suggesting an effect of 
growth hormone on endothelial structure and function. Interestingly the separate 
comparisons in this feature between fertile group and untreated and Gil treated infertile 
groups did not show significant differences apart from tendencies to decrease in 
untreated Turner's syndrome and untreated idiopathic POF groups were seen. This may 
be the result of the small sample size and thus high coefficients of variation in the infertile 
groups each of which consists of 3 subjects whereas the combined Turner's syndrome + 
POF group consists of 6 subjects. 
For a complete evaluation of the effect of Gil on the endometrial blood vessel 
morphology, arithmetic and harmonic mean basement membrane thicknesses were 
determined for Turner's syndrome and POF patients and these results were also 
compared to the fertile control group. Although there were no significant differences 
between any of the untreated and GH treated infertile groups, the infertile groups mostly 
differed from the fertile group. The arithmetic and harmonic mean basement membrane 
thicknesses were both significantly different between the day LH+6 fertile group and 
untreated and GH treated Turner's syndrome + idiopathic POF groups, being higher 
(around 20% in arithmetic mean thickness and 10% in the harmonic mean thickness) in 
the infertile groups. Separate basement membrane thickness comparisons between the 
day LH+6 fertile group and the Turner's syndrome and idiopathic POF groups 
demonstrated that the harmonic and arithmetic mean basement membrane thickness 
values of the Turner's syndrome and POF subjects were significantly higher (again, 
around 20% higher in arithmetic mean thickness and 10% in harmonic thickness) than 
the control group values, both before and after treatment with GH. These basement 
membrane evaluations suggest that the infertile subjects had thicker blood vessel 
basement membrane than the day LH+6 controls, and that the significance levels further 
increased when the infertile subjects received the GH treatment indicating an effect of 
GI I on the endometrial blood vessel structure and function. 
Basement membranes have been demonstrated in the attachment, migration, growth, 
repair and differentiation of the overlying cell populations as well as in the fluid filtration 
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and gas exchange (Wracko 1982). A thick endometrial blood vessel basement membrane 
may cause alterations of these functions in infertile groups. It could also indicate a lower 
fluid filtration and gas exchange between blood and endometrium in these groups, and 
this decreased transport rate may lead to a less normal endometrial development and 
function eventually causing infertility. However, it is likely that the increased basement 
membrane thickness could be only one of several underlying pathologies which all 
together may cause the infertility in these subfertile individuals. 
Young women, who lack ovaries or whose ovaries are not functional, make up a 
small but relatively important group of sterile patients. Hormone replacement therapy 
(IIRT) has been an interest of several investigators in the establishment of successful 
pregnancies in women with primary ovarian failure (Lutjen et a!. 1984; Navot et al. 
1986). There are different types of primary ovarian failure such as gonadal dysgenesis 
(either in a pure form with 46, XX chromosomal complement or in conjunction with 
Turner's syndrome - 45, X0) and premature ovarian failure (premature menopause). 
Patients with gonadal dysgenesis have primary amenorrhea and sexual infantilism 
whereas patients with premature ovarian failure usually present with permanent ovarian 
failure occurring after menarche but before the normal menopausal age (generally before 
the age of 35) (Coulam and Ryan 1979; Friedman et al. 1983). 
Two factors are probably crucial in successful embryo implantation: receptivity of the 
endometrium and synchronisation between endometrial and embryonic development. 
IIoth these factors depend on the cyclic hormonal activity of the ovary and timely release 
of a fertilizable oocyte. In a fertile cycle, the ovaries produce adequate quantities of sex 
steroids in a certain temporal pattern and ratio to promote the necessary growth of the 
cndometrium and to regulate its timely differentiation throughout the early stages of 
gestation (Maslar 1988). However, in the case of primary ovarian failure the 
development of a receptive endometrium, capable of supporting implantation and 
maintaining pregnancy, is achieved when the uterus is exposed to an appropriate 
sequence and ratio of oestrogen and progesterone (Navot et al. 1986; Younis et al. 
1994). Endometrial stimulation is performed sequentially by oestrogen in the follicular 
phase and by oestrogen and progesterone in the luteal phase. A precise co-ordination of 
these events are thought to maintain effective reproduction (Younis and Laufer 1992). It 
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is well established that oestrogen in the follicular phase is indispensable for cndonmtrial 
priming whereas the luteal phase progesterone is essential to allow implantation and to 
maintain pregnancy (Lenton et al. 1982; Lenton and Woodward 1988). In the case of 
patients with primary ovarian failure, as in the present study, a certain sequence and ratio 
of these sex steroids are required for the normal ovulation and the development of a 
receptive endometrium. Results of the present study indicated that the cndomctrial 
morphology of the infertile patients, who received standard hormone replacement 
therapy, significantly differed from the normal endometrial structure of the fertile 
subjects. These results may suggest that the abnormal endometrial development in 
patients with primary ovarian failure, especially in those with Turner's syndrome, is 
permanent and thus incurable. However, previous work has shown that such conditions 
can be treated to result in some successful pregnancies, despite the significant difFcrences 
in cndometrial morphology reported in the present study. 
While there appear to be no reports on the effects of GH on endometrial structure, 
there have been several reports on the effects of GH on other tissues (Beer et a!. 1994; 
Doi et a!. 1988,1990). In genetically dwarf (GH deficient) rats, the crypt volume and 
epithelial cell height of the small intestine were significantly lower than the controls, 
however, these reduced epithelial features were reversed to the control values when rats 
were treated with exogenous GH (Beer et a!. 1994). They suggested that Gil deficiency 
has subtle effects on intestinal epithelial morphology and reconstitution with Gil is 
capable of reversing many of these changes. In addition, mesangial cell proliferation 
followed by glomerulosclerosis was observed in the kidney of transgenie mice chronically 
expressing growth hormone and growth hormone releasing factor (Doi et a!. 1988, 
1990). In the present study, women with Turner's syndrome had abnormal cndometrial 
glandular epithelia when compared to controls, but this abnormality did not disappear 
when subjects were treated with Gi, suggesting that there might be differences in the 
physiology of different epithelial types, and each of these tissues may have their own 
different factors, hormonal actions and metabolic activities which influence their 
responsiveness to GH. 
In the human reproductive tract, the actions of GH, gonadotrophic hormones, sex 
steroids and the insulin-like growth factor (IGF) system are closely related to each other 
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(see Introduction). Growth hormone enhances ovulation via regulating the 
gonadotrophic hormone, sex steroid and IGF system actions which include; IGF-I action 
that is capable of substantial amplification of gonadotrophin hormonal action (Adashi et 
at. 1985). Alternatively, GH , 
in concert with oestrogens, may upregulate the 
intraovarian generation of IGF-I (Hernandez et al. 1989). Because IGF-I mRNA is 
stimulated by oestrogen (Murphy and Ghahary 1990) and IGFBP-I secretion by 
progesterone (Rutanen et at. 1986) and IGFBP-I inhibits binding of IGF-I to its 
endometrial IGF receptors (Rutanen et al. 1988), the IGF system is likely to be an 
important mechanism through which the biological actions of oestrogen and the anti- 
oestrogenic effects of progesterone are mediated. 
It has been suggested that progesterone-induced stromal IGFBP-I inhibits epithelial 
growth by inhibiting the action of IGFs (Seppala et al. 1994). Indeed, when the 
endometrium comes under the sustained influence of progesterone, i. e. during pregnancy 
or systemic progesterone treatment, the endometrium undergoes stromal hyperplasia and 
epithelial atrophy (Dallenbach-Helweg 1981). This is consistent with the data frone the 
present study that there were atrophic glandular epithelial cells when the morphology of 
the endometria of infertile groups were examined qualitatively aller hormone 
replacement therapy consisting of oestrogen and progesterone (Figure 4.8). 
Growth hormone and steroid hormone interaction has been a new field of interest in 
reproductive biology. Bezecny et al. (1992) reported a significant increase in oestrogen 
receptor concentration in the guinea-pig uterus after treatment with bovine growth 
hormone. In their study, the amount of cytosolic oestradiol receptor per unit of uterine 
weight was increased 7-14 fold in GH treated animals, and the nuclear oestradiol 
receptor concentration was 3-7 fold higher than in control animals. hie present data 
strongly suggest that GH administration may have substantial effects on the uterus, 
especially on endometrium, as well as having influences on the ovulation enhancement in 
ovaries. 
It appears that growth hormone, gonadotrophins, IGF system (with its ligands, 
receptors an binding proteins) and sex steroids (oestrogen and progesterone) have very 
complicated interactions and thus effects on the reproductive tract through the pituitary - 
ovary - endometrial axis (see earlier). However, despite its ovulation enhancing effect, 
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the exact role and mechanism of Gil in the reproductive biological use still remains 
unclear. 
Tic main conclusion to be drawn from the present study is that while untreated and 
Gil treated infertile groups did not differ significantly at the cndometrial stromal and 
vascular levels, these infertile groups (Turner's syndrome and idiopathic POF) differed 
significantly from the day LH+6 fertile group either with or without Gil administration. 
In addition, the significance levels between the fertile group and infertile groups were 
further increased in some of the stromal and vascular features when the infertile groups 
were treated with GH, suggesting that the GH treatment may have subsequent effects on 
the endometrial development of these infertile subjects. However, further studies are 
required for the understanding of GH action in the reproductive tract and especially in 
the endometrium for a better use of GH in this field. 
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CHAPTER 5 
HUMAN ENDOMETRIAL STROMAL MORPHOLOGY IN 
UNEXPLAINED RECURRENT MISCARRIAGE 
5.1. INTRODUCTION 
The World Health Organisation's (WHO) definition for miscarriage is "the expulsion 
or extraction from its mother of an embryo or fetus weighing 500g or less" (WHO 
1977). In repeated abortions, women manage to achieve pregnancy but on several 
occasions loose the pregnancy before it is viable or before baby has a reasonable chance 
of survival (Stirrat 1990a). The definition of recurrent miscarriage, agreed following an 
European Society of Human Reproduction and Embryology (ESHRE) workshop, is two 
or more consecutive pregnancy losses (Crosignani and Rubin 1991). It has been 
reported that recurrent miscarriage occurs in 1% of the total female population (Coulam 
1986). The aetiology of recurrent miscarriage varies according to many factors, but is 
often classified on the basis of whether the abortion occurs in the first trimester or in the 
second trimester of the pregnancy. 
lt has been estimated that up to 65% of all first trimester abortions are due to the 
fertilized oocyte being chromosomally faulty (Warburton and Strobino 1987; Olson and 
Magenis 1988). The remaining 35% of spontaneous abortions are due to undiscovered 
causes but there are several implicated factors including uterinal causes, hormonal 
deficiencies, faults in implantation, infections and others. It is the aim of the present 
study to investigate the endometrial morphology of women who have had recurrent 
miscarriages followed by successful pregnancies compared to subjects with persisting 
miscarriage. In both groups other common causes of miscarriage (such as chromosomal 
abnormalities, see later) can be discounted leaving the endometrium as a likely factor in 
the miscarriage. In order to give a full account of this topic, major causes for recurrent 
pregnancy losses are described below. 
5.1.1. ANATOMICAL DISORDERS 
The reported incidence of uterine abnormalities associated with recurrent miscarriage 
is between 15% and 30% (Harger et al. 1983; Stray-Pedersen and Stray-Pedersen 1984). 
The true incidence of congenital uterine anomaly in recurrent miscarriage is unknown 
(Stirrat 1990b), but congenital uterine anomalies appear to be present in about 12% of 
recurrent miscarriage patients (Bennett 1987). However, it is well established that 
successful pregnancy can occur in the presence of some uterine anomaly, and the 
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percentage of uterine anomalies remaining undiagnosed in the general female population 
is unknown. Due to this lack of information, it is not possible to conclude about the 
relative importance of uterine anomaly in recurrent miscarriage. 
Another anatomical disorder which may play an important role in recurrent 
miscarriage is cervical incompetence. In a study of 66 patients with 3 or more 
consecutive miscarriages, where no apparent cause could be found for their repeated 
loss, Ayers et al. (1982) found an 89% incidence of cervical incompetence in the first 
trimester of the pregnancy. The incidence of cervical incompetence in recurrent 
miscarriage has been reported to vary from 13% to 20% (Stray-Pedersen and Stray- 
Pedersen 1984; McDonald 1987). 
5.1.2. GENETIC CAUSES 
It is thought that at least 50% of first trimester pregnancy loss and 20% of second 
trimester pregnancy loss exhibit a fetal chromosomal abnormality (Olson and Magenis 
1988). However, the accuracy of these figures is speculative, because of the difficulties 
in culturing chromosomal material from abortus specimens and the unnoticed loss of very 
early fetuses. Repetitive aneuploidies, the most common of which is trisomy, appear to 
be significantly higher among recurrent miscarriers (de Braekeleer and Dao 1990). 
5.1.3. ENDOCRINE FACTORS 
insufficient luteal function associated with recurrent miscarriage has been reported to 
occur in 20-60% of cases, but there is no reliable way to recognise inadequate luteal 
function in the already pregnant patient (Fritz 1988). Endometrial biopsy examination of 
the non-pregnant uterus is the best way of determining the luteal phase defect in women, 
however, it requires careful sampling and a time consuming effort. Although it is the 
commonest endocrinopathy diagnosis in association with recurrent pregnancy loss, there 
is no consensus of luteal phase inadequacy, the method of diagnosis, or its proper 
treatment (Fritz 1988). The hypothesis is that the defective corpus luteum produces low 
levels of progesterone which are insufficient to allow proper endometrial development, 
implantation, and placentation. Studies have shown that peripheral oestrogen (McClure 
et al. 1993), and progesterone levels in some women suffering from recurrent 
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miscarriage appear to be lower than normal women (Fritz 1988). 1lowcvcr, other 
studies have found no evidence of a relationship between luteal phase defect and 
miscarriage (Baird et al. 1991). There has also been a lack of correlation between 
plasma progesterone levels and endometrial histology (Rosenfield et al. 1980) and it has 
recently been recognised that endometrial development is influenced not only by 
peripheral steroid hormone levels, but also by the intrinsic response of the endometrium 
to those hormones (Li et al. 1989). 
It has been suggested that polycystic ovary syndrome (PCOS) might be associated 
with an increased risk of recurrent miscarriage (Sagte et al. 1988). In their study 46 out 
of 56 (82%) women with recurrent miscarriage had PCOS compared with 2 out 11 
(18%) parous controls, and they postulated a hostile endometrial environment or 
abnormal production of immunoglobulins as possible causes for miscarriage. 
Thyroid dysfunction is another commonly quoted cause of recurrent pregnancy loss 
(llarger et a!. 1983; Stray-Pedersen and Stray-Pedersen 1984). Thyroid function tests 
are a traditional part of routine evaluation of the recurrent miscarriage cases. Diabetes 
mellitus is another traditionally quoted cause. In a study of spontaneous abortion among 
insulin-dependent-diabetic women the incidence of miscarriage was 15% in women with 
good diabetic control in early pregnancy and 45% in those with poor control (Miodovnik 
el al. 1985). It has been reported that diabetic women with good metabolic control arc 
probably no more likely to miscarry than non-diabetic women (Mills et al. 1988). 
Other chronic medical disorders such as epilepsy have been implicated in recurrent 
pregnancy loss but there is scant evidence for such speculations. 
5.1.4. IMMUNOLOGICAL CAUSES 
Immunological causes of recurrent miscarriage are probably the least well understood 
group, because the immunology of the normal pregnancy is yet to be fully described. 
Both autoimmune and alloimmune immunological mechanisms have been implicated in 
the aetiology of unexplained recurrent pregnancy loss. The most common autoimmune 
connective tissue disorder that affects women is systemic lupus erythematosus (SLE) or 
lupus anticoagulant (anticardiolipin) (Conley and Hartman 1952; Lubbe and Liggins 
1988). The presence of serum auto antibodies has been shown to correlate with adverse 
109 
pregnancy outcome, and fetal loss may complicate up to 70% of pregnancies in women 
with SLE (Scott and Bird 1990). 10 to 30% of SLE patients possess antiphospholipid 
antibodies (APA), and they are at increased risk of fetal loss, especially second and third 
trimester loss (Branch et al. 1985). 
Pregnancy immunology is a relatively new science and the mechanisms that an 
immunocompetent or immunoincompetent fetus surviving in a potentially hostile 
maternal immunological environment are poorly understood. There are two 
hypothesised mechanisms whereby the fetus is protected from maternal rejection: either 
that placental antigens may stimulate the production of blocking factors, or secondly they 
may alter the maternal immune cell function (Stirrat 1990b). The full story is likely to be 
a combination of factors. 
5.1.5. REPRODUCTIVE TRACT INFECTIONS 
The possibility that a bacterial or viral infective organism cause repeated pregnancy 
loss is very small, and it would have to persist for long periods of time, produce maternal 
symptoms so slight as to escape diagnosis and treatment, and gain access to the fetal 
compartment to cause loss either by infection of fetal tissue or by stimulation of an 
inflammatory response. Previous data suggest that microorganisms can cause individual 
pregnancy losses, but the role of maternal and fetal infections in recurrent first-trimester 
loss remains controversial (Watts and Eschenbach 1980). 
The other factors that can cause recurrent miscarriage are drug exposure, 
cnvironmental factors, such as smoking, and family history. For example, it appears that 
smokers are not only at increased risk of miscarriage, but the risk is directly proportional 
to the number of cigarettes smoked (Parazzini et al. 1991). 
Recurrent pregnancy loss appears to be a highly complicated phenomenon that occurs 
as result of several of the factors described above. It is the aim of the present study to 
determine the endometrial morphology in patients having persisting recurrent 
miscarriages in comparison with women that, previously having a recurrent miscarriage 
problem, recently had a successful pregnancy. 
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5.2. MATERIALS AND METHODS 
5.2.1. SUBJECTS AND EXPERIMENTAL DESIGN 
Twelve subjects were used in the present study, 6 individuals in the successful 
pregnancy group and 6 for unsuccessful pregnancy group. Subjects were recruited from 
the Recurrent Miscarriage clinic at the Jessop Hospital for Women, Sheffield. The 
inclusion criterion of subjects into the study was to have a history of 3 or more 
consecutive miscarriages prior to 28 weeks gestation. There was no apparent cause for 
repeated miscarriage, since no abnormality was detected after peripheral leukocyte 
karyotyping, antiphospholipid antibodies, protein S and C concentrations, endocervical 
culture for chlamydia and mycoplasma and hysterosalpingography (Serie et al. 1994). 
Unsuccessful pregnancy group subjects had 3 or more consecutive pregnancy losses and 
were currently miscarriers. Successful pregnancy group individuals also previously had 3 
or more consecutive miscarriages but then had successful pregnancy and delivery. In the 
present study, endometrial biopsies from those two groups were compared 
morphometrically in order to determine the differences in endometrial morphology 
between previously miscarrying and persistently miscarrying individuals. Endometrial 
biopsies were carried out at day LH+7 of the menstrual cycle in both groups. 
The endometrial biopsy procedure, tissue processing, sectioning and staining 
procedures for light and electron microscopy were the same as described in the Materials 
and Methods section of Chapter 2. 
5.2.2. STATISTICAL ANALYSIS 
In the present study, every endometrial feature was calculated on a `per individual' 
basis. Means and standard errors were calculated for each group and data were analysed 
using Student's unpaired 1-test where the conventional level of p<0.05 was taken as the 
level of significance. Morphometric results were compared statistically between 
recurrent miscarriage groups; the first group (successful pregnancy group)consistcd of 6 
individuals with a history of 3 or more previous repeated pregnancy losses but having 
successful pregnancies thereafter and the second group (unsuccessful pregnancy group) 
(n=6) consisted of previously and currently miscarrying individuals. 
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5.3. RESULTS 
In the present study, endometrial stromal and vascular morphologies were examined 
in two groups of patients; subjects with a persistent recurrent miscarriage problem and 
subjects who previously had recurrent pregnancy losses but had successful pregnancies 
thereafter. The quantitative morphological data were compared statistically in order to 
determine the differences between the unsuccessful pregnancy group and the successful 
pregnancy group. There were no significant differences in glandular, stromal and 
vascular features between successful and unsuccessful pregnancy groups, indicating no 
structural change in human endometrium after successful pregnancy. 
5.3.1. GLANDULAR EPITIIELIUM 
The volume fraction of gland occupied by gland cell was not significantly different 
between unsuccessful and successful pregnancy groups, nor the volume density of gland 
to endometrium (Table 5.1). The coefficients of variation in both features were 
consistently similar within the groups, being around 7% in the volume density of gland 
cell to gland feature and 30-35% in the volume fraction of endometrium occupied by 
gland, indicating a higher intersubject variation of the latter feature in both groups than 
the former feature. In addition, the qualitative investigation of the endometrial glandular 
epithelium demonstrated nuclear channel systems (NCS) (Figure 5.1) in the unsuccessful 
pregnancy group at day LH+7, a feature typical of human endometrial glandular 
epithelial cells between days LH+4 and LH+7 of the menstrual cycle (Dockery el al. 
1988b). 
5.3.2. STROMA 
Similar to the volume density of glandular epithelium to stroina, the volume fraction 
of endometrium occupied by stroma did not differ significantly between groups, nor did 
the volume density of stromal cell nucleus to endometrium (Table 5.3). The coefficients 
of variation in the volume density of stromal cell nucleus to endometrium were around 
20% in both successful and unsuccessful pregnancy groups, suggesting similar and 
relatively high intersubject variations in both groups. 
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Table 5.1: Comparison of glandular features between successful pregnancy group and 
unsuccessful pregnancy group. 
Feature Successful Pregnancy Unsuccessful Pregnancy 
Group (n=6) Group (n=6) 
Vv of Gland Occupied by Gland 0.855 ± 0.024 0,861 ± 0.023 
Cell 
Vv of Endometrium Occupied by 0.272 ±0.040 0.230 ± 0.029 
Gland 
Results are means ± SE 
n= number of individuals 
Table 5.2: Represents the stromal cell nuclear diameter data compared between 
successful pregnancy group and unsuccessful pregnancy group. 
Feature Successful Pregnancy 
Group (n=6) 
Unsuccessful Pregnancy 
Group (n=6) 
Stromal Cell Nucleus Profile Major 7.34 ± 0.28 6.90 ± 0.16 
Axis (µm) 
Stromal Cell Nucleus Profile Minor 3.91 ± 0.09 3.73 ± 0.10 
Axis (µm) 
Stromal Cell Nucleus Profile Mean 5.28 ± 0.08 5.01 ± 0.10 
Diameter (µm) 
Stromal Cell Nucleus Profile Axial 2.06 ± 0.14 1.99 ± 0.06 
Ratio 
Results are means ± SE 
n- number of individuals 
Table 5.3: Comparison of endometrial stromal volume fraction data between successful 
and unsuccessful pregnancy groups 
Features Successful Pregnancy 
Group (n=6) 
Unsuccessful Pregnancy 
Group (n=6) 
Vv of Endometrium Occupied by 0.728 ± 0.040 0.770 ± 0.029 
Stroma 
Vv of Endometrium Occupied by 0.132 ±0.010 0.120 ±0.011 
Stromal Cell Nucleus 
Vv of Stromal Cell Occupied by 0.503 ± 0.010 0.489 ± 0.014 
Nucleus 
Vv of Stromal Cell Nucl eus 0.733 ± 0.021 0.732 ± 0.023 
Occupied by Euchromatin 
Vv of Stromal Cell Occupied by 0.022 ± 0.002 0.025 ± 0.002 
Mitochondria 
Vv of Stromal Cell Occupied by 0.026 ± 0.005 0.038 ± 0.003 
"Secretory Apparatus " 
Vv of Stromal Cell Occupied by 0.034 ± 0.005 0.030 ± 0.002 
RER 
Results are means ± SE 
n number of individuals 
Figure 5.1: Unsuccessful pregnancy unexplained recurrent miscarriage group glandular 
cell which demonstrates a nuclear channel system (ncs). (G) Golgi apparatus. 
Staining: Uranyl Acetate - Lead Citrate 
Bar represents 1.10 µm 
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Although the stromal cell nuclear profile dimensions were not significantly different 
between groups (Table 5.2), the mean profile diameter tended (p<O. 10) to be higher in 
the successful pregnancy group. The mean stromal cell nuclear profile diameter was 
5.01 ltm in the unsuccessful pregnancy group and 5.28 ltm in the successful pregnancy 
group (Table 5.2), possibly indicating an increased stromal cellular size and activity. 
However, it was only a tendency of an increase and such implications arc speculative. 
The coefficient of variation in the stromal cell nuclear profile axial ratio was almost twice 
as much (17%) in the successful pregnancy group than the unsuccessful pregnancy group 
(7%) indicating a greater intersubject variation in the successful pregnancy individuals. 
There was no significant difference in the volume fraction of stromal cell occupied by 
nucleus. In addition, the volume density of euchromatin to stromal cell nucleus did not 
differ between groups nor did the volume density of stromal cell occupied by 
mitochondria (Table 5.3) (Figures 5.2a, b). On the other hand, there was a tendency of 
an increase in the volume density of "secretory apparatus" to stromal cell in the 
unsuccessful pregnancy group possibly indicating an increased secretory activity of the 
stromal cell in this group. It was 0.026 ± 0.005 in the successful group and 0.038 ± 
0.003 in the unsuccessful pregnancy group (Table 5.3). The coefficient of variation of 
this feature in the successful pregnancy group was about 50% which was almost 3 times 
greater than the unsuccessful group (20%). Yet again the volume fraction of rough 
cndoplasmic reticulum to stromal cell was not significantly different between groups with 
a higher coefficient of variation in the successful pregnancy individuals (37%) than the 
unsuccessful ones (19%). 
5.3.3. BLOOD VESSELS 
None of the volume fraction of endometrial blood vessel features [which were blood 
vessel lumen , blood vessel tissue and total blood vessel (vessel + lumen)] significantly 
differed between groups (Table 5.4), however the coefficient of variation in the 
unsuccessful pregnancy group was dramatically higher than the successful ones. For 
example, the coefficient of variation in blood vessel tissue was 8% in the successful 
group and 47% in the unsuccessful pregnancy group. Similarly, it was 14% and 50% 
respectively in the total blood vessel volume density, indicating that there was a greater 
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Table 5.4: Comparison of endometrial vascular volume fraction data between successful 
and unsuccessful pregnancy groups. 
Features Successful Unsuccessful 
Pregnancy Group Pregnancy Group 
(n=6) (n=6) 
Vv of Endometrium Occupied by Blood Vessel 0.009 ±0.002 0.013 ±0.005 
Lumen 
Vv of Endometrium Occupied by Blood Vessel 0.028 ±0.009 0.030 ±0.006 
Tissue 
VV of Endometrium Occupied by Blood Vessel 0.037 ± 0.002 0.043 ± 0.009 
Total (Vessels + Lumen) 
Results are means ± SE 
n= number of individuals 
Table 5.5: Comparison of endothelial cell volume fraction data between successful and 
unsuccessful pregnancy groups. 
Features Successful Pregnancy 
Group (n=6) 
Unsuccessful Pregnancy 
Group (n=6) 
Vv of Endothelial Cell Occupied by 0.561 ± 0.015 0.557 ± 0.025 
Nucleus 
Vv of Endothelial Cell Nucleus 0.750 ± 0.026 0.706 ± 0.014 
Occupied by Euchromatin 
Vv of Endothelial Cell Occupied by 0.019 ± 0.002 0.023 ± 0.003 
Mitochondria 
Vv of Endothelial Cell Occupied b 0.034 ± 0.005 0.039 ± 0.004 
"Secretory Apparatus" 
Vv of Endothelial Cell Occupied by 0.017 ± 0.002 0.015 ± 0.002 
RER 
Results are means ± SE 
n= number of individuals 
Figures 5.2a, b: Unexplained recurrent miscarriage stromal cells from unsuccessful (a) 
and successful (b) pregnancy groups at day LH+7 of the menstrual cycle. Both groups 
show euchromatic nuclei (N) and cytoplasmic projections. 
Staining: Uranyl Acetate - Lead Citrate 
(a) Bar represents 3.95 gm 
(b) Bar represents 3.95 µm. 
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intersubject variation in the unsuccessful pregnancy group in this feature. I lowever, th e 
implication of this remain unknown. 
The morphometric evaluation of the endothelial cell features did not show any 
significant differences, similar to stromal cells (Table 5.5). The volume densities of 
endothelial cell occupied by nucleus and the euchromatin to endothelial cell were not 
significantly different between groups, indicating no change in the endothelial cell nuclear 
shape and function. The endothelial cell organelle volume densities again did not show 
significant differences (Table 5.5). However, while the coefficient of variation in the 
mitochondrial feature was consistently similar in both groups, the coefficient of variation 
in the volume density of RER was greater in the unsuccessful pregnancy group (35%) 
than the successful pregnancy group (23%). In contrast, the coefficient of variation in 
the volume fraction of "secretory apparatus" to endothelial cell was greater in the 
successful group (33%) than the unsuccessful one (23%). 
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5.4. DISCUSSION 
The present study has examined the endometrial stromal and vascular morphologies 
in subjects with recurrent unexplained miscarriage. Two groups of individuals were 
used; members of the first group previously had 3 or more consecutive pregnancy losses, 
but then had a successful pregnancy and the other group included patients with a history 
of 3 or more previous consecutive miscarriages and persistent unexplained miscarriages. 
These particular infertile individuals were selected for the present study in order to 
determine whether or not there were any endometrial morphological differences between 
the 2 groups. To make subjects (unexplained recurrent miscarriers) eligible for the 
inclusion into the study, common causes for miscarriage [chromosomal anomalies, 
immunological and bacteriological factors (see earlier)] were excluded. The general 
hypothesis being that exclusion of other common, identifiable causes from the present 
study left the endometrial factor as the most likely cause for the miscarriage. however, 
this of course does not exclude other unknown causes for the persistent miscarriage 
which would influence the interpretation of the present study. 
Results of these two groups were also compared to day LI1+6 group results, in order 
to determine whether or not recurrent miscarriage patients differed from those normal 
fertile individuals (for comparison Table 2.1 and Table 5.1). The results of the day 
LH+6 fertile group were not repeated in the result section of this chapter since they 
were presented in Chapter 2. However, differences between recurrent miscarriage 
groups and the day LH+6 fertile group will be mentioned in this section in order to give a 
full profile of the endometrial morphology in persistent recurrent miscarriage and 
previous miscarriage cases. 
Previously miscarrying subjects in the "successful pregnancy group" had had at least 
one pregnancy with a single birth. However, data on the final outcome of pregnancies 
from previously miscarrying women remain controversial. Reginald et al. (1987) 
reported that 30% of such babies were small for gestational age, 28% were bona 
preterm, and the perinatal mortality rate was 161/1000 births, indicating a greater risk of 
these complications in women with the history of recurrent miscarriage. On the other 
hand, Hughes et a!. (1991) found no significant differences in the incidence of small-for- 
gestational age infants, prematurity, low-birth-weight infants and toxaemia between a 
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group consisting of women with a previous history of recurrent miscarriage and the 
control group. These data could suggest that women with previous miscarriages may 
still have some abnormalities related to their previous sub-fertility, however such 
suggestions remain speculative since an abnormal pregnancy outcome could be due to 
other reasons unconnected with any previous fertility problems. 
In the present study, the endometrial stromal and vascular features did not show any 
significant differences between the 2 groups. However, there were high coefficients of 
variation in some features, indicating their high intersubject variation within the group. 
In addition, stromal and vascular features of the two recurrent miscarriage groups 
differed from those of day LH+6 fertile groups indicating an abnormal endometrial 
structure in recurrent miscarriage patients, and perhaps more interestingly, it may 
indicate an abnormal endometrial development in those patients with previous 
miscarriage history who eventually had at least one successful pregnancy. 
5.4.1. GLANDULAR EPITHELIUM 
The volume densities of endometrium occupied by gland, and gland cell to gland did 
not differ between successful and unsuccessful pregnancy groups. However, the 
coefficient of variation in the gland to endometrium volume fraction was high in both 
groups indicating a large intersubject variation of this feature in both groups. 
In addition to the quantitative examination, qualitative observations of the 
endometrial gland cells in the unsuccessful pregnancy group demonstrated pre- 
implantation period characteristics such as the nuclear channel system (NCS). These are 
spiral channels within the nucleus which are continuous with the inner leaflet of the 
nuclear membrane. Although their function is still unclear, they consistently appear 
around day LH+4 and disappear soon after day LH+7 in normally cycling fertile women, 
under the influence of progesterone (Dockery and Rogers 1989). The presence of 
nuclear channel systems is crucial for development of normal cndometrium, and a recent 
report by Birkenfeld et a!. (1991) has suggested that the presence of nuclear channels 
`may serve as a fine marker of adequate secretory transformation'. It has also been 
reported that endometrial NCS formation was delayed in women with unexplained 
infertility (Dockery et a!. 1994). In the present study the presence of nuclear channels in 
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glandular epithelial cells of recurrent miscarriage individuals at day LI1+7 may indicate a 
normal endometrial development, and thus eliminates the possibility any gross distortion 
in endometrial development causing infertility in these individuals, although it does not 
rule out some minor delay. In addition there were no significant differences between the 
day LH+6 fertile group and unsuccessful and successful pregnancy groups, indicating 
that the glandular compartment of the human endometrium was not a major cause of 
infertility in patients with recurrent miscarriage. 
Serie et al. (1994) indicated a retarded endometrial development in recurrent 
miscarriage patients during the peri-implantation period in a morphological and 
immunohistochemical study. In their study, 15 out of 25 (60%) recurrent miscarriers had 
retarded endometrial development accompanied by reduced levels of four mucin-related 
secretory epitopes, determined by immunoliistochemistry. In addition, when the 
histological dating of the recurrent miscarriage group was compared to the chronological 
dating (LH dating), there was a2 day delay on average in the recurrent miscarriage 
group (Serie et al. 1994). In their study, the volume fraction of endometrium occupied 
by gland was significantly lower in the recurrent miscarriage group with retarded 
endometrium (22%) than the fertile control group (44%). However, the volume fraction 
of endometrium occupied by gland was not significantly different between the recurrent 
miscarriage group with unretarded endometrium and the control group. The volume 
density of gland occupied by gland cell was significantly higher in the recurrent 
miscarriage group with retarded endometrium (88%) than in the control group (72%). 
On the other hand, this feature was not significantly different between recurrent 
miscarriage group with normal endometrium and the control group. In addition, the 
number of subnuclear vacuoles per 100 gland cells was dramatically higher in the infertile 
group with retarded endometrium (4.70 per 100 gland cells) than the controls (0.70 per 
100 gland cells) and the recurrent miscarriage group with normal endotnetrium (also 0.70 
per gland 100 cells). 
In the present study comparison of endometrial glandular features between the 
recurrent miscarriage group and the previous recurrent miscarriage group were made. 
There were no significant differences between these 2 groups. It was not possible to 
make comparisons between day LH+7 fertile individuals and these recurrent miscarriage 
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groups, since control biopsies at day LH+7 were not available. However, there were no 
significant differences in the glandular features between the nearest available biopsies 
(day LH+6 fertile group) and any of the recurrent miscarriage groups (for comparison 
see Table 2.1 and Table 5.1). Recurrent miscarriage group biopsies were obtained at day 
LI1+7 and while it may not be entirely appropriate to compare the data between the day 
LH+6 and the day LH+7 groups, these were the best controls available at the time. Also 
there were no significant differences between day LH+6 and day LH+8 fertile groups 
(see Table 2.1), suggesting that it is unlikely that major differences in endometrial 
glandular values occurred between the day LH+7 and the day L1I+6 endometria. This 
unchanged endometrial glandular morphology may indicate that the reason for repeated 
pregnancy losses may not he with endometrial glandular development, but could be due 
to other unknown pathologies in the stromal and vascular compartments. 
Saleh et al. (1995) investigated the peri-implantation period luminal epithelial 
differences between fertile women and women with several types of infertility including 
recurrent miscarriages using morphometric methods at the light microscopical level. In 
their study, most of the luminal epithelial features did not differ between the fertile group 
and the recurrent miscarriage group, apart from the luminal epithelial cell height which 
was significantly reduced in the recurrent miscarriage group. In addition they found 
numerically higher coefficients of variation within the recurrent miscarriage group when 
compared to the fertile group. However, their study was only at the light microscopical 
level and compared only basic luminal epithelial cell features. In addition, recurrent 
miscarriage is not a failure of implantation (which may be due to luminal epithelium) but 
rejection of the embryo some time after implantation and therefore Saleh's report may 
not provide much useful information to the present study. Endometrial factors in 
rejection of the implanted embryo are more likely to be due to either blood vessels or 
stroma. 
In the present study, there were no significant differences in glandular features 
between the persistent recurrent miscarriage group and the group with previous 
recurrent miscarriages but recent successful pregnancies. Thus, it may be that such high 
intersubject variations (CVs) could suggest sub-groups within the population studied. 
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Better diagnosis of these potential sub-groups would be likely to substantially improve 
our quantitative assessment of these samples. 
Although in most recurrent miscarriage cases no apparent reason for pregnancy loss 
can be found, recent evidence indicates that endometrial function plays an important role 
for continuation of pregnancy (Stirrat 1990b; Tulppala et a!. 1993; Li et al. 1994). It has 
been reported that luteal phase defect (LPD) of endometrium was present in 17% of 
habitual aborters (Tulppala et al. 1991). Determination of serum placental protein 14 
(PP14) levels is reported to be an accurate and reliable indicator for the diagnosis of 
LPD (Klentzeris et al. 1994; Tulppala et a!. 1995; Dalton et al. 1995). It has been 
suggested that in the luteal phase of the menstrual cycle, serum PP 14 levels were lower 
in patients with habitual abortion than in fertile control women, but the differences in 
PP14 levels between habitual aborters with or without LPD were not significant 
(Tulppala et al. 1995). They speculated that "deficient production of endometrial PP14 
may result in an altered immunological environment during the early phases of 
pregnancy". Dalton et al. (1995) also suggested a correlation between retarded 
endometrium and lower PP14 levels in patients with recurrent miscarriage. However, 
the explanation for these phenomena in human fertility still remains unknown, and more 
effort is needed for a fully understanding on this field of human reproductive biology. 
5.4.2. STROMA 
The volume fraction of endometrium occupied by stroma was not significantly 
different between successful and unsuccessful pregnancy groups and this result was 
consistent with the unchanged glandular volume density. The volume fraction of stromal 
cell nucleus to endometrium did not change when the successful and unsuccessful 
pregnancy groups were compared statistically, and when considered with the data above, 
this could suggest an unchanged packing density of stromal cells in recurrent 
miscarriage individuals. The coefficients of variation in both successful and unsuccessful 
pregnancy groups were around 20% which was relatively high. 
The stromal cell nuclear profile dimensions showed no significant differences between 
the 2 groups, although there was a tendency of an increase in the stronial cell mean 
profile diameter in the unsuccessful pregnancy group. This numerically higher (5%) 
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stromal cell nucleus mean profile diameter in the successful pregnancy group could 
suggest an increased nuclear size and activity in this group. However, on average the 
volume densities of stromal cell occupied by nucleus and euchromatin to stromal cell 
nucleus did not differ significantly between groups, indicating no change in the stromal 
nuclear volume and transcriptional rate. In addition, the stromal cell profile axial ratio 
did not differ between groups indicating no change in the stromal cell nuclear shape. The 
coeff cient of variation in the stromal cell nuclear axial ratio was more than two fold that 
of the successful pregnancy group (17%) when compared to the unsuccessful group 
(7%), indicating a greater intersubject variation in the former group. 
The volume fraction of stromal cell occupied by mitochondria did not differ between 
groups suggesting that there was no change of metabolic demand between persistently 
miscarrying and previously miscarrying individuals. Similarly, the volume density of 
RER to stromal cell was not different between groups, again indicating no change of 
synthetic activity in stromal cells. On the other hand, the volume density of "secretory 
apparatus" to stromal cell tended to be higher in the unsuccessful pregnancy group, 
suggesting an increased secretory activity or membrane turnover between the two 
groups. Although the numerical difference between mean values was relatively high 
(31%) it was not significant, probably due to the high coefficients of variation of this 
feature in the successful pregnancy group (50%) and unsuccessful ones (20%). In 
addition, the coefficient of variation in the volume fraction of stromal cell occupied by 
RER in the successful pregnancy group (37%) was double that of the unsuccessful one 
(19%). 
In contrast to the comparison between two recurrent miscarriage groups, there were 
significant differences between the day LI1+6 fertile group and both recurrent 
miscarriage groups (see Tables 2.2 - 2.3 and Tables 5.2 - 5.3 for details). For example 
the mean profile diameter of the stromal cell nucleus was significantly higher in the 
successful pregnancy group than the day LH+6 group. This feature was not significantly 
different between the fertile group and the unsuccessful pregnancy group. Since the 
results were already presented in previous sections, they have not been repeated licre. In 
addition, while some stromal features were significantly different between the day LI1+6 
group and the unsuccessful pregnancy group, some differed significantly between fertile 
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group and successful pregnancy group, indicating an unstable pattern of results between 
groups. These differences may also suggest an abnormal endometrial stromal 
development in the recurrent miscarriage patients, which could affect the later stromal 
cell differentiation (decidualization). 
5.4.3. BLOOD VESSELS 
At the light microscope level, none of the endometrial blood vessel features differed 
significantly between groups, however, the coefficients of variation in these features 
(blood vessel lumen, tissue and total blood vessel volume densities) were consistently 
higher in the unsuccessful pregnancy group than the successful ones, indicating a greater 
range of endometrial vascularization in the persistently miscarrying individuals. This high 
intersubject variation in the unsuccessful pregnancy group could be due to different 
underlying pathologies in individuals allocated to the same group. 
At the electron microscope level, the morphometric evaluation of the endothelial ccll 
features showed no significant differences between recurrent miscarriage groups. 
However, the coefficients of variation in some features were relatively high in both 
groups, indicating a high intersubject variation within groups. Although there were no 
significant differences between the 2 recurrent miscarriage groups in blood vessel 
endothelial cell features, some features in both groups differed significantly when 
compared to the day LH+6 fertile group. For example, the volume fraction of 
endothelial cell nucleus occupied by euchromatin was significantly lower in recurrent 
miscarriage groups than the fertile group, indicating a lower level of transcription in 
endothelial cell nucleus in both recurrent miscarriage groups. This low transcriptional 
rate in endothelial cell was consistent with a decreased volume fraction of endothelial cell 
occupied by RER in both recurrent miscarriage groups. These differences in endothelial 
cell synthetic activity may indicate an involvement of blood vessels in the failure of the 
pregnancy and finally rejection of the embryo by endometrium. 
Rejection of the embryo occurs after implantation and placentation has begun; it is 
convenient to now review the events that take place during these stages of a conception 
cycle. The depth of trophoblastic invasion is influenced by the degree of decidual 
response. Where the decidual response is inadequate, invasion is much more aggressive 
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and penetrating (Johnson and Everitt 1988). The maternal blood vessels in the uterus are 
eroded to nurture the trophoblastic cells in maternal blood. With the formation and 
invasion of the decidua, implantation is completed, a physical hold and a nutritional 
source of decidua is established, and the basis of placental development (leading to 
adjacent blood circulations and exchange of nutrients) is initiated (Guillomot et a!. 
1993). 
As the mesoderm of the conceptus becomes more extensive, it develops blood 
vessels and forms an extensive vascular network. Blood formation occurs in the yolk sac 
mesoderm and a primitive heart forms in the cardiac mesoderm within the developing 
embryo itself. With further development, the vascularity in the conceptus becomes 
particularly marked in the yolk sac mesoderm and where the yolk sac and chorionic 
mesoderm fuse together. A corresponding vascularity develops within the endometrium 
adjacent to this site of fusion, and together the two adjacent, highly vascular sites form 
the placenta (Johnson and Everitt 1988), with the decidua on the maternal site of the 
placenta. The functional chorio-allantoic placenta is characterized by 1) extensive 
proliferation of the chorionic tissue to form villi that penetrate into, and interdigitate 
with, the endometrial tissue, and 2) by highly developed vascularity of both fetal and 
maternal components (Johnson and Everitt 1988). These developments in fetal and 
maternal sites are important to mention in this section, since the loss of pregnancy occurs 
during this time of the pregnancy, and any abnormality in these processes could lead to 
the miscarriage of the embryo. 
Miscarriage is not a failure of implantation, but it is the rejection of already implanted 
embryo. Therefore stromal and vascular compartments, rather than glandular and 
luminal epithelia, are likely to be major endomctrial contributors for the rejection of 
embryo, and thus failure of the pregnancy. Results of the present study generally agree 
with this hypothesis that recurrent miscarriage individuals differed frone the fertile group 
at the stromal cell and blood vessel levels, indicating the importance of these 
compartments throughout the pregnancy process. 
Although there are a small number of reports dealing with the cndometrial 
morphology in women with unexplained recurrent miscarriage, these reports mainly 
involve the morphology of glandular and luminal epithelial compartments of the human 
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endometrium at the light microscopical level. The present study appears to be the first 
one dealing with the morphological changes that occur in the endometrial stromal and 
vascular components. In addition, it is the first one to examine endometrial glands using 
objective stereological methods at the light and electron microscope levels in cases of 
unexplained recurrent pregnancy losses. 
Endometrial secretions may also play a big role in the recurrent miscarriage. The 
precise role of the secreted factors is unknown, but they are postulated to have a role in 
embryo nourishment and implantation, and therefore may be essential for successful 
pregnancy (Dalton et al. 1995). Endometrial secretory activity may be important in 
conditions such as recurrent miscarriage where the problem may be due to endometrial 
dysfunction. Proteins such as PP 14 (Tulppala et al. 1995) and CA 125 (Klentzeris et 
al. 1994) are secreted from endometrial glands, and are believed to play crucial role in 
the continuation of a conception cycle. These endometrial secretions must be 
considered as potential factors of repeated pregnancy losses. Several sub-groups were 
also indicated by Serle et al. (1994) within the recurrent miscarriage groups consisting 
of patients with retarded endometrium and patients with unretarded endomctrium. In the 
present study, high coefficients of variation in some endometrial features support this 
hypothesis, and inclusion criteria into the recurrent miscarriage groups should be 
precisely chosen in such studies. 
In summary, there were no significant differences in the stromal and vascular parts of 
the endometrium between successful and unsuccessful pregnancy groups. however, the 
coefficients of variation of most of the endometrial features were higher in the 
unsuccessful pregnancy group than the successful pregnancy group whereas in some 
features, it was higher in the successful pregnancy group. It can be concluded that the 
stromal and vascular morphologies did not differ significantly around the time of 
implantation in women with persistent pregnancy losses from those who had previous 
recurrent miscarriages but had successful pregnancy. On the other hand, these recurrent 
miscarriage groups differed significantly from the day LI1+6 fertile group, suggesting an 
abnormal endometrial development at the stromal and endothelial cell levels in recurrent 
miscarriage individuals. However, examination of these endometrial compartments at 
the later stages of the menstrual cycle may be more appropriate since crucial events 
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(such as decidualization) take place towards the end of a conception cycle. In addition, 
more effort is needed for a complete understanding of mechanisms that cause the 
recurrent pregnancy loss and complicated interactions between steroid hormone levels, 
cndometrial structure and function (especially endometrial secretions), and the 
development of maternal and fetal tissues such as decidua formation and placentation in 
the case of recurrent miscarriage. 
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CHAPTER 6 
ESTABLISHMENT OF A 3-DIMENSIONAL TISSUE CULTURE 
MODEL FOR HUMAN ENDOMETRIAL STROMAL CELLS 
6.1. INTRODUCTION 
The mechanisms of recognition and adhesion of the blastocyst to the cndometrial 
epithelium and embedding of the embryo into the endometrial stroma are poorly 
understood phenomena in Man. he precise cytological events which occur during 
interaction between embryo and endometrium are not known, and direct In vivo 
microscopic studies of the structural changes that occur in the endometrial epithelium 
and stroma during implantation and gestation of a conception cycle are virtually 
impossible in humans for both ethical and practical reasons. In vivo animal experiments 
may be of some use in these studies, but remain limited since the processes of 
implantation in animals is very different in detail from those in Man. In vitro endometrial 
cell culture models using human tissue have been reported by several investigators (e. g. 
Luginbuhl 1968; Bongso et al. 1988; Hill et al. 1993 and 1994; Dentin-Ley et al. 1994) 
in an attempt to overcome the existing difficulties in the understanding of the cellular 
events that take place in the human endometrium around the time of implantation, and 
also during the later stages of the pregnancy involving gestation and placentation. 
Previous studies on in vitro human endometrial morphology have concentrated on 
epithelial cells and were performed using organ culture systems (Luginbuhl 1968), 
traditional monolayer cell culture techniques (Liszczak et al. 1977; I3ongso et al. 1988) 
and three-dimensional cell culture methods (Bentin-Ley et al. 1994; Hill et al. 1994) that 
allow cells to grow in polarized conditions so they appear similar to those seen in vivo. 
It is well established that the morphology of epithelial cells in monolayer culture does not 
resemble to those seen in vivo and they do not demonstrate a full complement of cellular 
structures such as apical surface structures and cellular polarization whereas those in 
three-dimensional culture systems closely resemble cells in vivo (11111 et al. 1994). 
I lowever, there is less published information on stromal cells in vitro. 
The present thesis has examined the effects of various hormonal influences on the 
stromal compartment of endometrium. However, it is ethically and practically impossible 
to examine detailed effects of repeated honnonc treatment on the same women during 
the same cycle In vivo. Therefore in this chapter an experiment is reported that was 
designed to produce a novel In vitro model system of human stromal cells and to use it to 
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examine the effects of hormonal administration on cultured cells and where possible to 
relate it to in vivo conditions reported previously. 
6.1.1. ENDOMETRIAL TISSUE AND CELL CULTURE MODELS 
The first endometrial in vitro model was described by Ehrmann et al. (1961) using 
endometrial tissue explants . In this method, endometrial curretings or strips from 
hysterectomy specimens were cut into 1 or 2 mm fragments and placed in Petri dishes 
covered with gel surfaces and then a nutrient agar (medium) was added to the culture 
dishes. These so-called tissue explants were cultured in this media for up to 10 days and 
were used for specific purposes such as morphological investigation (Luginbulil 1968). 
However, endometrial tissues cultured with this method had a poor survival rate and the 
cells in the stromal compartment of human endometrium had particularly poor survival 
rates in this culture system (Luginbuhl 1968). 
Traditional monolayer cell culture has also been used for morphological and 
especially for physiological studies. In this technique, cells were grown in culture dishes 
containing nutrient medium and additional substances such as steroid hormones 
(Liszczak et al. 1977; Bongso et al. 1988). It has been suggested that the morphology 
of cells grown in monolayer culture were similar to those seen in vivo (Liszczak et a!. 
1977). However, polarization of the epithelial cells (markers of the cell polarization 
include apical surface specializations such as cilia and microvilli) is not achieved in 
monolayer culture systems as indicated by microscopic studies (I lilt et al. 1994). 
In recent years, three-dimensional cell culture models have been developed (I Iill et a!. 
1994; Bentin"Ley et a!. 1994). In these culture systems, epithelial cells are grown on or 
in an artificial ECM in a multiwell culture plate using a millicell insert that contains a 
filter at the bottom allowing the cells to be nourished from their bases. It has been 
shown that epithelial cells grown with this technique are morphologically much closer to 
those In vivo than the cells in monolaycr culture (Hill et al. 1994). Bentin"Ley et al. 
(1994) used a slightly different endometrial cell culture model for a three-dimensional 
growth of epithelial cells. In their model, stromal cells were seeded onto a collagen gel 
and epithelial cells were cultured on top of this stromal cell layer. Microscopical 
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observations showed a polarized growth of epithelial cells with abundant apical surface 
specializations. 
In recent years human endometrial stromal cell differentiation (including 
decidualization) and the production of some cytokines and growth factors (such as 
interleukins) by decidual cells has become an important area of interest in human 
reproductive biology. For the reasons mentioned earlier, human in vivo studies on this 
subject can provide little information. Therefore new is vitro stromal cell culture models 
are needed for a better understanding of the events that take place in the human 
endometrial stromal compartment under the influence of sex steroids in the menstrual 
cycle and during pregnancy. One aim of the present study was to grow stromal enriched 
human endometrium in three-dimensional culture as a model for ißt vivo conditions. The 
second aim was to use this model to study the effects of oestrogen and progesterone on 
stromal cell morphology at light and electron microscope levels. This should be regarded 
as a preliminary study on human endometrial stromal cell morphology in a novel three- 
dimensional culture model and so a large part of the study deals with the technical 
aspects of the culture system such as the stromal and epithelial cell separation techniques. 
However, preliminary reports on the qualitative morphological appearance of the stromal 
cells obtained with this culture model both with and without hormonal supplementation 
are also included. 
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6.2. MATERIALS AND METHODS 
6.2.1. SUBJECTS AND EXPERIMENTAL DESIGN 
Endometrial biopsy tissue from 5 individuals were used in the present study; 2 were 
taken in the proliferative and 3 in the secretory phase of the menstrual cycle. Biopsies 
were obtained with informed consent and Ethic's Committee approval from subjects 
attending the Jessop Hospital for Women, Sheffield (see Table 6.1 for details of the 
subjects used). From each biopsy a piece of tissue was fixed in 3% glutaraldehyde in 
0.1M phosphate buffer, and processed for standard electron microscopical observations 
(see earlier). This specimen provided a morphological reference, and was designated the 
"original biopsy". It was used to make comparisons, where possible, between 
endometrial stromal cell structure in vitro and normal human stromal cell morphology in 
vivo. The remaining tissue was processed for in vitro tissue culture experiments (see 
later). The first aim of the present study was to produce a good ii: vitro model of 
stromal cells in vivo. In addition, the morphological differences between proliferative 
phase and secretory phase endometrial stromal cell primary cultures were evaluated. The 
effects of ovarian sex steroids on the stromal cells in vitro were also examined at each 
stage of the menstrual cycle. 
Table 6.1: Shows the age, cycle length and biopsy date of subjects used in the present 
study. 
Subjects Age (years) Cycle Length (days) Biopsy Date (in cycle) 
1 33 28 15 (Secretory) 
2 39 28 21 (Secretory) 
3 48 28 18 (Secretory) 
4 38 28 2 (Proliferative) 
5 47 26 8 (Proliferative) 
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6.2.2. TISSUE CULTURE 
6.2.2.1. PILOT STUDY: SELECTION OF TIIE BEST METIIOI) FOR 
STROMAL CELL SEPARATION 
At the beginning of the present study, two separation techniques were performed to 
decide which gave the best cell separation method for obtaining the stromal cell rich 
cultures. These are described below (also see Figure 6.1). 
Endometrial biopsies were removed using a Sliarmann's curette (Downs Surgical, 
Sheffield, UK) by an experienced gynaecologist, and following this procedure 
cndometrial tissues were washed with several changes of 10% Hank's balanced salt 
solution (HBSS, Life Technologies Ltd., Paisley, Scotland) in distilled water to remove 
any blood, non-endometrial tissue and cellular debris. The tissue was then chopped 
finely with a sharp surgical blade and washed further in 10% HBSS. The finely chopped 
tissue was placed in dissociation media consisting of 0.25% collagenasc (Signa 
Chemicals Co., UK) in HBSS to remove connective tissue. The mixture was incubated 
in a water bath at 37 °C for 2 hours with mechanical disruption intermittently by a 
vortex. After 2 hours of dissociation, the supernatant was removed into two centrifuge 
tubes to which 10% HBSS was added to stop further collagenase digestion. The first 
tube ("settled" tube) was left for 10 minutes to settle down the epithelial cells which arc 
larger and heavier than the stromal cells, whereas the second tube ("spun" tube) was 
centrifuged at 500 rpm for 5 minutes. Then supernatants from both tubes were collected 
separately into 2 other tubes, and further centrifuged at 1000 rpm for 5 minutes. One nil 
of Dulbecco's Hams F12 (DMEM-F12, Life Technologies Ltd., Paisley, Scotland) 
media was added into each tube and 0.5 ml of the resulting cell suspensions were seeded 
onto covcrslips in monolaycr culture dishes. The remaining 0.5 ml of cell suspensions 
were cytospun (Cytospin, Shandon Southern, UK) onto glass slides (at 400-500 rpm 
speed for 2 minutes) and stained with cytokeratin antibody for epithelial cell 
demonstration and vimentin antibody for stromal cell demonstration (sec next section for 
details of the immunocytochemical staining protocol). Cells in monolayer culture dishes 
were also processed for immunocytochemistry following 6 days of incubation. This last 
procedure was performed to examine if the proportion of epithelial and stromal cells 
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Figure 6.1: Flow chart summarises the human endometrial stromal cell separation and 
culture procedures. 
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Sec Figure 6.2 
changed after 6 days of culture and to determine the final outcome of the cell types. 
Results of both cell separation methods were evaluated, and it was decided to use the 
second ("spun") method for the rest of experiments. 
6.2.2.2. PREPARATION OF CELLS IN 3-DIMENSIONAL CULTURES 
The pellet containing stromal cells (after centrifugation at 1000 rpm for 5 minutes) 
was collected and resuspended in DMEM-F12 culturing media (amount of media used 
depended on the volume of the cells and ranged from 2 ml to 5 ml). Half millilitre of cell 
suspension was seeded into each Matrigel (Collaborative Biomedical Products, Bedford, 
USA) coated millicell insert (Millipore, U. K. ) (see Appendix 2) and 0.5 ml of DMCM. 
F12 media was placed around the millicell insert (Figure 6.2a). The multiwell culture 
plate (Costar, USA) was then placed in an incubator with an atmosphere of 5% C02 and 
95% air at 37 °C. Medium was changed every 2 days and the culturing time for these 
stromal cells was approximately 6-7 days (see Figure 6.1). Following 6 days in culture, 
cells were washed with pre-warmed 0.1 M phosphate buffer and pre-warmed 3% 
glutaraldehyde was added into culture plates (the remaining procedures such as tissue 
fixation, dehydration, embedding, sectioning and staining protocols for electron 
microscopy was the same as described in Chapter 2 Materials and Methods section. 
Except that the insert was cut up into smaller pieces before being embedded along with 
the cells it contained). The separation procedure of the stromal cells from epithelial cells 
was slightly modified from the report by Bongso et al. (1988). 
6.2.3. CYTOKERATIN AND VIMENTIN IMMUNOSTAINING METHOD 
(ALKALINE PIIOSPIIATASE - ANTI-ALKALINE PIIOSPIIATASE : APAAI' 
TECHNIQUE) 
Iminunocytocliemical staining (APAAP) proccdure of human cndomctrial cclls was 
modified frone the report by Cordell et a!. (1984). Cytospun cells and cultured cells in 
monolaycr culture dishes were fixed in pre-cooled 50: 50 metlhanol/acetone fixative for I 
minute 30 seconds. Cells were then washed in TBS (tris buffered saline) (pHI 7.6) for 5 
minutes. Approximately 30 µl of monoclonal antibody [either anti-cytokcratin 
(Monoclonal Anti-Pan Cytokeratin: Sigma Immunoclhemicals, UK)- at 1: 100 dilution or 
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Figures 6.2a, b, c: (a) demonstrates the diagram of the 3-dimensional culture system used 
in the present study. Figures 6.2b and (c) show electron micrographs of stromal cells 
taken from in vivo and in vitro samples respectively. The appearance of these cells is 
generally similar. (N) nucleus. 
Staining: Uranyl Acetate - Lead Citrate 
(b) Bar represents 1.75 gm 
(c) Bar represents 1.80 pm 
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anti-vimentin (Monoclonal Anti-Vimentin: Sigma Immunocliemicals, UK)- at 1: 50 
dilution] was applied for 2 hours at room temperature then washed in TIIS for 5 minutes. 
The cells were incubated in rabbit anti-mouse (RAM - Rabbit Anti-Mouse 
Immunoglobulins, Dako A/S, Denmark) polyclonal antibody (preparation of RAM is 
given in Appendix 2) at a dilution of 1: 20 (30 jtl) for 30 minutes at room temperature, 
and cells were washed in TBS for 5 minutes. Cells were then incubated in mouse 
monoclonal alkaline phosphatase - anti-alkaline phosphatase complex (APAAP: Sigma 
Immunochemicals, U. K. ) (Figure 6.3) for 30 minutes at room temperature and washed in 
TBS for 5 minutes. RAM and APAAP steps of the procedure were repeated to amplify 
the reaction. Substrate-Fast Red solution (10 mg of Fast Red TR-Salt in 10 ml of 
substrate) were applied for approximately 15 minutes (preparation of the substrate is 
given in Appendix 2). The cells were washed in running water, counter stained with 
haematoxylen for a few minutes and then mounted with glycerine. Cytokeratin or 
vimentin positive cell cytoplasms were stained in orange or red colour (Figures 6.5a, b). 
6.2.4. OESTROGEN AND PROGESTERONE SUPPLEMENTATION OF 
HUMAN ENDOMETRIAL STROMAL CELLS IN CULTURE 
Steroid hormone administration of the stromal cell culture was performed in order to 
determine the effects of oestrogen and progesterone on stromal cell ultrastructure in 
vitro. To do this, 0.5 ml of DMEM-F12 media containing oestrogen and/or 
progesterone hormones (in 10-6M dilution) was added into the culture plates. This 
procedure was repeated in every change of media, which occurred every 2 days. 
Oestrogen used in the present study was ß-estradiol (Sigma Chemicals, UK), and a 
synthetic progesterone (Sigma Chemicals, UK) was used. Both hormones were 
dissolved in absolute ethanol (up to the 10 '2 M dilution), and these 10 -2 M solutions 
were diluted to a final concentration of 10 '6M using DMEM-F12 medium. For each 
biopsy, one set of hormone supplementation protocol was performed in a multiwell 
culture plate; e. g. 1 well for oestrogen, 1 for progesterone, 1 for oestrogen + 
progesterone combination and one for unsupplemented cell growth. 
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Figure 6.3: Schematic illustration of the monoclonal APAAP procedure (modified from 
Cordell et al. 1984). 
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Figures 6.4a, b: Phase-contrast microscopical appearance of "settled" cells (a) and 
"spun" cells (b) after 6 days in monolayer culture. While "settled" group culture 
contains large cells (arrow) (presumed epithelial; see Figure 6.5a), "spun" group culture 
consists of mostly smaller cells (presumed stromal; see Figure 6.5b). 
(a) Bar represents 13 pm 
(b) Bar represents 11.5 µm. 
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Figures 6.5a, b: Immunocytochemical demonstration of "spun" group cells after 6 days 
in monolaycr culture. (a) demonstrates small number of anti-cytokeratin stained large 
cells (small arrow) obtained by the "spun" procedure whereas (b) shows abundant anti- 
vimentin positive cells (arrow) obtained by the same procedure. Note the cytoplasmic 
projections (empty arrow) that are characteristic for stromal cells. 
Staining: (a) Monoclonal anti-cytokcratin - APAAP 
(b) Monoclonal anti-vimcntin - APAAP 
(a) Bar rcprescnts 29 um 
(b) Bar represents 30 ttm 
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6.3. RESULTS 
In the present study a three-dimensional endometrial stromal cell culture model was 
used, in order to determine the in vitro morphology of endometrial stromal cells obtained 
from the proliferative and secretory phases of the menstrual cycle. In addition, stromal 
cell cultures were treated with oestrogen and progesterone to evaluate the effects of 
steroid hormones on stromal cell morphology at both parts of the cycle in vitro. After 
six days in culture, cells were processed and examined by electron microscopy. 
6.3.1. TECHNICAL RESULTS 
For confirmation that the stromal and epithelial cell separation methods were 
successful, cell suspensions (after collagenase digestion) were divided into two tubes and 
processed as described in section 6.2.2. Immunocytochemical staining of cells that 
directly cytospun onto glass slides from "settled" cell suspension showed a number of 
cytokeratin positive large epithelial cells and cell clumps, whereas the "spun" group cell 
suspension contained fewer cytokeratin positive cells and abundant vimentin positive, 
smaller stromal cells. Cell morphology after a6 day culture period was examined using 
direct phase-contrast microscopical observation and using light microscopy before and 
after culture on immunostained cells. 
Phase-contrast microscopical examination of "settled" cells in culture showed large 
epithelial cells as well as smaller stromal cells (Figure 6.4a), whereas the "spun" cell 
culture dish contained fewer epithelial cells and more fibroblast-like smaller cells (Figure 
6.4b). These direct phase-contrast microscopical observations also showed that the cell 
separation procedure did not damage the cell structure. Cells in monolayer culture 
dishes had the usual cellular appearances, containing cytoplasmic projections and normal 
nuclear morphology. Following phase-contrast microscopical observations, both "spun" 
and "settled" cell cultures were stained with anti-cytokeratin for epithelial cells and with 
anti-vimentin for stromal cells. "Settled" cells showed a considerable number of large 
anti-cytokeratin positive cells and cell clumps which were defined as epithelial cells. On 
the other hand, "spun" cells contained fewer anti-cytokeratin positive cells, and abundant 
anti-vimentin positive cells were observed in this group (Figures 6.5a, b). While anti- 
vimentin positive stromal cells contained characteristic cytoplasmic projections along 
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with "spindle" cellular shape, anti-cytokeratin positive epithelial cells demonstrated large 
cytoplasmic volume, and they also formed cell clumps typical of epithelial cells. These 
observations indicated that cells after the separation procedure preserved their 
morphology, and no apparent adverse effect of the process on cell structure was evident. 
Following immunocytochemical observations, it was decided to use the second 
("spun") cell separation technique, since this method clearly provided a stromal enriched 
population of cells at the start of the cultures which was maintained after 6 days in vitro. 
Following 6 days of culture, cells were processed for electron microscopy and examined 
by using a Phillips 301 electron microscope. A detailed descriptive morphology of the 
human endometrial stromal cells were determined in vitro. 
6.3.2. BIOLOGICAL RESULTS 
Cells grown for 6 days in a three-dimensional culture model had an appearance of 
endometrial stromal cells seen in vivo at the electron microscope level. They had oval 
shaped nuclei containing abundant euchromatin material and cytoplasmic projections 
were also regular features of these cells (Figure 6.2c). Cells were rich in cytoplasmic 
organelles: rough endoplasmic reticulum (RER) was in its regular arrangement as 
observed in vivo; mitochondria were small in size and had a normal cristae structure; 
lipid droplets, Golgi apparatus, cytoplasmic vacuoles and vesicles were other cytoplasmic 
components seen at electron microscopical level in vitro and in vivo. In summary, 
endometrial cells grown in this culture system had a similar appearance to those stromal 
cells observed in human endometrium in vivo (Figures 6.2b, c). 
In the present study, stromal cells from two groups of endometrial biopsies 
(proliferative and secretory phase) were cultured in a three-dimensional system and 
examined morphologically with and without sex steroid hormone supplementation in 
vitro. Unsupplemented cultured stromal cells obtained from the proliferative phase 
contained oval shaped nuclei with abundant euchromatic material. Their cytoplasm had 
numerous projections and organelles with the appearance of normal structure (Figure 
6.2c and Figure 6.6a). The cytoplasm also had lipid droplets that are typical for cultured 
endometrial cells. Intracytoplasmic vesicles and vacuoles were also observed in the 
unsupplemented proliferative phase group. There were no dramatic structural 
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Figures 6.6a, b: Unsupplemented group endometrial stromal cells cultured in the 3-D 
culture system obtained from proliferative phase (a) and secretory phase (b) endometria. 
Both groups contained oval shaped euchromatic nuclei (N) and regular cytoplasmic 
organelles and inclusions. (Lp) lipid. 
Staining: Uranyl acetate - Lead citrate 
(a) Bar represents 1.95 µm 
(b) Bar represents 1.75 µm 
/' 
f' 
Figures 6.7a, b: Progesterone supplemented stromal cells cultured in the 3-D model 
system obtained from proliferative phase (a) and secretory phase (b) endometria. There 
are no substantial structural differences between cultured stromal cells at either stage of 
the cycle. Oval shaped euchromatic nuclei (N) and normal amount of cytoplasmic 
organelles are seen in both group cells. 
Staining: Uranyl Acetate - Lead Citrate 
(a) Bar represents 1.00 µm 
(b) Bar represents 3.80 µm. 
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Figures 6.8a, b: Ocstrogcn supplemented cultured stromal cells obtained from 
proliferative phase (a) and secretory phase (b) human cndomctria. While oestrogen 
supplementation caused no effect on cells obtained at the proliferative phase (which have 
round cuchromatic nuclei (N) and normal cytoplasmic structures), oestrogen 
administration caused substantial changes in stromal cells obtained at the secretory phase 
of the menstrual cycle. Irregular shaped heterochromatic nuclei (N) and atrophic 
organdies were frequently observed in these cells. 
Staining: Uranyl Acetate - Lead Citrate 
(a) Bar represents 1.75 ltm 
(b) Bar represents 1.801tm 
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Figures 6.9a, b: Combined oestrogen + progesterone supplemented cultured stromal 
cells obtained from the proliferative phase (a) and the secretory phase (b) human 
endometria. While proliferative phase cultured cells contained irregular shaped 
hetcrochromatic nuclei and normal amount of organelles, secretory phase cultured 
stromal cells had rounded nuclei (N) with prominent nucleolus (No) along «ith 
apparently increased secretory activity: vesicles (arrow) may be seen in the cytoplasm. 
Staining: Uranyl Acetate - Lead citrate 
(a) Bar represents 1.05 In 
(b) Bar represents 3.65 ltm 
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differences between proliferative phase and secretory phase unsupplemented group 
human endometrial stromal cells in culture (Figures 6.6a, b). 
The morphology of cultured endometrial stromal cells to which progesterone 
supplements had been added showed no apparent differences to the unsupplemented cells 
that were cultured from either proliferative or secretory phase samples. There were also 
no differences between progesterone supplemented endometrial stromal cells obtained 
from either proliferative or secretory phases of the menstrual cycle (Figures 6.7a, b). 
While oestrogen supplemented cells showed no significant morphological differences 
from unsupplemented cells in the proliferative phase (Figure 6.8a), stromal cells with the 
same treatment which were obtained during the secretory phase contained hypertrophic 
cytoplasmic organelles (Figure 6.8b). Oestrogen supplemented stromal cells that were 
taken from proliferative phase endometrium had rounded eucl romatie nuclei, cytoplasm 
which contained mitochondria with normal structure and a few intracytoplasmic vesicles 
were also present (Figure 6.8a). On the other hand, cultured oestrogen supplemented 
cells obtained from secretory phase endometrium had irregular shaped nuclei with 
frequent heterochromatic material, their cytoplasm included many vacuoles and lipid 
droplets, and large number of pinocytotic vesicles along with lysosomal structures were 
also evident (Figure 6.8b). 
While the combination of oestrogen and progesterone supplementation caused no 
change in cultured stromal cells obtained from the proliferative phase endometrium 
(Figure 6.9a), cells obtained during the secretory phase of the cycle contained increased 
numbers of intracytoplasmic vacuoles and vesicles, suggesting an increased secretory 
activity or internal transport in these cells caused by the combination of sex hormones 
(Figure 6.9b). Oestrogen + progesterone supplemented proliferative phase stromal cell 
had irregular shaped small nuclei that contained heterochromatic material, and their 
cytoplasm had number of small mitochondria along with RER and Golgi apparatus in 
their normal appearance (Figure 6.9a). However, after combined steroid treatment of 
cultured stromal cells obtained from secretory phase endometrium, these cells showed 
rounded euchromatic nucleus with a nucleolus, and their cytoplasm contained extensive 
"secretory apparatus" and RER (Figure 6.9b), which were characteristic appearance of 
active secreting cells seen in in vivo human endometrium. Furthermore, these cells 
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treated with the combination of both hormones in the secretory phase had an appearance 
of stromal cells in vivo during late secretory phase of the menstrual cycle. 
In summary, immunocytochemistry has confirmed that the endometrial stromal cell 
separation method was a successful one. Electron microscopical observation of the 
cultured stromal cells established that the present three-dimensional culture system 
produced cells with appearance in vitro close to those seen in vivo. Hormonal 
supplementation had variable effects depending on the stage of the cycle when the tissue 
was taken. 
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6.4. DISCUSSION 
Since it is difficult to perform in vivo experiments in humans during implantation and 
gestation of a conception cycle, an in vitro model is required. It is crucial to grow cells 
in vitro which are as similar in structure as possible to those In vivo. In the present 
study, a successful endometrial stromal cell isolation method was established, and human 
endometrial stromal cells were grown in a novel three-dimensional culture model system 
in order to establish cells in vitro with an appearance of normal stromal cells in vivo. In 
addition, the effect of cell culture on stromal cell structure was determined at two 
different stages of the menstrual cycle (proliferative and secretory phase), and the effects 
of oestrogen and progesterone hormone supplementation on the stromal cell morphology 
at these stages were also examined. Since this is a novel method for human endometrial 
stromal cell culture, technical and biological results of the study will be discussed in 
separate sections. 
6.4.1. TECHNICAL ASPECTS OF THE STRO31AL CELL CULTURE MODEL 
Cytokeratin and vimentin are intermediate filaments that have been identified on the 
basis of their protein composition and cellular distribution (Ross et al. 1989). These 
chemically distinct types of intermediate filaments are composed of subunits at different 
molecular weight. Cytokeratin is of 40 000-65 000 molecular weight and characteristic 
for epithelial cells, whereas vimentin has a molecular weight of 55 000 and is found in 
cells of mesenchymal origin (Ross et a!. 1989). The use of antibodies, that are specific 
to the filament types, is an accurate and reliable method for the identification of the cell 
types in tissues and can also be used in the diagnosis of tumour origins. In the present 
study, vimentin and cytokeratin antibodies were used for the identification of stromal and 
cpitlielial cells in human endometrial cultures. 
Immunocytochemical observations of human endometrial cells before and after the 
culturing process revealed that the cell isolation method used in the present study 
provided a stromal enriched cell suspension. hie cell suspension obtained after 5 
minutes centrifugation at 500 rpm contained mostly anti"vimentin positive small cells 
which are defined as the cells with stromal origin. On the other hand, the cells that were 
obtained by settling the cell suspension for 10 minutes, contained relatively more anti. 
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cytokeratin positive cells, which were defined as epithelial cells, than the "spun" method 
Furthermore, immunocytochemistry results of both cell suspensions after 6 days in 
monolayer culture showed that cell population contained mostly anti-vimentin positive 
cells in the cultures obtained using the centrifugation technique, whereas the cells 
obtained by the cell settling method included relatively larger numbers of anti-cytokcratin 
positive cells after 6 days culture. In addition to the qualitative examination of the 
immunostained culture cells, an approximate estimation of stromal and epithelial cell 
proportions in culture was also determined using an image analysing microcomputer 
(Quantimet 970, Cambridge Instruments Ltd., UK). Stromal and epithelial cell 
proportion /n vivo was estimated (which is 1: 5 in favour of epithelial cells; this is the 
relative volumes of the cells, not their numbers. Since epithelial cells arc larger than 
stromal cells the number distribution would be less than 1 in 5) from volume fraction 
data obtained previously, and by measuring total area of anti-vimentin positive (stromal) 
and anti-cytokeratin positive (epithelial) cell areas using the above instrument. A small, 
systematic random sample of stained cells was used from 2 slides of each preparation. 
The final outcome of the endometrial cells after 6 days in culture was a proportion of 
1: 8 in favour of the stromal cells. Although this estimate of stromal and cpitlhclial cell 
proportion* in culture was very preliminary, cell proportion in culture was determined to 
help the interpretation of cell separation method. This result suggested that the 
cndometrial cells in culture were mainly stromal cells, and confirmed the cell isolation 
technique. 
These results indicate that the stromal cell isolation method used in the present study 
was both successful and reliable. The reliability of the cell separation method is 
especially important for the final outcome of the experiment. The separation of the 
stromal cells was not intended to be a total separation, but a stromal cell enrichment for 
use in the 3-dimensional culture experiments. No polarised glandular structures were 
observed during the electron microscopical examination of the cultured tissue, further 
confirming the success of cell separation by the method used in the present study. 
Several cell separation techniques have been reported in in vitro studies dealing with 
human cndometrial cells in culture (Bongso et a!. 1988; Schatz et al. 1990; Ncgami and 
Tominaga 1991; Hatayama et a!. 1994). Bongso et a!. (1988) centrifuged the whole 
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endometrial cell suspension at 100 g for 5 minutes, after leaving the tissue 2 hours in 
0.25% collagenase in HBSS at 37 °C. They repeated this step once more, and then 
centrifuged the remaining supernatant (containing stromal cells) at 400 g for 5 minutes, 
resuspended the cell pellet with medium and cultured the cells in culture flasks. ilongso 
et a!. (1988) recognized epithelial and stromal cells by identifying their morphologies 
using Nomarski's inverted optics, but no immunocytocliemical staining for cell type 
identification was reported. In the present study, the technique used by Dongso et at. 
(1988) was modified by the centrifugation of the whole cell suspension after 2 hours in 
0.25% collagenase at 500 rpm for 5 minutes, and further centrifugation of supernatant 
(containing stromal cells) at 1000 rpm for 5 minutes in order to improve the yield of 
stromal cells in the final suspension. Also an immunocytochemical method was used in 
the present study to distinguish the stroma and epithelial cells in order to accurately 
determine the relative proportion of these cell types after the separation procedure. 
Results of this method confirmed that at least 85-90% of the cell population were 
stromal cells. 
The filtration of the cell suspension through a stainless steel sieve is another method 
used for cell isolation process in in vitro studies (Holinka and Gurpide 1987; Schatz et 
al. 1990; Negami and Tominaga 1991). Schatz et al. (1990) filtered an cndometrial cell 
suspension through a stainless steel sieve, then they baclwaslhed the epithelial cells from 
the sieve. Further isolation of stromal cells in the filtrate was made by taking advantage 
of the more rapid adhesion of the stromal cells than the contaminant cells (epitlhelial and 
blood cells) to tissue culture plastic. On the other hand, there were 2 reasons in the 
present study not to use the cell filtration technique: 1) the present study deals with the 
morphology of the endometrial cells, and filtration process through a metal filter may 
have an adverse effect on the cell morphology, and 2) the present study did not aim to 
completely separate epithelial and stromal cells, but to produce a stroma"enriched 
suspension since pilot studies suggest these give better growth than pure cultures. 
lilatayama et al. (1994) used a different cell isolation method for the examination of 
macrophage colony- stimulating factor (M-CSF) production by human endometrial 
stromal cells. They left the centrifuge tube, containing the dissociated cell suspension, 
upright for 10 minutes and collected the supernatant excluding the lowermost 2 ml of the 
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suspension (consisting of epithelial cells). They repeated this procedure several times 
leaving each cell suspension for 10 minutes. The final cell suspension contained 90% 
viable stromal cells. Their efforts at stromal cell isolation was a time consuming 
procedure since they had to spend at least an hour to settle down the epithelial cells and 
this time could have affected the cells' later viability in culture. In the present study, the 
settling time for epithelial cells was accelerated by centrifuging the cell suspension at low 
speed. In the present study, the percentage of stromal cells at the end of the isolation 
process was at least 85-90%, as determined by using an image analysing microcomputer 
on antibody stained cultured endometrial cells. It can be seen that the final proportion 
of stromal cells after cell separation in the present study and that of Ilatayama et a!. 
(1994) were very similar. However, the method used in the present study is much 
quicker. 
There were some technical difficulties in the present study; for example, the stromal- 
enriched cell 3-D cultures contained very few cells, since they were grown on small 
inserts, in very thin layers of Matrigel. This caused great difficulty in the sectioning of 
Epon blocks since there were so few cells present. Similarly, the electron microscopical 
evaluation of these sections which contained small number of stromal cells was also very 
difficult and time consuming since cells were widely spread throughout the blocks, 
resulting many sections to be cut to observe 1 or 2 cells per section. 
In the present study, stromal cells grown in a three-dimensional culture model showed 
similar appearances to those irr vivo, at the electron microscope level (Figure 6.2b and c). 
Oval shaped nuclei with abundant euchromatin and cytoplasmic projections were regular 
features of these cells. Cells were rich in cytoplasmic organelies; RER was in its regular 
arrangement, mitochondria were small in size and with a normal structure (all suggesting 
active, healthy, secreting cells). It is suggested that the three-dimensional culture system 
used in the present study produced stromal cells with a morphology very similar to that 
seen In vivo and it is therefore a suitable model for In vivo conditions in Man. 
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6.4.2. BIOLOGICAL ASPECTS OF HUMAN ENDOMETRIAL STROMAL 
CELLS IN CULTURE 
Human endometrial cell cultures are used in a wide range of research areas including 
physiologic (Irwin et al. 1989; Schatz et al. 1990; Negami and Tominaga 1991), 
morphologic (Luginbuhl 1968; Liszczak et al. 1977; Hill et al. 1994) and metabolic 
(Jacobs and Carson 1991; Watson et al. 1994) experiments. 
One purpose of using endometrial tissue cultures is to detect the effects of steroid 
hormones on the production of different substances by human endometrial cells. Irwin et 
al. (1989) examined the effects of oestradiol and progesterone on the production of 
prolactin (PRL) by human endometrial stromal cells in monolayer cultures. They 
suggested that the treatment of stromal cells with sex steroids increased the PRL 
secretion by cultured stromal cells and, since PRL is a marker of decidualization in 
humans, they further suggested that the physiological doses of sex steroids they used 
induce the decidualization process of endometrial stromal cells in vitro. Negami and 
Tominaga (1991) examined the effects of PRL on cultured human endoinetrial cells, and 
they suggested that PRL acts as a stimulator at low doses and acts as an inhibitor at high 
doses of the attachment and growth of cultured endometrial epithelial and stromal cells. 
Human endometrial cells secrete cytokines in response to ovarian steroid hormones. 
Hatayama et al. (1994) showed an enhanced production of macrophage colony- 
stimulating factor (M"CSF) by human endometrial stromal cells when they were treated 
with progesterone in culture. These authors concluded that human endometrial stromal 
cells secrete M-CSF in a progesterone dependent manner during the process of 
decidualization. 
Receptor binding studies of several factors in endometrial cells is another field that 
can be performed in vitro. Watson et al. (1994) determined the binding characteristics 
of epidermal growth factor (EGF; plays an important role in the regulation of uterine cell 
growth and differentiation) receptor in isolated human endometrial glands and stromal 
cells in culture. Study on the of ects of cytokines on cultured endometrial cells is another 
use of cell culture techniques in vitro. The effect of interleukin-10 (IL-10; is synthesized 
and secreted by human decidua, stimulates IL -6 production and regulates PGE2 release 
from endometrial glands - Tabibzadeh 1990) on the production of prostaglandins by 
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cultured human decidual cells was determined (Kennard et al. 1995), and it induced 
prostaglandin E2 (PGE2) and PGF2a production and increased cyclooxigenase-2 (COX-2) 
levels in a time-dependent manner in cultured human decidual cells. 
In addition to these physiological and metabolic studies, human endometrial cell 
cultures have also been used for morphological purposes. Luginbulil (1968) determined 
the effects of tissue culture on human endometrium by using explants in culture dishes. 
In this early study, tissue explants of human endometrium had a poor survival rate in 
culture due to technical difficulties. In particular the stromal compartment of 
endometrium was affected by the relatively crude explant culture procedure. Liszczak et 
a!. (1977) performed a morphological study on the effects of ovarian steroids using 
human endometrial monolayer cultures, and they suggested that the use of monolayer 
cell culture methods provides a useful model system for the morphological investigation 
of human endometrium in vitro. However, later reports on this issue have revealed that 
the monolayer cell culture models are not appropriate in terms of morphology and cells 
obtained with this technique do not resemble to those seen in vivo (Hill et al. 1993 and 
1994; Bentin-Ley et al. 1994). Hill et a!. (1994) used a three dimensional cell culture 
model using human endometrial epithelial cells. They compared the morphological 
differences between endometrial epithelial cells cultured in monolayer and the cells 
cultured in the three dimensional model. The cells in monolayer culture dishes were flat 
in shape and had poor cellular membrane specializations such as microvilli and cilia, 
whereas the cells cultured in three dimensional system were polarized [they had 
prominent basement membrane, apical surface structures (microvilli and cilia) and lateral 
membrane specializations such as desmosomes and tight junctions], they were columnar 
in shape, and had organelle rich cytoplasm (Hill et al. 1994). 
In the present study, the effects of oestrogen and progesterone hormone 
supplementation on the structure of stromal cells were also determined in a three- 
dimensional culture model on tissue taken at 2 different stages of the menstrual cycle. 
Stromal cell morphology in culture seemed to be effected by oestrogen treatment at the 
secretory phase of the menstrual cycle, whereas no effect of oestrogen was seen at the 
proliferative phase. This appears contradictory to the situation in vivo where oestrogen 
causes the changes typical of the proliferative stage of the menstrual cycle while not 
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being present to a great extent in the secretory phase. Stromal cells taken from the 
secretory phase endometrium had hypertrophic cellular structures such as enlarged 
vacuoles and vesicles following oestrogen treatment. This result may indicate a hyper- 
oestrogenic effect, since the endometrial cells had already been primed by oestrogcn 
before the biopsies were taken and would not normally be exposed to such high levels of 
oestrogen at this stage. However, further studies using several different concentrations 
of hormone treatment on stromal cells and during several different stages of the cycle arc 
required to confirm this suggestion. While progesterone supplementation alone caused 
no changes in stromal cell morphology in vitro neither at the proliferative nor at the 
secretory stages, the combination of oestrogen and progesterone supplementation (at the 
same concentrations) caused a slight apparent increase in the number and the size of the 
cytoplasmic vacuoles and vesicles (so-called "secretory apparatus") of stromal cells 
cultured from the secretory phase endometria, suggesting an increased secretory activity 
in these cells. It may be suggested that the cells treated with combined steroid hormones 
(oestrogen + progesterone) had the appearance of stromal cells from later stages of the 
menstrual cycle in vivo than these treated with oestrogen alone. Yet again this is a novel 
culture method examining the effects of sex steroids on stromal cell morphology in a 
three-dimensional system, and more work is required for a complete understanding of 
this phenomenon. 
Hill et al. (1994) reported that endometrial epithelial cells in a three-dimensional 
culture system tended to have more rounded and euchromatic nuclei when treated with 
oestrogen than when unsupplemented. However, cells to which progesterone 
supplements had been added showed no dramatic differences compared to the 
unsupplemented cells, and the response of cells supplemented with both oestrogen and 
progesterone together did not show significant differences from those given 
progesterone alone (Hill et al. 1994). However, their study was on human cndometrial 
epithelial cells and the present study was on stromal cells. Therefore it is difficult to 
make direct comparisons between 2 cell types treated with steroids since they are of 
different origin, and also their response to steroid hormones are likely to be different. 
Irwin et al. (1989) grew human endometrial stromal cells in monolaycr culture dishes 
and reported that progesterone supplementation increased proliferation rates of stronial 
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cells and oestrogen and progesterone combined, further stimulated growth but oestrogen 
alone had no effect. In addition to the growth rate, they also examined the ultrastructure 
of cultured stromal cells after treatment with steroid hormones, and found extensively 
developed Golgi complexes, RER and well-developed prominent gap junctions in the 
well-developed cytoplasm. They also suggested that oestrogen + progesterone 
combined, caused stromal cells to resemble those described during decidualization In 
vivo. However, cells that Irwin et at. (1989) used for in vitro experiments were 
passaged and subcultured cells and steroid supplementation was made after 1 to 2 weeks 
in culture. Furthermore, monolayer cell culture is not the best method for ultrastructural 
observations since the cells have a flat appearance with poorly developed cytoplasmic 
organelles (Hill et al. 1994). In brief they do not resemble to those seen In vivo. 
On the other hand, in the present study, primary stromal-enriched cells were cultured 
6 days in a three-dimensional culture chamber, and the effects of oestrogen and 
progesterone on the ultrastructure of stromal cells were examined using these primary 
cell cultures. In the present study, any change seen in cellular ultrastructure is likely to 
be due to the effect of the hormonal treatment rather than the differentiation of the 
primary cells as an effect of long culturing period or due to the distortion of normal cell 
structure due to monolayer culture (as in the Irwin study). 
Holinka and Gurpide (1987) examined the proliferative potential of the human 
endometrial stroma in monolayer culture. They also compared the effects of different 
culture media and different hormone treatment regimes on the morphology of the stromal 
cells at the light microscope level. They found a great proliferative potential of stromal 
cells in serial subcultures, and further suggested distinct changes in morphology when the 
cells were exposed to progesterone. They also suggested that hormonal effects on 
morphology required a relatively long period of exposure (2 weeks) and that these 
morphologic changes were obtained in primary as well as secondary cultures. As 
discussed in the Irwin study, long culture period could affect the characteristics of the 
cell and so make it different from those seen in short term primary cultures. In addition, 
their study examined the stromal cell morphology only at the light microscope level using 
a phase-contrast microscope, and no ultrastructural observations were made. 
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In conclusion, the present study has established a novel three-dimensional culture 
system for human endometrial stromal cells in vitro which can be used as a model for In 
vivo experiments. Stromal cells in this culture model appeared very similar to those 
observed in vivo. In addition, an attempt was made to examine the effects of sex steroid 
hormone administration on the ultrastructure of the stromal cells in this culture model. 
While stromal cells from secretory endometria that were treated with oestrogen seemed 
to have a hypertrophic structure, progesterone alone had no effect on the ultrastructure 
of the stromal cells at either stages, whereas oestrogen + progesterone combination 
treatment on tissue taken from the secretory phase produced cells with a close 
resemblance to those observed in the human endometrial stroma in vivo. More studies 
are needed on this phenomenon for a complete understanding of the behaviour and 
structure of human endometrial stromal cells in vitro. 
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CHAPTER 7 
GENERAL DISCUSSION AND CONCLUSIONS 
7.1. GENERAL DISCUSSION 
The mechanisms of implantation and embedding of the embryo into the endomctrium 
under the influence of the ovarian steroid hormones is a highly complex phenomenum 
which involves hormonal interactions between several organs (the so-called 
`hypothalamo - pituitary - ovarian - endometrial axis"). The endomctrium is probably 
the most important part of the reproductive tract since it is the site for successful 
implantation and development of the embryo. While luminal and glandular epithelia play 
important roles in the apposition, adhesion and initial invasion of the blastocyst, it is the 
endometrial stroma which takes the main role in development of the decidual tissue and 
the blood vessels of the maternal placental tissue which arc likely to be crucial in 
maintaining a successful pregnancy. 
A total of five experiments have been reported in the present thesis, ranging from 
studies on the fertile and infertile human endometrial stroma In vivo to In vitro models of 
cndometrial tissue. Chapter 2 dealt with the morphological changes that occur in 
endometrial stroma (including blood vessels) of normally ovulating fertile women during 
the mid to late luteal phase of the menstrual cycle (which is the time that stromal cells 
differentiate and form decidual tissue). In later chapters, the effects of ovulation 
induction and ovulation enhancement treatments (clomipliene citrate and growth 
hormone) on the endometrial stromal and vascular structures of normal fertile women 
and of women with several fertility problems (Turner's syndrome and idiopathic POF) 
have been reported. In addition, quantitative stromal and vascular structural differences 
were evaluated between women with persistent unexplained recurrent miscarriage and 
women with previous history of unexplained recurrent miscarriages but a subsequent 
successful pregnancy in order to provide descriptive data on any possible "cndometrial 
factor" in this field of infertility, which is still unclear. 
Objective stereological methods were used on a wide range of features in order to 
determine the changes in endometrial stromal and vascular morphologies between fertile 
and infertile women, and also to determine the effects of several infertility treatments on 
these compartments. In the last chapter of the thesis, a novel three-dimensional In vitro 
culture model was established which can be used as a model for in vivo conditions and 
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the effects of steroid hormones on the morphology of the stromal cells grown in this 
culture system were investigated qualitatively at light and electron microscope levels. 
The 2nd chapter of the present thesis reported quantitatively and qualitatively the 
morphological changes that occur in stromal and vascular compartments of the normal 
fertile human endometrium during mid to late stages of the luteal phase. This part of the 
study was especially important since there is a lack of published information on the 
descriptive morphology of human endometrial stroma and blood vessels, and crucial 
events such as the differentiation of stromal cells (as occurs in decidualization) and 
changes in blood vessels that occur during this stage of a conception cycle. 
In humans, decidualization takes place during the post-implantation period of a 
conception cycle under the influence of progesterone. The stromal cells display a similar 
type of modification during a non-conceptional menstrual cycle at around LI1+7 which is 
called pseudo-decidualization, and these cells form the maternal decidual part of time 
developing placenta in case of a conception. Decidual cells are believed to play crucial 
roles in the later stages of implantation and in the maintenance of pregnancy through the 
control of trophoblast invasion (Pijnenborg et a!. 1980), nourishment of the blastocyst 
(Kearns and Lala 1983), endocrine (PRL) secretion (Maslar et al. 1980), and protection 
of the embryo from maternal immune rejection (Golander et a!. 1981). Despite these 
crucial functions, little is known about the morphological changes that take place in the 
differentiation process of stromal cells into decidual cells (sec earlier) and this remains an 
important area for further study. In the present study, stromal cells were evaluated 
regardles of whether they were pseudo-decidual cells or undifferentiated stromal cells. 
However, other cell types such as white blood cells and smooth muscle cells were 
excluded when the morphometrical measurements were performed. 
Qualitative light and electron microscopical examination of the cndometrial glandular 
epithelium throughout the luteal phase demonstrated large amounts of glycogen-like 
material in the subnuclear region of epithelial cells at day Lll+4 of the cycle in normal 
fertile cndometrium. At this time stromal cells also contained glycogen-like material. 
These observations could indicate that both compartments of the human cndometrium 
are well prepared for the support and nourishment of a possible - "to be implanted" 
embryo before the implantation process. These findings were also consistent with 
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previous studies on this subject which have shown that maximum subnuclear glycogen 
accumulation in glandular epithelial cells occurs around day L11+4 of the lutcal phase 
(Dockery et at. 1988a). However, there appears to be no published reports on the 
presence of glycogen-like material in human endometrial stromal cells throughout the 
luteal phase, and the present study appears to be the first one demonstrating this material 
in human endometrial stromal cells at the ultrastructural leveL 
The present study showed that stromal cells underwent dramatic changes throughout 
the luteal phase. Stromal cell nuclear profile minor axis and profile axial ratio along with 
the mean profile diameter steadily increased towards the end of the cycle, indicating a 
wider and therefore rounder stromal cell nuclear shape during this time of the cycle. 
Tliis, combined with the observation of an unchanged nucleus to stromal cell volume 
fraction suggested an increased cytoplasmic volume of the stromal cells in the late stages 
of the luteal phase. In addition, volume fractions of "secretory apparatus" to cell and 
RER to cell also increased towards the end of menstrual cycle. These quantitative 
observations were also consistent with the qualitative examination of the stromal cells 
during this time; stromal cell cytoplasm demonstrated increased amounts of organelles 
along with the presence of abundant collagen fibres in the extracellular matrix, indicating 
an increased activity of stromal cells around the time that decidualization process would 
take place. 
Endometrial vascular morphology differed during the times examined; while the 
volume fraction of nucleus to endothelial cell decreased, the volume fractions of all 
cytoplasmic organelles (mitochondria, "secretory apparatus", RER) to endothelial cell 
significantly increased towards the end of the menstrual cycle. In addition, the vascular 
basement membrane became dramatically thicker in the later lutcal phase than in early 
stages. The thickness of the blood vessel basement membrane is one feature which can 
affect diffusion between blood and surrounding tissue. Thus increased vascular basement 
membrane thickness towards the end of the cycle may indicate a decreased level of 
diffusion or transport through the endothelial tissue and the basement membrane at this 
time. Basement membranes are continuously eroded and renewed in a cyclical fashion 
(Wracko 1982), and it is either an increased rate of basement membrane renewal or a 
decreased rate of basement membrane erosion that caused the increase in blood vessel 
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basement membrane thickness towards the end of the menstrual cycle. The interaction 
between the production of ovarian steroids, the dynamics of the blood vessels of the 
functional layer, the permeability of the capillary endothelial cells and the development of 
oedema in the endometrial stroma are highly complex phenomena which are still 
incompletely understood. Therefore in the present thesis, the exact reason for these 
vascular changes that occurred towards the end of the luteal phase remains speculative. 
In conclusion, the present study established a full description of stromal and vascular 
morphology throughout the luteal phase of normal fertile women, and thus provides 
baseline data for future work on human endometrial morphology. 
The present thesis has reported the effects of an anti-oestrogenic drug (clomiphene 
citrate) on the endometrial stromal and vascular morphologies in normal fertile women. 
CC acts as an oestrogen antagonist in the hypothalamic site where it appears to block 
oestrogen receptors (Huppert 1979). It is used for induction of ovulation in anovulatory 
women via blockage of oestrogen receptors so causing a continuous secretion of 
gonadotrophins which eventually induce ovulation, and care must be taken to avoid 
hyperstimulation when using CC treatment. However, its' effects on the different 
compartments of the reproductive tract are unclear. Its' anti-oestrogenic action may 
cause adverse effects directly on the endometrium thereby reducing its' beneficial effects 
on ovulation. Most previous reports on the effects of CC on endometrial morphology 
have been performed in women being treated for infertility, and it is not possible to 
exclude any underlying pathology from their results. However, the present study 
examined the effects of CC on the endometrial stromal and blood vessel structures using 
the same group of women, which were of proven fertility so any effects seen in these 
endometrial compartments should be the result of CC treatment and not any underlying 
pathology. 
Results have shown that treatment with CC did not cause major changes in glandular 
and stromal features whereas blood vessels seemed to be slightly affected by the 
treatment. Although the exact reason for structural changes in blood vessels following 
CC treatment is unclear, some speculative suggestions could be made. Eicosanoids 
(including prostaglandins, leukotrines and related substances) are potent biological 
mediators which are produced by variety of tissues including those in the endometrium 
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and decidua (Shaw et al. 1994). These substances act as local hormones with a major 
influence on vasomotor tone, as mediators of vasoconstriction, vasodilatation and vessel 
permeability (Shaw et al. 1994). Prostaglandin (PG) dehydrogenase inactivates I'Gs by 
oxidising the 15-hydroxyl group, and thus plays a key role in controlling their effective 
local concentrations (Kelly et al. 1994). This enzyme is thought to be under the control 
of steroid hormones and is found in human endometrium at high levels in the secretory 
phase (Downie et al. 1974). It has been shown that the amount of PG dehydrogenase is 
increased during the secretory phase of the menstrual cycle following treatment with CC 
(Kelly et al. 1994). It could be speculated that slightly changed endometrial vascular 
morphology after CC treatment may be related to prostaglandin inactivation by CC in 
endometrium, which plays an important role in the permeability of the vessels, and has 
both vasoconstrictor and vasodilator functions. 
It may be concluded that CC has no adverse effect on normal human endometrium in 
terms of morphology. In addition, the present study also provided a full profile of 
normal fertile human endometrial structure under the influence of an anti-oestrogenic 
drug, and thus filled a gap in this field of fertility treatment. 
The fourth chapter of the present thesis has dealt with the effects of growth hormone 
treatment, with and without hormone replacement therapy, on endometrial stromal and 
vascular compartments in 2 groups of patients; those with Turner's syndrome and those 
with idiopathic premature ovarian failure (POF). These two groups were chosen since 
both had no ovarian function but the cause of this failure was very different in the 2 
groups. GH has been used for the treatment of children with hypopituitarism and short 
stature, and also has been used to treat patients with Turner's syndrome to improve final 
height achieved (Wilton 1987). More recently, Gil has been used to augment the 
response of the human ovary to stimulation by menopausal gonadotrophins (i lonmburg el 
al. 1990). It is likely that GH will be used more of en in the future for the treatment of 
infertility. A review of the literature on Gil action in the reproductive tract indicates that 
GIL along with gonadotrophins, the IGF system (with its ligands, receptors and binding 
proteins) and ovarian steroids have very complicated interactions and thus effects on the 
reproductive tract through the pituitary - ovarian - endometrial axis. However, despite 
its ovulation enhancing effect, the exact mechanism of Gil action in fertility treatment 
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remains unknown. Chapter 4 of the present thesis aimed to investigate the effects of GI I 
supplementation on human endometrial stromal and vascular morphologies in infertile 
women undergoing HRT and thereby throw some light on the mechanisms of GI I action. 
While there were no major changes in overall endometrial morphology between any 
of the untreated and GH treated infertile groups, features differed significantly between 
the fertile day LH+6 group and infertile groups with or without Gil treatment, 
suggesting an impairment in the development of endometrium especially in Tunner's 
syndrome patients. However, idiopathic POF individuals seemed to have more normal 
endometrial morphology and a better response to GH and HRT treatments than the 
Turner's syndrome group. GH administration has been reported to increase the cytosolic 
and nuclear oestrogen receptor concentrations in guinea-pig uterus (Bezecny et a!. 
1992). The present data strongly suggest that GH treatment may have substantial effects 
on the uterus, especially on the endometrium, as well as having influences on the 
ovulation enhancement in ovary. 
Miscarriage is defined as "the expulsion or extraction of an embryo or fetus, weighing 
500g or less, from its mother" (WHO 1977). In recurrent miscarriages, women manage 
to achieve pregnancy, but on 3 or more consecutive occasions loose the embryo before it 
is viable. Several reasons (including anatomical, genetic and immunological disorders) 
has been implicated for repeated pregnancy losses, however a large percentage of 
recurrent miscarriage cases still remain unexplained. The studies reported in the 5th 
chapter of the present thesis has been designed to determine if an "endometrial factor" 
exists in unexplained persistent pregnancy losses. Miscarriage is not a failure of 
implantation, but it is the rejection of an already implanted embryo. Therefore stromal 
and vascular compartments, rather than glandular and luminal epithelia, are likely to be 
major endometrial contributors for the rejection of an embryo. Taking this hypothesis as 
a starting point, the 5th chapter aimed to examine the endomctrial and vascular 
morphologies in two groups of women; the first group was recruited from women with 
persistent unexplained pregnancy losses, and the second group consisted of similar 
women with a history of previous recurrent miscarriages but at least one successful 
pregnancy. 
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Results demonstrated no morphological difTerences between successful and 
unsuccessful pregnancy groups in stromal and vascular structures, however the 
coefficients of variation of some features were higher in unsuccessful group whereas in 
some features they were higher in the successful pregnancy group. These results 
suggested the possible existence of subgroups within the groups. Both recurrent 
miscarriage groups differed significantly from the day LII+6 fertile group, indicating an 
abnormal endometrial development at the stromal and endothelial cell levels in these 
individuals. It is suggested that examination of these compartments at later stages of the 
menstrual cycle may be more appropriate since most morphological and physiological 
changes in the stroma take place when the placenta is developing in a conception cycle 
and which coincides with the period that rejection of an embryo from the endometrium 
often occurs. 
The precise cytological events that occur during interaction between embryo and 
endometrium are not entirely known, and direct in vivo microscopic studies of the 
structural changes that occur in human endometrial epithelium and stroma during 
implantation and gestation are virtually impossible to study in humans for ethical and 
technical reasons. In vivo animal experiments remain limited since the processes of 
implantation in animals is very different in detail from those in Man. A reliable and 
accurate in vitro model system is clearly required. Therefore the last chapter of present 
thesis was designed to establish a novel in vitro model system of human stromal cells and 
to use it to examine the effects of hormonal supplementation on the cultured cells and 
where possible to relate it to in vivo conditions reported in previous chapters. 
In the 6th chapter, immunocytochemical observations of human endometrial cells 
before and after the culturing process revealed that the cell isolation method used in this 
experiment provided a stroma-enriched cell suspension that contained abundant anti- 
vimentin positive cells. In addition, electron microscopical observations following the 
culture of this cell suspension in a 3-dimensional culture system on an artificial ECM 
showed stromal cells with a close resemblance to those seen ißt vivo. Furthermore, 
oestrogen supplementation of these cultures produced cells with degenerative cellular 
structures whereas progesterone alone caused no changes, and oestrogen + progesterone 
combined treatment caused increased secretory changes in cultured stromal cells. In 
conclusion, a successful stromal cell isolation technique and a 3-D culture technique 
were produced in this preliminary experiment which has established a starting point for 
the study of human endometrial stromal cells in in vitro conditions which arc very close 
to in vivo conditions. 
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The common theme of the present thesis was to evaluate the ovarian sex steroid hormone 
action in human endometrial stroma at the morphological level. While oestrogen is 
responsible for tissue proliferation throughout the proliferative phase, progesterone causes 
secretory changes in human endometrium during the luteal phase. In normally cycling fertile 
women, changing levels of oestrogen and progesterone throughout the menstrual cycle arc 
reflected by sequential changes in endometrial structure and function (Johannisson el al. 
1982,1987; Dockery and Rogers 1989), leading to the successful implantation of the 
blastocyst into a receptive endometrium. Therefore in the second chapter of the present 
thesis, extensive structural changes were made of the changes in stromal cells and blood 
vessels which occur in the normal human endometrium during the mid to late luteal phase 
(when progesterone is the dominant hormonal profile). These observations were consistent 
with, but an extension of previous reports (More et al. 1974a; Dockery et al. 1990). A 
significant correlation has been shown between plasma progesterone levels and the mean area 
of endometrial capillaries (Peek et al. 1992) further supporting the dependence of 
endometrial tissue on ovarian hormones. This also agreed with the findings of the present 
study. 
Decidualization is a crucial event that occurs in post-implantation human cndometrium. 
During this process stromal cells undergo extensive differentiation which is reflected by 
expression of new products (Huang et a!. 1987; Clemmons et a!. 1990; Tabanelli et al. 1992) 
and extensive morphological changes (Lawn et al. 1971; Tekelioglu-Uysal et al. 1975; 
Bijovsky and Abrahamson 1992). This differentiation process of endometrial stromal cells is 
under the control of progesterone, probably in concert with relaxin (Bryant-Greenwood 
1991) and growth factors (Irwin et a!. 1991). Biochemically, stromal cells at this stage of 
differentiation produce prolactin and ECM proteins (Maslar et a!. 1980), and express 
oestrogen and progesterone receptors (Leavitt and Takeda 1986) which provide the 
mechanism for these stromal cell functions. A similar differentiation process (pseudo. 
decidualization) also occurs in non-pregnant human endometrium in the late lutcal phase of 
the cycle (Flamigni et al. 1991). The time period examined in the present study coincides 
with the time that pseudo-decidualization occurs, therefore increased morphological profiles 
of human cndometrial stroma observed in the present study throughout this period may well 
indicate this differentiation process in non-conception cycle. 
The anti-oestrogenic drug (CC) treatment (often used clinically to induce ovulation) may 
cause structural changes in human endometrium via changes in the oestrogen receptor 
concentrations and actions in this compartment thereby causing a discrepancy between 
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ovulation (70%) and conception rates (30%) in women treated with CC (Wu 1984). Infertile 
women are not the best subjects to evaluate this effect because of their underlying 
pathologies, which may itself affect the influence of the drug treatment. There are two 
groups of reports dealing with the effects of CC treatment; the first group used infertile 
subjects and found adverse effects of CC treatment on oestrogen and progesterone receptor 
(ER and PR) concentrations (Koike et al. 1994) and endometrial structure (Benda 1992; 
Bonhoff et a!. 1993); the second group used fertile subjects and found no effect of CC on ER 
and PR concentrations (Hecht et a!. 1989) and endometrial morphology (Li et at. 1992). The 
present thesis also used normal fertile women to evaluate the effects of CC on human 
endometrial stromal and vascular morphologies and found no apparent e ect, being 
consistent with the second group of reports. 
A possible synergistic action of GH and steroid hormones for the enhancement of 
ovulation induction has been suggested (Homburg et al. 1988,1990). However, this 
synergistic mechanism of GH and oestrogen may also have direct effects on cndometrial 
structure and function. To examine this possibility, women with intact ovaries arc not the 
best subjects to use since GH may exhibit its effects via liypothalamo-pituitary-ovarian axis in 
women with functional ovaries. Therefore in the present study, two groups of women 
(Tuner's syndrome and idiopathic POF) with dysfunctional ovaries were used to eliminate 
the possibility of the indirect effect of GH and steroids via ovaries. Results of the present 
study showed no structural changes in these women either before or aller Gil treatment along 
with HRT. However, the Turner's syndrome group seemed to be poor responders to 
treatment, which also agreed with previous reports (Li et al. 199lb; Rogers el al. 1992). 
Unexplained recurrent miscarriage is that where all factors which can currently be 
diagnosed (such as chromosomal anomalies and immunological factors) have been excluded, 
leaving the endometrium as the likely `problem'. This may well be related to endocrine 
influences and it has been closely related to luteal phase defect by several authors (Tulppala e1 
al. 1991; Serie et al. 1994; Dalton et al. 1995). Serie et al. 1994 found retarded endomctrial 
development in women with recurrent miscarriage when compared to the control group. On 
the other hand, in the present study unchanged human endometrial morphology between 
successful and unsuccessful pregnancy groups were found. However, high coefficients of 
variance within groups indicated the existence of subgroups. Therefore more caution must be 
used for the definition of inclusion criteria into groups in the case of recurrent miscarriage. 
151b 
7.2. CONCLUSIONS 
The first aim of the present study was to establish baseline data on the morphology of 
fertile human endometrial stromal and vascular compartments during the mid to late 
luteal phase of the cycle. This was successfully done using objective morpliometry and 
appropriate staining methods. 
It has been reported that ovulation induction by CC has a success rate of 70%, 
whereas the pregnancy rate remains at about 30% (Wu 1984). This could be the result 
of an adverse effect of CC administration on endometrium, however the present study 
demonstrated that the CC treatment had no substantial effects on stromal morphology, 
and thus this is unlikely to be the cause of the discrepancy between ovulation and 
fertilization rates. 
The effects of GH treatment with or without HRT on human endometrial stroma and 
blood vessels were evaluated in two groups of sub-fertile women with non-functioning 
ovaries. The use of GH to enhance ovulation in infertile women is relatively new and its 
structural effects on the endometrium are relatively unknown. Results showed that GII 
treatment caused no substantial effects on endometrial structure in the experimental 
groups, although both of these groups were dramatically different from the day LII+6 
control endometrium. Of the 2 experimental groups studied, Turner's syndrome subjects 
showed no change either with or without HRT, women with idiopathic POF did respond 
to GH treatment in some ways. 
The present study was also designed to evaluate the endometrial stromal and vascular 
structural differences between persistent unexplained recurrent miscarriage subjects and a 
group with previous similar history of unexplained recurrent miscarriage, but at least one 
successful pregnancy. Results demonstrated no significant differences between groups at 
the level of endometrial stromal and blood vessel morphology, however high coefficient 
of variations indicated the existence of subgroups within groups, indicating that better 
diagnosis of this condition is required to improve experimental investigation into 
structural events. 
The last chapter of the present study aimed to establish an In vitro 3-dimensional 
culture model for human endometrial stromal cells and to evaluate the effects of sex 
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steroids on stromal cell in culture, both of these aims were successful and this model can 
be used for further in vitro studies. 
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FUTURE WORK 
Future research on this subject area could be seen along the following lines: 
Absolute volumes of human endometrial stroma, blood vessels and stromal and 
endothelial cell can be determined at different stages of the menstrual cycle using 
appropriate stereological methods such as volume weighted mean volume. This may be 
important since they can be used as reference points for calculations of absolute volumes 
of different cellular components including mitochondria, RER and "secretory apparatus". 
In the present study, the morphological evaluation of human cndomctrial stromal 
compartment in unexplained recurrent miscarriage patients suggested that the 
investigation of this compartment during later stages of the menstrual cycle and on well 
defined recurrent miscarriage subjects (to avoid the effects of different aetiologies within 
the groups) could be more appropriate. 
The effects of growth hormone treatment on human endometrial development must 
be examined using fertile human endometrial tissue, since the underlying pathologies of 
infertile subjects could affect the results of the experiment . To 
do this, the in vitro 3- 
dimensional cell culture system, that was successfully established in the present study, 
could be used as a model for human endometrium in vivo. 
Also the effects of ovulation induction regimes (such as the clomipliene citrate 
treatment) could be performed on cultured endomctrial cells in vitro, as could 
progesterone receptor blockade using, for example, RU 487. 
The effects of steroid hormone supplementation at several different dosages on 
stromal cell morphology could be examined using the 3-dimensional cell culture method. 
In addition, the influence of different drug treatments on human endonutrial stromal cells 
can also be investigated in vitro. 
The implantation procedure in humans is impossible to study in vivo, but further 
development of the 3-D culture system established in the present thesis, can be modified 
by growing endometrial epithelial cells on top of the stromal cells, and human embryos 
can be put on cells in culture. However, such studies may have ethical and practical 
difficulties, such as obtaining the human embryos, and such studies also require precise 
timing and planning as well as a good experimental design such as amount and 
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proportion of sex steroids, endometrial biopsy time, proportion of stromal and cpithclial 
cells in culture and so on. 
The decidualization process of the human cndometrial stromal cells in late lutcal 
phase of the cycle is still an unclear plienomcnon, and a new understanding of this subject 
can be established by using different amounts and proportions of ocstrogcn and 
progesterone hormone supplementations on stromal cells in the present culture model. 
The angiogenic process during the formation of placental tissues in pregnant human 
endometrium is another subject that more attention must be paid. To overcome the 
difficulties for in vivo human experiments, in vitro culture methods for blood vessel 
endothelial cells could be established. 
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APPENDICES 
APPENDIX 1 
FIXATION 
" PREPARATION OF 3% GLUTARALDEHYDE SOLUTION IN PHOSPHATE BUFFER 
Add 12 ml of 25% glutaraldehyde stock solution to 88 ml of 0.1M sodium phosphate bufFer 
(pH 7.4). 
" PREPARATION OF 0. IM SODIUM PHOSPHATE BUFFER 
1. Dissolve 3.56 grammes of Na2HPO4.2H20 in 100 ml of distilled water (solution A). 
2. Dissolve 3.12 grammes of NaIi2PO4.21120 in 100 ml of distilled water (solution u). 
3. Mix 36 ml of solution A with 14m1 of solution 13(0.2M phosphate buffer). 
Add 50 ml distilled water to the 0.2M phosphate buffer (0.1 M phosphate buffer ). 
LIGIIT MICROSCOPY 
" PREPARATION OF JB4 RESIN 
Catalysed J134 
-solution 
A: Dissolve 0.45 grammes of catalyst in 50 nil of J134 solution A 
and stir for 30 minutes at room temperature. 
Jß4 embedding solution: Mix 25 ml of catalysed JB4 solution A and I nil ofJB4 solution 13 
and use within 10-15 minutes. 
ELECTRON MICROSCOPY 
" PREPARATION OF EPON RESIN 
10.16 gm Agar 100 Resin(Agar, Essex, UK). 
7.50 gm MNA (Methyl Nadic Anhydride) (Agar, Essex, UK). 
6.25 gm DDSA (Dodeccnyl Succinic Anhydride) (Agar, Essex, UK). 
0.72 gm DDMA (n-Benzyldimetlhylaminc) (Agar, Essex, UK). 
" PREPARATION OF GELATINE METHENAMINE SILVER (GMS) SOLUTION 
1.50 ml of 3% aqueous methenamine. 
2. Add 5 ml of 5% aqueous silver nitrate, drop by drop with constant mixing. 
3. Make up the solution to 95 ml by adding 40 ml distilled water. 
4. Add 5-6 ml of 5% sodium tetraborate and mix. 
This solution must be made fresh just before use and kept in the dark. 
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APPENDIX 2 
" PREPARATION OF MATRIGEL COATED MILLICELL INSERTS 
Matrigel is stored at -20 °C and thawed at 4 °C. Procedure is carried out on a cold 
block to avoid setting too soon. 
1. Millicell inserts are removed from the packing and placed into the well. 
2. Approximately 50 ltl of Matrigel is placed in the insert ensuring that the bottom is 
totally covered with matrigel. 
3. Approximately 0.5 ml of cell suspension is added into the insert and the same amount of 
DMEM-F12 media is added around the insert. 
" PREPARATION OF DMEM-F12 CULTURING MEDIA 
All ingredients are collected together, all the bottle tops are loosen and all the bottle 
necks are flamed in order to prevent possible contamination. 
In a sterile bottle add: 
2.5 ml of Foetal Calf Serum (Imperial, UK) 
2.5 ml of Nu Serum 
1.0 ml of Streptomycin/Penicillin (Life Technologies, Paisley, Scotland) 
1.0 ml of L-glutamine (Life Technologies, Paisley, Scotland) 
3.0 ml of Sodium Bicarbonate (Life Technologies, Paisley, Scotland) 
2.0 ml of I IEPES 
88 ml of Dulbecco's Hams F12 media (Life Technologies, Paisley, Scotland) 
Final solution media is filtered through a Millipore filter into another sterile bottle. 
" PREPARATION OF THE SUBSTRATE-FAST RED COMPLEX FOR CYTOKERATIN 
AND VIMENTIN IMMUNOSTAINING 
2 mg Naphtol AS Phosphate 
0.2 ml Dimethylformamide 
9.8 ml 0.1 M Tris buffer (p118.2) 
10 Al 1M Levainisole 
10 mg Fast Red TR Salt 
Filter the final solution directly onto the slide. 
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APPENDIX 3 
" WORKED EXAMPLE OF VOLUME FRACTION CALCULATIONS 
Volume fraction measurements of endometrial glandular, stromal and vascular features 
were performed by counting the points of the related features on superimposed grid points 
(Weibel 1979). Following determination of total points that have fallen on the feature (e. g. 
stroma), this number is divided by total number of points that have fallen on the whole 
feature (e. g. endometrium). Mean value of each equation gives the volume fraction value of 
that feature (e. g. volume fraction of endometrium occupied by stroma). Example given 
below was taken from block number J792 (recurrent miscarriage individual) of the volume 
fraction measurements of glandular and stromal features at the light microscope level. 
Total number of points on Glands: 234 
Total number of points on Stroma: 513 
Total number ofpoint on Endometrium: 747 
" The volume fraction of endometrium occupied by glands: 234/747 0.313 
" The volume fraction of endometrium occupied by stroma: 513/747 0.687 
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APPENDIX 5 
" WORKED EXAMPLE OF ARITHMETIC MEAN BASEMENT MEMBRANE: 
THICKNESS MEASUREMENT (Ilirose et a!. 1982) 
An ordinary ruler is used to measure the orthogonal intercepts of the grid fallen on blood 
vessel basement membrane. Data were taken from Growth Hormone Group (J782). 
Qd= E length (mm) / number of observations 
Qa=492/ 137=3.591 mm 
Ta= Qa(3.591) x n/4 (0.79) x 106/magnification (25 164) = 112.08 nnm 
* To- Arithmetic mean thickness 
* fa- Mean arithmetic width of the blood vessel basement membrane 
* 7t/4 - Correction factor for arithmetic mean thickness estimation 
* 106- is used to convert the final value from millimetres to nanometers 
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APPENDIX 6: Sampling tree slowing the sampling steps used in for Vv csimatcs in the 
present experiment. The number of individuals per group differed for each set of 
experiment, and this information, along with the numbers of block, micrograph and fields 
used is given in the appropriate Materials and Methods section of each chapter. 
SUBJECTS 
BIOPSIES 
(One per Individual) 
BLOCKS (JB4) 
Light Microscopy 
(n=Z) 
SECTIONS 
(One per Block) 
FIELDS OF VIEW 
(10 from each section) 
BLOCKS (Epon) 
Electron Microscopy 
(n=3) 
SECTIONS 
(One randomly selected from each of 2 blocks) 
FIELDS OF VIEW 
(Stromal cells) 
(10 from each section) 
FIELDS OF VIEW 
(Blood vessels) 
(10 from each section) 
NUMBER OF TEST POINTS NUMBER OF TEST POINTS NUMBER OF TEST POINTS 
(49 per field of view) (450 per field of view) (300 per field of view) 
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